P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
1.098e-06 | -13.72 | neuromuscular junction | cellular component | GO:0031594 | 75 | 5 | 19108 | 47 |
FCHSD2,NLGN1,LAMA2,ERBB4,ANK3 |
5.922e-06 | -12.04 | intracellular ferritin complex | cellular component | GO:0008043 | 2 | 2 | 19108 | 47 |
FTL,FTH1 |
5.922e-06 | -12.04 | ferritin complex | cellular component | GO:0070288 | 2 | 2 | 19108 | 47 |
FTL,FTH1 |
8.014e-06 | -11.73 | FERRITIN_1 | prosite domains | PS00540 | 2 | 2 | 12186 | 35 |
FTL,FTH1 |
1.888e-05 | -10.88 | ITM2 | interpro domains | IPR040145 | 3 | 2 | 18521 | 47 |
ITM2A,ITM2B |
1.976e-05 | -10.83 | tissue regeneration | biological process | GO:0042246 | 65 | 4 | 18204 | 45 |
CD9,APOD,ERBB4,CD81 |
2.227e-05 | -10.71 | IGSF8 (immunoglobulin superfamily member 8) | protein interactions | 93185 | 228 | 6 | 19454 | 49 |
ITM2B,CD9,FTL,CD81,FTH1,RPL11 |
3.400e-05 | -10.29 | - | gene3d domains | 1.20.1260.10 | 4 | 2 | 14470 | 35 |
FTH1,FTL |
3.574e-05 | -10.24 | Ferritin | pfam domains | PF00210 | 4 | 2 | 17795 | 44 |
FTH1,FTL |
3.574e-05 | -10.24 | myoblast fusion involved in skeletal muscle regeneration | biological process | GO:0014905 | 4 | 2 | 18204 | 45 |
CD9,CD81 |
3.770e-05 | -10.19 | Ferritin_CS | interpro domains | IPR014034 | 4 | 2 | 18521 | 47 |
FTL,FTH1 |
3.770e-05 | -10.19 | Ferritin-like | interpro domains | IPR012347 | 4 | 2 | 18521 | 47 |
FTH1,FTL |
3.770e-05 | -10.19 | Ferritin | interpro domains | IPR001519 | 4 | 2 | 18521 | 47 |
FTL,FTH1 |
3.770e-05 | -10.19 | Ferritin_DPS_dom | interpro domains | IPR008331 | 4 | 2 | 18521 | 47 |
FTL,FTH1 |
3.770e-05 | -10.19 | Ferritin-like_diiron | interpro domains | IPR009040 | 4 | 2 | 18521 | 47 |
FTL,FTH1 |
3.894e-05 | -10.15 | regeneration | biological process | GO:0031099 | 155 | 5 | 18204 | 45 |
CD9,APOD,ERBB4,CD81,OMG |
4.791e-05 | -9.95 | FERRITIN_2 | prosite domains | PS00204 | 4 | 2 | 12186 | 35 |
FTL,FTH1 |
4.791e-05 | -9.95 | FERRITIN_LIKE | prosite domains | PS50905 | 4 | 2 | 12186 | 35 |
FTL,FTH1 |
4.818e-05 | -9.94 | neuron differentiation | biological process | GO:0030182 | 1081 | 11 | 18204 | 45 |
NLGN1,NRXN3,ANK3,LAMA2,APOD,IL1RAPL1,NKX6-2,CTNNA2,AUTS2,ERBB4,OMG |
6.768e-05 | -9.60 | neurogenesis | biological process | GO:0022008 | 1334 | 12 | 18204 | 45 |
OMG,NKX6-2,CTNNA2,ERBB4,AUTS2,IL1RAPL1,LAMA2,CD9,APOD,NRXN3,ANK3,NLGN1 |
8.907e-05 | -9.33 | intracellular sequestering of iron ion | biological process | GO:0006880 | 6 | 2 | 18204 | 45 |
FTH1,FTL |
8.981e-05 | -9.32 | generation of neurons | biological process | GO:0048699 | 1158 | 11 | 18204 | 45 |
AUTS2,ERBB4,CTNNA2,NKX6-2,OMG,ANK3,NRXN3,APOD,NLGN1,LAMA2,IL1RAPL1 |
1.245e-04 | -8.99 | sequestering of iron ion | biological process | GO:0097577 | 7 | 2 | 18204 | 45 |
FTH1,FTL |
1.313e-04 | -8.94 | Ferritin-like_SF | interpro domains | IPR009078 | 7 | 2 | 18521 | 47 |
FTH1,FTL |
1.497e-04 | -8.81 | nervous system development | biological process | GO:0007399 | 2185 | 15 | 18204 | 45 |
NRXN3,ITM2B,ANK3,NLGN1,OMG,PLLP,NKX6-2,CTNNA2,ERBB4,AUTS2,IL1RAPL1,MARCKSL1,LAMA2,CD9,APOD |
1.657e-04 | -8.71 | myotube differentiation involved in skeletal muscle regeneration | biological process | GO:0014908 | 8 | 2 | 18204 | 45 |
CD9,CD81 |
1.837e-04 | -8.60 | cell junction | cellular component | GO:0030054 | 2224 | 15 | 19108 | 47 |
IL1RAPL1,NLGN1,ANK3,B2M,CD81,OPALIN,CTNNA2,CADM2,ERBB4,NRXN3,LAMA2,LRRTM3,CD9,FCHSD2,RPL28 |
1.849e-04 | -8.60 | TRO (trophinin) | protein interactions | 7216 | 44 | 3 | 19454 | 49 |
RPL28,FTL,ERBB4 |
1.942e-04 | -8.55 | cell development | biological process | GO:0048468 | 2236 | 15 | 18204 | 45 |
NLGN1,B2M,ANK3,NRXN3,CD81,APOD,LAMA2,OMG,CAPN3,ITM2A,ERBB4,AUTS2,CTNNA2,NKX6-2,PDE5A |
2.000e-04 | -8.52 | NDUFB5 (NADH:ubiquinone oxidoreductase subunit B5) | protein interactions | 4711 | 115 | 4 | 19454 | 49 |
ITM2A,FTL,MARCKSL1,NDUFC2 |
2.083e-04 | -8.48 | BRICHOS | smart domains | SM01039 | 9 | 2 | 9717 | 24 |
ITM2B,ITM2A |
2.127e-04 | -8.46 | BRICHOS | pfam domains | PF04089 | 9 | 2 | 17795 | 44 |
ITM2B,ITM2A |
2.127e-04 | -8.46 | cyclooxygenase pathway | biological process | GO:0019371 | 9 | 2 | 18204 | 45 |
PTGDS,CBR1 |
2.127e-04 | -8.46 | presynaptic membrane assembly | biological process | GO:0097105 | 9 | 2 | 18204 | 45 |
IL1RAPL1,NLGN1 |
2.207e-04 | -8.42 | CSNK1G2 (casein kinase 1 gamma 2) | protein interactions | 1455 | 118 | 4 | 19454 | 49 |
OPALIN,PPP1R14A,DBNDD2,FTL |
2.244e-04 | -8.40 | BRICHOS_dom | interpro domains | IPR007084 | 9 | 2 | 18521 | 47 |
ITM2B,ITM2A |
2.262e-04 | -8.39 | membrane | cellular component | GO:0016020 | 9220 | 35 | 19108 | 47 |
RNASEK,CD9,FTL,CADM2,OPALIN,CTNNA2,PTGDS,ITM2B,ERBB4,EMC10,DAD1,IL1RAPL1,FCHSD2,LAMA2,LRRTM3,NRXN3,BCL2L14,RPL28,ITM2A,CAPN3,FTH1,PLXDC2,CD81,NDUFC2,TRIM59,MARCKSL1,ZFYVE16,PPP2R2B,CLDND1,B2M,OMG,NLGN1,RPL11,PLLP,ANK3 |
2.453e-04 | -8.31 | ferric iron binding | molecular function | GO:0008199 | 10 | 2 | 18094 | 43 |
FTL,FTH1 |
2.587e-04 | -8.26 | PTPRD (protein tyrosine phosphatase receptor type D) | protein interactions | 5789 | 123 | 4 | 19454 | 49 |
OPALIN,RPL28,IL1RAPL1,CLDND1 |
2.620e-04 | -8.25 | neuron projection development | biological process | GO:0031175 | 693 | 8 | 18204 | 45 |
LAMA2,NLGN1,APOD,NRXN3,ANK3,OMG,CTNNA2,AUTS2 |
2.655e-04 | -8.23 | presynaptic membrane organization | biological process | GO:0097090 | 10 | 2 | 18204 | 45 |
IL1RAPL1,NLGN1 |
2.761e-04 | -8.19 | CAPN5 (calpain 5) | protein interactions | 726 | 10 | 2 | 19454 | 49 |
CAPN3,CD81 |
2.849e-04 | -8.16 | BRICHOS | prosite domains | PS50869 | 9 | 2 | 12186 | 35 |
ITM2A,ITM2B |
2.866e-04 | -8.16 | iron ion transport | biological process | GO:0006826 | 52 | 3 | 18204 | 45 |
FTH1,FTL,B2M |
3.043e-04 | -8.10 | CCR2 (C-C motif chemokine receptor 2) | protein interactions | 729230 | 52 | 3 | 19454 | 49 |
CD81,EMC10,PLLP |
3.207e-04 | -8.05 | cell adhesion molecule binding | molecular function | GO:0050839 | 560 | 7 | 18094 | 43 |
ANK3,NLGN1,SPP1,CD81,CD9,NRXN3,CTNNA2 |
3.240e-04 | -8.03 | sequestering of metal ion | biological process | GO:0051238 | 11 | 2 | 18204 | 45 |
FTL,FTH1 |
3.290e-04 | -8.02 | GPR35 (G protein-coupled receptor 35) | protein interactions | 2859 | 131 | 4 | 19454 | 49 |
DAD1,PLLP,CD81,FTH1 |
4.093e-04 | -7.80 | Lipocalin_CS | interpro domains | IPR022272 | 12 | 2 | 18521 | 47 |
APOD,PTGDS |
4.179e-04 | -7.78 | anatomical structure development | biological process | GO:0048856 | 5207 | 24 | 18204 | 45 |
CD81,NRXN3,EMC10,B2M,OMG,CTNNA2,NKX6-2,PLLP,IL1RAPL1,MARCKSL1,SPP1,LAMA2,DAD1,ITM2B,ANK3,CBR1,NLGN1,CAPN3,PDE5A,ERBB4,ITM2A,AUTS2,CD9,APOD |
4.213e-04 | -7.77 | synaptic membrane | cellular component | GO:0097060 | 400 | 6 | 19108 | 47 |
LRRTM3,NRXN3,IL1RAPL1,NLGN1,ANK3,ERBB4 |
4.337e-04 | -7.74 | LIPOCALIN | prosite domains | PS00213 | 11 | 2 | 12186 | 35 |
PTGDS,APOD |
4.377e-04 | -7.73 | membrane assembly | biological process | GO:0071709 | 60 | 3 | 18204 | 45 |
IL1RAPL1,ANK3,NLGN1 |
4.664e-04 | -7.67 | LIPOCALIN | prints domains | PR00179 | 8 | 2 | 5227 | 22 |
APOD,PTGDS |
4.871e-04 | -7.63 | structural molecule activity | molecular function | GO:0005198 | 793 | 8 | 18094 | 43 |
CAPN3,RPL28,ANK3,CTNNA2,B2M,PLLP,LAMA2,RPL11 |
5.225e-04 | -7.56 | 4.1m | smart domains | SM00294 | 14 | 2 | 9717 | 24 |
NRXN3,CADM2 |
5.248e-04 | -7.55 | extracellular exosome | cellular component | GO:0070062 | 2175 | 14 | 19108 | 47 |
RPL11,MARCKSL1,B2M,FTH1,APOD,RNASE1,PTGDS,CD81,ITM2B,SPP1,FTL,CD9,RPL28,CBR1 |
5.535e-04 | -7.50 | axon development | biological process | GO:0061564 | 420 | 6 | 18204 | 45 |
APOD,LAMA2,ANK3,NRXN3,AUTS2,CTNNA2 |
5.539e-04 | -7.50 | positive regulation of synapse assembly | biological process | GO:0051965 | 65 | 3 | 18204 | 45 |
IL1RAPL1,LRRTM3,NLGN1 |
5.539e-04 | -7.50 | membrane biogenesis | biological process | GO:0044091 | 65 | 3 | 18204 | 45 |
NLGN1,IL1RAPL1,ANK3 |
5.604e-04 | -7.49 | Interactions of neurexins and neuroligins at synapses | REACTOME pathways | R-HSA-6794361 | 58 | 3 | 10285 | 29 |
LRRTM3,NRXN3,NLGN1 |
5.620e-04 | -7.48 | cell differentiation | biological process | GO:0030154 | 3645 | 19 | 18204 | 45 |
CD81,NRXN3,ANK3,CBR1,B2M,NLGN1,NKX6-2,PDE5A,CTNNA2,AUTS2,ERBB4,ITM2A,CAPN3,OMG,LAMA2,CD9,SPP1,APOD,IL1RAPL1 |
5.625e-04 | -7.48 | Neurexin-like | interpro domains | IPR003585 | 14 | 2 | 18521 | 47 |
NRXN3,CADM2 |
5.681e-04 | -7.47 | cellular developmental process | biological process | GO:0048869 | 3648 | 19 | 18204 | 45 |
ANK3,CBR1,NRXN3,CD81,NLGN1,B2M,ITM2A,ERBB4,AUTS2,CTNNA2,PDE5A,NKX6-2,OMG,CAPN3,APOD,LAMA2,SPP1,CD9,IL1RAPL1 |
6.046e-04 | -7.41 | postsynaptic membrane | cellular component | GO:0045211 | 280 | 5 | 19108 | 47 |
ANK3,ERBB4,LRRTM3,IL1RAPL1,NLGN1 |
6.092e-04 | -7.40 | autolysosome | cellular component | GO:0044754 | 15 | 2 | 19108 | 47 |
FTH1,FTL |
6.289e-04 | -7.37 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 15 | 16828 | 47 |
AUTS2,PLXDC2,RPL11,PPP2R2B,NRXN3,ANK3,ANKUB1,ERBB4,CBR1,PDE5A,ENO4,LAMA2,CADM2,CD81,NLGN1 |
6.289e-04 | -7.37 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 15 | 16828 | 47 |
LAMA2,CADM2,ENO4,NLGN1,CD81,PPP2R2B,PLXDC2,RPL11,AUTS2,PDE5A,CBR1,ANKUB1,NRXN3,ANK3,ERBB4 |
6.838e-04 | -7.29 | APOA1 (apolipoprotein A1) | protein interactions | 335 | 159 | 4 | 19454 | 49 |
CD81,APOD,PPP2R2B,SPP1 |
6.882e-04 | -7.28 | intracellular iron ion homeostasis | biological process | GO:0006879 | 70 | 3 | 18204 | 45 |
B2M,FTH1,FTL |
6.896e-04 | -7.28 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 15 | 16828 | 47 |
ENO4,CADM2,LAMA2,CD81,NLGN1,AUTS2,PLXDC2,RPL11,PPP2R2B,ERBB4,NRXN3,ANK3,ANKUB1,CBR1,PDE5A |
6.935e-04 | -7.27 | receptor-mediated endocytosis | biological process | GO:0006898 | 163 | 4 | 18204 | 45 |
CD9,FCHSD2,RNASEK,CD81 |
7.014e-04 | -7.26 | neuron cell-cell adhesion | biological process | GO:0007158 | 16 | 2 | 18204 | 45 |
NLGN1,NRXN3 |
7.301e-04 | -7.22 | ALCAM (activated leukocyte cell adhesion molecule) | protein interactions | 214 | 70 | 3 | 19454 | 49 |
CD9,CD81,APOD |
7.879e-04 | -7.15 | Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | REACTOME pathways | R-HSA-2162123 | 15 | 2 | 10285 | 29 |
PTGDS,CBR1 |
8.378e-04 | -7.08 | extracellular vesicle | cellular component | GO:1903561 | 2278 | 14 | 19108 | 47 |
MARCKSL1,B2M,RPL11,SPP1,FTL,CD9,RPL28,CBR1,FTH1,APOD,PTGDS,CD81,RNASE1,ITM2B |
8.415e-04 | -7.08 | extracellular organelle | cellular component | GO:0043230 | 2279 | 14 | 19108 | 47 |
B2M,MARCKSL1,RPL11,RPL28,CBR1,SPP1,CD9,FTL,ITM2B,APOD,FTH1,CD81,PTGDS,RNASE1 |
8.415e-04 | -7.08 | extracellular membrane-bounded organelle | cellular component | GO:0065010 | 2279 | 14 | 19108 | 47 |
APOD,FTH1,PTGDS,RNASE1,CD81,ITM2B,CD9,FTL,SPP1,CBR1,RPL28,RPL11,MARCKSL1,B2M |
8.508e-04 | -7.07 | regulation of nervous system development | biological process | GO:0051960 | 456 | 6 | 18204 | 45 |
NLGN1,B2M,SPP1,IL1RAPL1,NKX6-2,LRRTM3 |
9.105e-04 | -7.00 | protein localization to membrane | biological process | GO:0072657 | 462 | 6 | 18204 | 45 |
ANK3,CAPN3,CD81,EMC10,ERBB4,NLGN1 |
9.948e-04 | -6.91 | presynapse assembly | biological process | GO:0099054 | 19 | 2 | 18204 | 45 |
NLGN1,IL1RAPL1 |
9.948e-04 | -6.91 | regulation of circadian sleep/wake cycle | biological process | GO:0042749 | 19 | 2 | 18204 | 45 |
NLGN1,PTGDS |
9.948e-04 | -6.91 | negative regulation of amyloid precursor protein biosynthetic process | biological process | GO:0042985 | 19 | 2 | 18204 | 45 |
ITM2B,ITM2A |
1.034e-03 | -6.87 | OXTR (oxytocin receptor) | protein interactions | 5021 | 19 | 2 | 19454 | 49 |
EMC10,CD81 |
1.034e-03 | -6.87 | NLGN1 (neuroligin 1) | protein interactions | 22871 | 19 | 2 | 19454 | 49 |
NRXN3,NLGN1 |
1.034e-03 | -6.87 | HBEGF (heparin binding EGF like growth factor) | protein interactions | 1839 | 19 | 2 | 19454 | 49 |
ERBB4,CD9 |
1.055e-03 | -6.85 | Protein-protein interactions at synapses | REACTOME pathways | R-HSA-6794362 | 72 | 3 | 10285 | 29 |
NRXN3,NLGN1,LRRTM3 |
1.084e-03 | -6.83 | neuron development | biological process | GO:0048666 | 859 | 8 | 18204 | 45 |
NRXN3,ANK3,OMG,CTNNA2,LAMA2,NLGN1,APOD,AUTS2 |
1.111e-03 | -6.80 | cellular response to metal ion | biological process | GO:0071248 | 185 | 4 | 18204 | 45 |
ANK3,CAPN3,NLGN1,B2M |
1.182e-03 | -6.74 | neuron projection morphogenesis | biological process | GO:0048812 | 486 | 6 | 18204 | 45 |
ANK3,NRXN3,AUTS2,NLGN1,LAMA2,CTNNA2 |
1.218e-03 | -6.71 | prostaglandin biosynthetic process | biological process | GO:0001516 | 21 | 2 | 18204 | 45 |
CBR1,PTGDS |
1.218e-03 | -6.71 | prostanoid biosynthetic process | biological process | GO:0046457 | 21 | 2 | 18204 | 45 |
CBR1,PTGDS |
1.231e-03 | -6.70 | amyloid-beta binding | molecular function | GO:0001540 | 89 | 3 | 18094 | 43 |
ITM2A,NLGN1,ITM2B |
1.246e-03 | -6.69 | plasma membrane bounded cell projection morphogenesis | biological process | GO:0120039 | 491 | 6 | 18204 | 45 |
NLGN1,AUTS2,CTNNA2,LAMA2,ANK3,NRXN3 |
1.252e-03 | -6.68 | neuron projection | cellular component | GO:0043005 | 1331 | 10 | 19108 | 47 |
LAMA2,FCHSD2,RPL28,APOD,IL1RAPL1,CTNNA2,CADM2,NLGN1,ANK3,AUTS2 |
1.266e-03 | -6.67 | TTLL4 (tubulin tyrosine ligase like 4) | protein interactions | 9654 | 21 | 2 | 19454 | 49 |
FTL,ANK3 |
1.266e-03 | -6.67 | HHV8GK18_gp83 (K14) | protein interactions | 4961465 | 21 | 2 | 19454 | 49 |
ITM2B,EMC10 |
1.284e-03 | -6.66 | Tetraspanin_CS | interpro domains | IPR018503 | 21 | 2 | 18521 | 47 |
CD81,CD9 |
1.312e-03 | -6.64 | cell projection morphogenesis | biological process | GO:0048858 | 496 | 6 | 18204 | 45 |
CTNNA2,LAMA2,NLGN1,AUTS2,NRXN3,ANK3 |
1.326e-03 | -6.63 | synaptic cleft | cellular component | GO:0043083 | 22 | 2 | 19108 | 47 |
LAMA2,NLGN1 |
1.450e-03 | -6.54 | secondary lysosome | cellular component | GO:0005767 | 23 | 2 | 19108 | 47 |
FTH1,FTL |
1.520e-03 | -6.49 | MC4R (melanocortin 4 receptor) | protein interactions | 4160 | 23 | 2 | 19454 | 49 |
PLLP,CD81 |
1.559e-03 | -6.46 | Scavenging by Class A Receptors | REACTOME pathways | R-HSA-3000480 | 21 | 2 | 10285 | 29 |
FTL,FTH1 |
1.626e-03 | -6.42 | TM4_1 | prosite domains | PS00421 | 21 | 2 | 12186 | 35 |
CD81,CD9 |
1.656e-03 | -6.40 | NRXN3 (neurexin 3) | protein interactions | 9369 | 24 | 2 | 19454 | 49 |
NLGN1,LRRTM3 |
1.667e-03 | -6.40 | transition metal ion transport | biological process | GO:0000041 | 95 | 3 | 18204 | 45 |
B2M,FTL,FTH1 |
1.729e-03 | -6.36 | negative regulation of glycoprotein biosynthetic process | biological process | GO:0010561 | 25 | 2 | 18204 | 45 |
ITM2B,ITM2A |
1.729e-03 | -6.36 | presynapse organization | biological process | GO:0099172 | 25 | 2 | 18204 | 45 |
NLGN1,IL1RAPL1 |
1.729e-03 | -6.36 | ferrous iron binding | molecular function | GO:0008198 | 26 | 2 | 18094 | 43 |
FTL,FTH1 |
1.797e-03 | -6.32 | ZDHHC21 (zinc finger DHHC-type palmitoyltransferase 21) | protein interactions | 340481 | 25 | 2 | 19454 | 49 |
TRIM59,RNASEK |
1.817e-03 | -6.31 | developmental process | biological process | GO:0032502 | 5716 | 24 | 18204 | 45 |
ITM2B,ANK3,CBR1,NLGN1,PDE5A,ITM2A,ERBB4,AUTS2,CAPN3,CD9,APOD,CD81,NRXN3,B2M,EMC10,PLLP,NKX6-2,CTNNA2,OMG,SPP1,LAMA2,DAD1,IL1RAPL1,MARCKSL1 |
1.822e-03 | -6.31 | maintenance of location in cell | biological process | GO:0051651 | 98 | 3 | 18204 | 45 |
FTL,ANK3,FTH1 |
1.865e-03 | -6.28 | MHC class II protein complex binding | molecular function | GO:0023026 | 27 | 2 | 18094 | 43 |
CD81,B2M |
1.870e-03 | -6.28 | positive regulation of T cell cytokine production | biological process | GO:0002726 | 26 | 2 | 18204 | 45 |
B2M,CD81 |
1.870e-03 | -6.28 | regulation of amyloid precursor protein biosynthetic process | biological process | GO:0042984 | 26 | 2 | 18204 | 45 |
ITM2B,ITM2A |
1.875e-03 | -6.28 | human chr3q11.2|3q12.1 | chromosome location | human chr3q11.2|3q12.1 | 1 | 1 | 26134 | 49 |
CLDND1 |
1.875e-03 | -6.28 | human chr14q24.3-q31.1 | chromosome location | human chr14q24.3-q31.1 | 1 | 1 | 26134 | 49 |
NRXN3 |
1.875e-03 | -6.28 | human chrXp21.3-p21.2 | chromosome location | human chrXp21.3-p21.2 | 1 | 1 | 26134 | 49 |
IL1RAPL1 |
1.897e-03 | -6.27 | cellular response to inorganic substance | biological process | GO:0071241 | 214 | 4 | 18204 | 45 |
B2M,NLGN1,CAPN3,ANK3 |
1.931e-03 | -6.25 | CD53 (CD53 molecule) | protein interactions | 963 | 98 | 3 | 19454 | 49 |
CD9,CD81,APOD |
1.951e-03 | -6.24 | cell adhesion | biological process | GO:0007155 | 942 | 8 | 18204 | 45 |
CD9,SPP1,NLGN1,IL1RAPL1,CADM2,CTNNA2,NRXN3,OMG |
1.979e-03 | -6.23 | extracellular region | cellular component | GO:0005576 | 4350 | 20 | 19108 | 47 |
FTH1,APOD,RNASE1,CD81,PTGDS,ITM2B,ERBB4,EMC10,CD9,FTL,LRRTM3,LAMA2,SPP1,CBR1,RPL28,NLGN1,RPL11,MARCKSL1,CNDP1,B2M |
1.996e-03 | -6.22 | regulation of cell junction assembly | biological process | GO:1901888 | 217 | 4 | 18204 | 45 |
IL1RAPL1,LRRTM3,NLGN1,APOD |
2.018e-03 | -6.21 | axonogenesis | biological process | GO:0007409 | 366 | 5 | 18204 | 45 |
ANK3,NRXN3,AUTS2,LAMA2,CTNNA2 |
2.089e-03 | -6.17 | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | COSMIC cancer mutations | central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype | 653 | 7 | 16828 | 47 |
NRXN3,ERBB4,IL1RAPL1,PLLP,NLGN1,AUTS2,PLXDC2 |
2.095e-03 | -6.17 | SLC22A1 (solute carrier family 22 member 1) | protein interactions | 6580 | 27 | 2 | 19454 | 49 |
SPP1,CD9 |
2.095e-03 | -6.17 | RBP4 (retinol binding protein 4) | protein interactions | 5950 | 27 | 2 | 19454 | 49 |
FTH1,MARCKSL1 |
2.095e-03 | -6.17 | CD19 (CD19 molecule) | protein interactions | 930 | 27 | 2 | 19454 | 49 |
CD9,CD81 |
2.104e-03 | -6.16 | ZCCHC17 (zinc finger CCHC-type containing 17) | protein interactions | 51538 | 101 | 3 | 19454 | 49 |
FTL,RPL28,RPL11 |
2.107e-03 | -6.16 | SHH_subtype | COSMIC cancer mutations | SHH_subtype | 654 | 7 | 16828 | 47 |
ERBB4,NRXN3,IL1RAPL1,PLLP,NLGN1,AUTS2,PLXDC2 |
2.168e-03 | -6.13 | negative regulation of glycoprotein metabolic process | biological process | GO:1903019 | 28 | 2 | 18204 | 45 |
ITM2B,ITM2A |
2.195e-03 | -6.12 | localization within membrane | biological process | GO:0051668 | 549 | 6 | 18204 | 45 |
ERBB4,ANK3,CAPN3,CD81,NLGN1,EMC10 |
2.244e-03 | -6.10 | positive regulation of multicellular organismal process | biological process | GO:0051240 | 1691 | 11 | 18204 | 45 |
PDE5A,NKX6-2,ERBB4,CAPN3,CD81,LRRTM3,B2M,SPP1,NLGN1,EMC10,IL1RAPL1 |
2.281e-03 | -6.08 | MAP1LC3B (microtubule associated protein 1 light chain 3 beta) | protein interactions | 81631 | 541 | 6 | 19454 | 49 |
RPL28,ANK3,FTH1,B2M,FTL,RPL11 |
2.284e-03 | -6.08 | Tetraspanin_animals | interpro domains | IPR000301 | 28 | 2 | 18521 | 47 |
CD9,CD81 |
2.325e-03 | -6.06 | myoblast fusion | biological process | GO:0007520 | 29 | 2 | 18204 | 45 |
CD81,CD9 |
2.376e-03 | -6.04 | ligase regulator activity | molecular function | GO:0055103 | 1 | 1 | 18094 | 43 |
CAPN3 |
2.376e-03 | -6.04 | 15-hydroxyprostaglandin dehydrogenase (NADP+) activity | molecular function | GO:0047021 | 1 | 1 | 18094 | 43 |
CBR1 |
2.376e-03 | -6.04 | prostaglandin-E2 9-reductase activity | molecular function | GO:0050221 | 1 | 1 | 18094 | 43 |
CBR1 |
2.416e-03 | -6.03 | TTBK1 (tau tubulin kinase 1) | protein interactions | 84630 | 29 | 2 | 19454 | 49 |
ANK3,RPL11 |
2.416e-03 | -6.03 | LRRTM4 (leucine rich repeat transmembrane neuronal 4) | protein interactions | 80059 | 29 | 2 | 19454 | 49 |
LRRTM3,NRXN3 |
2.419e-03 | -6.02 | - | gene3d domains | 6.10.250.880 | 1 | 1 | 14470 | 35 |
ERBB4 |
2.419e-03 | -6.02 | - | gene3d domains | 3.30.1440.10 | 1 | 1 | 14470 | 35 |
RPL11 |
2.470e-03 | -6.00 | OSTEO | smart domains | SM00017 | 1 | 1 | 9717 | 24 |
SPP1 |
2.472e-03 | -6.00 | neurexin clustering involved in presynaptic membrane assembly | biological process | GO:0097115 | 1 | 1 | 18204 | 45 |
NLGN1 |
2.472e-03 | -6.00 | macrophage fusion | biological process | GO:0034238 | 1 | 1 | 18204 | 45 |
CD81 |
2.472e-03 | -6.00 | negative regulation of lipoprotein oxidation | biological process | GO:0034443 | 1 | 1 | 18204 | 45 |
APOD |
2.472e-03 | -6.00 | CD4-positive, alpha-beta T cell costimulation | biological process | GO:0035783 | 1 | 1 | 18204 | 45 |
CD81 |
2.472e-03 | -6.00 | cell-cell adhesion involved in synapse maturation | biological process | GO:0090125 | 1 | 1 | 18204 | 45 |
NLGN1 |
2.472e-03 | -6.00 | positive regulation of adaptive immune memory response | biological process | GO:1905676 | 1 | 1 | 18204 | 45 |
CD81 |
2.472e-03 | -6.00 | negative regulation of collateral sprouting of intact axon in response to injury | biological process | GO:0048685 | 1 | 1 | 18204 | 45 |
SPP1 |
2.472e-03 | -6.00 | calcium-dependent self proteolysis | biological process | GO:1990092 | 1 | 1 | 18204 | 45 |
CAPN3 |
2.472e-03 | -6.00 | cellular response to iron(III) ion | biological process | GO:0071283 | 1 | 1 | 18204 | 45 |
B2M |
2.472e-03 | -6.00 | cytoskeletal matrix organization at active zone | biological process | GO:0048789 | 1 | 1 | 18204 | 45 |
NLGN1 |
2.472e-03 | -6.00 | positive regulation of membrane depolarization during cardiac muscle cell action potential | biological process | GO:1900827 | 1 | 1 | 18204 | 45 |
ANK3 |
2.472e-03 | -6.00 | negative regulation of lipoprotein lipid oxidation | biological process | GO:0060588 | 1 | 1 | 18204 | 45 |
APOD |
2.472e-03 | -6.00 | regulation of collateral sprouting of intact axon in response to injury | biological process | GO:0048683 | 1 | 1 | 18204 | 45 |
SPP1 |
2.473e-03 | -6.00 | Ribosomal_L5 | pfam domains | PF00281 | 1 | 1 | 17795 | 44 |
RPL11 |
2.473e-03 | -6.00 | Ribosomal_L5_C | pfam domains | PF00673 | 1 | 1 | 17795 | 44 |
RPL11 |
2.473e-03 | -6.00 | Lipocalin_2 | pfam domains | PF08212 | 1 | 1 | 17795 | 44 |
APOD |
2.473e-03 | -6.00 | ECM10 | pfam domains | PF21203 | 1 | 1 | 17795 | 44 |
EMC10 |
2.473e-03 | -6.00 | DAD | pfam domains | PF02109 | 1 | 1 | 17795 | 44 |
DAD1 |
2.473e-03 | -6.00 | Osteopontin | pfam domains | PF00865 | 1 | 1 | 17795 | 44 |
SPP1 |
2.473e-03 | -6.00 | Calpain_u2 | pfam domains | PF16648 | 1 | 1 | 17795 | 44 |
CAPN3 |
2.487e-03 | -6.00 | regulation of Arp2/3 complex-mediated actin nucleation | biological process | GO:0034315 | 30 | 2 | 18204 | 45 |
CTNNA2,FCHSD2 |
2.487e-03 | -6.00 | neuron projection regeneration | biological process | GO:0031102 | 30 | 2 | 18204 | 45 |
APOD,OMG |
2.495e-03 | -5.99 | ECSIT (ECSIT signaling integrator) | protein interactions | 51295 | 226 | 4 | 19454 | 49 |
NDUFC2,APOD,TRIM59,PPP2R2B |
2.519e-03 | -5.98 | Rnf128 (ring finger protein 128) | protein interactions | 66889 | 1 | 1 | 19454 | 49 |
CD81 |
2.519e-03 | -5.98 | DAG1 (dystroglycan 1) | protein interactions | 281439 | 1 | 1 | 19454 | 49 |
LAMA2 |
2.519e-03 | -5.98 | CAPN14 (calpain 14) | protein interactions | 440854 | 1 | 1 | 19454 | 49 |
CAPN3 |
2.529e-03 | -5.98 | Tetraspanin | gene3d domains | 1.10.1450.10 | 31 | 2 | 14470 | 35 |
CD81,CD9 |
2.533e-03 | -5.98 | positive regulation of cell junction assembly | biological process | GO:1901890 | 110 | 3 | 18204 | 45 |
NLGN1,IL1RAPL1,LRRTM3 |
2.538e-03 | -5.98 | RNase_K | interpro domains | IPR026770 | 1 | 1 | 18521 | 47 |
RNASEK |
2.538e-03 | -5.98 | ANKUB1 | interpro domains | IPR042788 | 1 | 1 | 18521 | 47 |
ANKUB1 |
2.538e-03 | -5.98 | Osteopontin_CS | interpro domains | IPR019841 | 1 | 1 | 18521 | 47 |
SPP1 |
2.538e-03 | -5.98 | Ribosomal_uL5_C | interpro domains | IPR031309 | 1 | 1 | 18521 | 47 |
RPL11 |
2.538e-03 | -5.98 | CLDN1 | interpro domains | IPR042356 | 1 | 1 | 18521 | 47 |
CLDND1 |
2.538e-03 | -5.98 | DAD/Ost2 | interpro domains | IPR003038 | 1 | 1 | 18521 | 47 |
DAD1 |
2.538e-03 | -5.98 | Opalin | interpro domains | IPR026609 | 1 | 1 | 18521 | 47 |
OPALIN |
2.538e-03 | -5.98 | Ribosomal_uL5_dom_sf | interpro domains | IPR022803 | 1 | 1 | 18521 | 47 |
RPL11 |
2.538e-03 | -5.98 | B2Microglobulin | interpro domains | IPR015707 | 1 | 1 | 18521 | 47 |
B2M |
2.538e-03 | -5.98 | FCHSD2_F-BAR_dom | interpro domains | IPR034934 | 1 | 1 | 18521 | 47 |
FCHSD2 |
2.538e-03 | -5.98 | ApolipopD | interpro domains | IPR002969 | 1 | 1 | 18521 | 47 |
APOD |
2.538e-03 | -5.98 | Ank3_Death | interpro domains | IPR037971 | 1 | 1 | 18521 | 47 |
ANK3 |
2.538e-03 | -5.98 | Ribosomal_uL5_N | interpro domains | IPR031310 | 1 | 1 | 18521 | 47 |
RPL11 |
2.538e-03 | -5.98 | Ribosomal_uL5 | interpro domains | IPR002132 | 1 | 1 | 18521 | 47 |
RPL11 |
2.538e-03 | -5.98 | Ribosomal_uL5_CS | interpro domains | IPR020929 | 1 | 1 | 18521 | 47 |
RPL11 |
2.538e-03 | -5.98 | Osteopontin | interpro domains | IPR002038 | 1 | 1 | 18521 | 47 |
SPP1 |
2.538e-03 | -5.98 | DD_ENO4 | interpro domains | IPR047500 | 1 | 1 | 18521 | 47 |
ENO4 |
2.538e-03 | -5.98 | FCHSD2_SH3_2 | interpro domains | IPR035556 | 1 | 1 | 18521 | 47 |
FCHSD2 |
2.538e-03 | -5.98 | CAPN3_PEF | interpro domains | IPR029531 | 1 | 1 | 18521 | 47 |
CAPN3 |
2.538e-03 | -5.98 | CD9_LEL | interpro domains | IPR042055 | 1 | 1 | 18521 | 47 |
CD9 |
2.538e-03 | -5.98 | ApoD_vertbrte | interpro domains | IPR026222 | 1 | 1 | 18521 | 47 |
APOD |
2.538e-03 | -5.98 | Ribosomal_eL28 | interpro domains | IPR002672 | 1 | 1 | 18521 | 47 |
RPL28 |
2.546e-03 | -5.97 | DRD2 (dopamine receptor D2) | protein interactions | 1813 | 108 | 3 | 19454 | 49 |
SPP1,PLLP,CLDND1 |
2.584e-03 | -5.96 | HTR2B (5-hydroxytryptamine receptor 2B) | protein interactions | 3357 | 30 | 2 | 19454 | 49 |
PLLP,CBR1 |
2.584e-03 | -5.96 | RANGRF (RAN guanine nucleotide release factor) | protein interactions | 29098 | 30 | 2 | 19454 | 49 |
PLXDC2,B2M |
2.640e-03 | -5.94 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | 1523 | 11 | 16828 | 47 |
NLGN1,CD9,CADM2,LAMA2,ERBB4,NRXN3,ANK3,PDE5A,ITM2A,PLXDC2,PPP2R2B |
2.640e-03 | -5.94 | acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | acute_myeloid_leukaemia_therapy_related | 1523 | 11 | 16828 | 47 |
CADM2,PPP2R2B,LAMA2,ITM2A,PLXDC2,CD9,NLGN1,PDE5A,ERBB4,ANK3,NRXN3 |
2.668e-03 | -5.93 | synapse | cellular component | GO:0045202 | 1473 | 10 | 19108 | 47 |
CADM2,NLGN1,IL1RAPL1,ERBB4,ANK3,FCHSD2,LRRTM3,LAMA2,NRXN3,RPL28 |
2.797e-03 | -5.88 | Lipocln_cytosolic_FA-bd_dom | interpro domains | IPR000566 | 31 | 2 | 18521 | 47 |
APOD,PTGDS |
2.797e-03 | -5.88 | Tetraspanin_EC2_sf | interpro domains | IPR008952 | 31 | 2 | 18521 | 47 |
CD81,CD9 |
2.840e-03 | -5.86 | cytosolic ribosome | cellular component | GO:0022626 | 115 | 3 | 19108 | 47 |
RPL28,APOD,RPL11 |
2.857e-03 | -5.86 | regulation of multicellular organismal development | biological process | GO:2000026 | 1484 | 10 | 18204 | 45 |
NKX6-2,ERBB4,LRRTM3,CAPN3,LAMA2,SPP1,B2M,NLGN1,IL1RAPL1,EMC10 |
2.872e-03 | -5.85 | OSTEOPONTIN | prosite domains | PS00884 | 1 | 1 | 12186 | 35 |
SPP1 |
2.872e-03 | -5.85 | RIBOSOMAL_L5 | prosite domains | PS00358 | 1 | 1 | 12186 | 35 |
RPL11 |
3.005e-03 | -5.81 | Tetraspanin | pfam domains | PF00335 | 33 | 2 | 17795 | 44 |
CD81,CD9 |
3.016e-03 | -5.80 | regulation of synapse assembly | biological process | GO:0051963 | 117 | 3 | 18204 | 45 |
IL1RAPL1,LRRTM3,NLGN1 |
3.056e-03 | -5.79 | negative regulation of cell population proliferation | biological process | GO:0008285 | 791 | 7 | 18204 | 45 |
FTH1,PTGDS,PDE5A,B2M,CD9,ERBB4,APOD |
3.081e-03 | -5.78 | PRKCA (protein kinase C alpha) | protein interactions | 5578 | 395 | 5 | 19454 | 49 |
FTH1,PPP1R14A,CD9,SPP1,OPALIN |
3.090e-03 | -5.78 | synapse assembly | biological process | GO:0007416 | 118 | 3 | 18204 | 45 |
ERBB4,NLGN1,IL1RAPL1 |
3.117e-03 | -5.77 | GLP1R (glucagon like peptide 1 receptor) | protein interactions | 2740 | 116 | 3 | 19454 | 49 |
DAD1,CD81,FTL |
3.140e-03 | -5.76 | regulation of synapse organization | biological process | GO:0050807 | 246 | 4 | 18204 | 45 |
LRRTM3,IL1RAPL1,NLGN1,CTNNA2 |
3.165e-03 | -5.76 | Tetraspanin/Peripherin | interpro domains | IPR018499 | 33 | 2 | 18521 | 47 |
CD9,CD81 |
3.188e-03 | -5.75 | skeletal muscle tissue regeneration | biological process | GO:0043403 | 34 | 2 | 18204 | 45 |
CD9,CD81 |
3.221e-03 | -5.74 | peptide binding | molecular function | GO:0042277 | 258 | 4 | 18094 | 43 |
B2M,ITM2A,ITM2B,NLGN1 |
3.271e-03 | -5.72 | DDR1 (discoidin domain receptor tyrosine kinase 1) | protein interactions | 780 | 118 | 3 | 19454 | 49 |
OPALIN,ITM2A,CLDND1 |
3.355e-03 | -5.70 | endoplasmic reticulum protein-containing complex | cellular component | GO:0140534 | 122 | 3 | 19108 | 47 |
EMC10,B2M,DAD1 |
3.376e-03 | -5.69 | regulation of presynapse organization | biological process | GO:0099174 | 35 | 2 | 18204 | 45 |
IL1RAPL1,LRRTM3 |
3.376e-03 | -5.69 | regulation of presynapse assembly | biological process | GO:1905606 | 35 | 2 | 18204 | 45 |
LRRTM3,IL1RAPL1 |
3.401e-03 | -5.68 | - | gene3d domains | 2.40.128.20 | 36 | 2 | 14470 | 35 |
PTGDS,APOD |
3.416e-03 | -5.68 | regulation of cell adhesion | biological process | GO:0030155 | 807 | 7 | 18204 | 45 |
APOD,B2M,LAMA2,CD9,ANK3,CD81,PDE5A |
3.423e-03 | -5.68 | regulation of synapse structure or activity | biological process | GO:0050803 | 252 | 4 | 18204 | 45 |
IL1RAPL1,LRRTM3,CTNNA2,NLGN1 |
3.430e-03 | -5.68 | ITGA5 (integrin subunit alpha 5) | protein interactions | 3678 | 120 | 3 | 19454 | 49 |
CD9,CD81,SPP1 |
3.485e-03 | -5.66 | MHC protein complex binding | molecular function | GO:0023023 | 37 | 2 | 18094 | 43 |
B2M,CD81 |
3.507e-03 | -5.65 | ZNF724 (zinc finger protein 724) | protein interactions | 440519 | 35 | 2 | 19454 | 49 |
RPL28,RPL11 |
3.532e-03 | -5.65 | chondroblastoma | COSMIC cancer mutations | chondroblastoma | 534 | 6 | 16828 | 47 |
NLGN1,ANK3,NRXN3,LAMA2,PPP2R2B,CD9 |
3.568e-03 | -5.64 | syncytium formation by plasma membrane fusion | biological process | GO:0000768 | 36 | 2 | 18204 | 45 |
CD81,CD9 |
3.568e-03 | -5.64 | regulation of homotypic cell-cell adhesion | biological process | GO:0034110 | 36 | 2 | 18204 | 45 |
ANK3,CD9 |
3.568e-03 | -5.64 | cell-cell fusion | biological process | GO:0140253 | 36 | 2 | 18204 | 45 |
CD9,CD81 |
3.569e-03 | -5.64 | Laminin_G_2 | pfam domains | PF02210 | 36 | 2 | 17795 | 44 |
NRXN3,LAMA2 |
3.593e-03 | -5.63 | postsynaptic specialization membrane | cellular component | GO:0099634 | 125 | 3 | 19108 | 47 |
LRRTM3,NLGN1,ERBB4 |
3.676e-03 | -5.61 | VKORC1 (vitamin K epoxide reductase complex subunit 1) | protein interactions | 79001 | 123 | 3 | 19454 | 49 |
CD9,FTL,CD81 |
3.707e-03 | -5.60 | SDR16C5 (short chain dehydrogenase/reductase family 16C member 5) | protein interactions | 195814 | 36 | 2 | 19454 | 49 |
FTH1,PPP2R2B |
3.759e-03 | -5.58 | Calycin | interpro domains | IPR012674 | 36 | 2 | 18521 | 47 |
PTGDS,APOD |
3.766e-03 | -5.58 | response to lipoprotein particle | biological process | GO:0055094 | 37 | 2 | 18204 | 45 |
CD81,CD9 |
3.766e-03 | -5.58 | cellular response to low-density lipoprotein particle stimulus | biological process | GO:0071404 | 37 | 2 | 18204 | 45 |
CD9,CD81 |
3.800e-03 | -5.57 | negative regulation of neuron projection development | biological process | GO:0010977 | 127 | 3 | 18204 | 45 |
NLGN1,SPP1,B2M |
3.802e-03 | -5.57 | growth | biological process | GO:0040007 | 424 | 5 | 18204 | 45 |
CD81,ERBB4,AUTS2,APOD,CD9 |
3.802e-03 | -5.57 | developmental growth | biological process | GO:0048589 | 424 | 5 | 18204 | 45 |
CD81,CD9,ERBB4,APOD,AUTS2 |
3.885e-03 | -5.55 | myelination | biological process | GO:0042552 | 128 | 3 | 18204 | 45 |
NKX6-2,PLLP,CD9 |
3.913e-03 | -5.54 | CD46 (CD46 molecule) | protein interactions | 4179 | 37 | 2 | 19454 | 49 |
CD9,CD81 |
3.947e-03 | -5.53 | dendrite | cellular component | GO:0030425 | 620 | 6 | 19108 | 47 |
LAMA2,RPL28,IL1RAPL1,APOD,NLGN1,ANK3 |
3.970e-03 | -5.53 | unsaturated fatty acid biosynthetic process | biological process | GO:0006636 | 38 | 2 | 18204 | 45 |
CBR1,PTGDS |
3.970e-03 | -5.53 | regulation of T cell cytokine production | biological process | GO:0002724 | 38 | 2 | 18204 | 45 |
CD81,B2M |
4.009e-03 | -5.52 | dendritic tree | cellular component | GO:0097447 | 622 | 6 | 19108 | 47 |
RPL28,LAMA2,ANK3,NLGN1,APOD,IL1RAPL1 |
4.057e-03 | -5.51 | ensheathment of neurons | biological process | GO:0007272 | 130 | 3 | 18204 | 45 |
PLLP,NKX6-2,CD9 |
4.057e-03 | -5.51 | axon ensheathment | biological process | GO:0008366 | 130 | 3 | 18204 | 45 |
CD9,PLLP,NKX6-2 |
4.063e-03 | -5.51 | phosphatidylinositol-3,4,5-trisphosphate binding | molecular function | GO:0005547 | 40 | 2 | 18094 | 43 |
ZFYVE16,FCHSD2 |
4.111e-03 | -5.49 | RPF1 (ribosome production factor 1 homolog) | protein interactions | 80135 | 128 | 3 | 19454 | 49 |
FTL,RPL28,RPL11 |
4.123e-03 | -5.49 | PIGM (phosphatidylinositol glycan anchor biosynthesis class M) | protein interactions | 93183 | 38 | 2 | 19454 | 49 |
CNDP1,OPALIN |
4.178e-03 | -5.48 | regulation of actin nucleation | biological process | GO:0051125 | 39 | 2 | 18204 | 45 |
FCHSD2,CTNNA2 |
4.178e-03 | -5.48 | syncytium formation | biological process | GO:0006949 | 39 | 2 | 18204 | 45 |
CD81,CD9 |
4.209e-03 | -5.47 | APODVERTBRTE | prints domains | PR02058 | 1 | 1 | 5227 | 22 |
APOD |
4.209e-03 | -5.47 | APOLIPOPROTD | prints domains | PR01219 | 1 | 1 | 5227 | 22 |
APOD |
4.209e-03 | -5.47 | OSTEOPONTIN | prints domains | PR00216 | 1 | 1 | 5227 | 22 |
SPP1 |
4.234e-03 | -5.46 | negative regulation of neurogenesis | biological process | GO:0050768 | 132 | 3 | 18204 | 45 |
SPP1,NKX6-2,B2M |
4.247e-03 | -5.46 | somatodendritic compartment | cellular component | GO:0036477 | 842 | 7 | 19108 | 47 |
CADM2,NLGN1,IL1RAPL1,APOD,ANK3,LAMA2,RPL28 |
4.272e-03 | -5.46 | multicellular organism development | biological process | GO:0007275 | 3957 | 18 | 18204 | 45 |
ITM2B,NRXN3,ANK3,EMC10,NLGN1,OMG,PLLP,NKX6-2,CTNNA2,AUTS2,ERBB4,IL1RAPL1,MARCKSL1,LAMA2,SPP1,CD9,APOD,DAD1 |
4.307e-03 | -5.45 | LamG | smart domains | SM00282 | 40 | 2 | 9717 | 24 |
LAMA2,NRXN3 |
4.339e-03 | -5.44 | ZNF354A (zinc finger protein 354A) | protein interactions | 6940 | 39 | 2 | 19454 | 49 |
RPL28,RPL11 |
4.350e-03 | -5.44 | GPX8 (glutathione peroxidase 8 (putative)) | protein interactions | 493869 | 264 | 4 | 19454 | 49 |
APOD,CLDND1,CD81,PLLP |
4.391e-03 | -5.43 | cellular response to lipoprotein particle stimulus | biological process | GO:0071402 | 40 | 2 | 18204 | 45 |
CD9,CD81 |
4.391e-03 | -5.43 | prostaglandin metabolic process | biological process | GO:0006693 | 40 | 2 | 18204 | 45 |
CBR1,PTGDS |
4.493e-03 | -5.41 | LAM_G_DOMAIN | prosite domains | PS50025 | 35 | 2 | 12186 | 35 |
NRXN3,LAMA2 |
4.561e-03 | -5.39 | CTNNBIP1 (catenin beta interacting protein 1) | protein interactions | 56998 | 40 | 2 | 19454 | 49 |
CTNNA2,PPP2R2B |
4.577e-03 | -5.39 | cell morphogenesis involved in neuron differentiation | biological process | GO:0048667 | 443 | 5 | 18204 | 45 |
AUTS2,CTNNA2,LAMA2,ANK3,NRXN3 |
4.577e-03 | -5.39 | regulation of neuron projection development | biological process | GO:0010975 | 443 | 5 | 18204 | 45 |
IL1RAPL1,NLGN1,B2M,CTNNA2,SPP1 |
4.608e-03 | -5.38 | prostanoid metabolic process | biological process | GO:0006692 | 41 | 2 | 18204 | 45 |
CBR1,PTGDS |
4.747e-03 | -5.35 | iron ion sequestering activity | molecular function | GO:0140315 | 2 | 1 | 18094 | 43 |
FTH1 |
4.747e-03 | -5.35 | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | molecular function | GO:0047020 | 2 | 1 | 18094 | 43 |
CBR1 |
4.770e-03 | -5.35 | BMP4 (bone morphogenetic protein 4) | protein interactions | 652 | 135 | 3 | 19454 | 49 |
RPL11,APOD,RPL28 |
4.793e-03 | -5.34 | negative regulation of nervous system development | biological process | GO:0051961 | 138 | 3 | 18204 | 45 |
SPP1,B2M,NKX6-2 |
4.818e-03 | -5.34 | postsynapse | cellular component | GO:0098794 | 646 | 6 | 19108 | 47 |
ANK3,ERBB4,IL1RAPL1,NLGN1,LAMA2,LRRTM3 |
4.832e-03 | -5.33 | - | gene3d domains | 3.30.500.40 | 2 | 1 | 14470 | 35 |
ZFYVE16 |
4.832e-03 | -5.33 | - | gene3d domains | 3.30.390.110 | 2 | 1 | 14470 | 35 |
RPL28 |
4.832e-03 | -5.33 | Vinculin, Vh2 four-helix bundle | gene3d domains | 1.20.120.810 | 2 | 1 | 14470 | 35 |
CTNNA2 |
4.832e-03 | -5.33 | Domain of unknown function (DUF3480), N-terminal subdomain | gene3d domains | 3.30.1360.220 | 2 | 1 | 14470 | 35 |
ZFYVE16 |
4.853e-03 | -5.33 | Laminin_G | interpro domains | IPR001791 | 41 | 2 | 18521 | 47 |
NRXN3,LAMA2 |
4.913e-03 | -5.32 | stereocilium shaft | cellular component | GO:0120043 | 2 | 1 | 19108 | 47 |
FCHSD2 |
4.934e-03 | -5.31 | DUF3480 | smart domains | SM01421 | 2 | 1 | 9717 | 24 |
ZFYVE16 |
4.938e-03 | -5.31 | regulation of ferrous iron binding | biological process | GO:1904432 | 2 | 1 | 18204 | 45 |
B2M |
4.938e-03 | -5.31 | positive regulation of ferrous iron binding | biological process | GO:1904434 | 2 | 1 | 18204 | 45 |
B2M |
4.938e-03 | -5.31 | maintenance of protein location in membrane | biological process | GO:0072658 | 2 | 1 | 18204 | 45 |
ANK3 |
4.938e-03 | -5.31 | positive regulation of oocyte development | biological process | GO:0060282 | 2 | 1 | 18204 | 45 |
PDE5A |
4.938e-03 | -5.31 | establishment of planar polarity involved in nephron morphogenesis | biological process | GO:0072046 | 2 | 1 | 18204 | 45 |
ERBB4 |
4.938e-03 | -5.31 | regulation of transferrin receptor binding | biological process | GO:1904435 | 2 | 1 | 18204 | 45 |
B2M |
4.938e-03 | -5.31 | positive regulation of satellite cell activation involved in skeletal muscle regeneration | biological process | GO:0014718 | 2 | 1 | 18204 | 45 |
CAPN3 |
4.938e-03 | -5.31 | regulation of lipoprotein oxidation | biological process | GO:0034442 | 2 | 1 | 18204 | 45 |
APOD |
4.938e-03 | -5.31 | negative regulation of smooth muscle cell-matrix adhesion | biological process | GO:2000098 | 2 | 1 | 18204 | 45 |
APOD |
4.938e-03 | -5.31 | regulation of neuromuscular synaptic transmission | biological process | GO:1900073 | 2 | 1 | 18204 | 45 |
NLGN1 |
4.938e-03 | -5.31 | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent | biological process | GO:0002481 | 2 | 1 | 18204 | 45 |
B2M |
4.938e-03 | -5.31 | positive regulation of estradiol secretion | biological process | GO:2000866 | 2 | 1 | 18204 | 45 |
SPP1 |
4.938e-03 | -5.31 | positive regulation of transferrin receptor binding | biological process | GO:1904437 | 2 | 1 | 18204 | 45 |
B2M |
4.938e-03 | -5.31 | maintenance of protein location in plasma membrane | biological process | GO:0072660 | 2 | 1 | 18204 | 45 |
ANK3 |
4.938e-03 | -5.31 | positive regulation of neuromuscular synaptic transmission | biological process | GO:1900075 | 2 | 1 | 18204 | 45 |
NLGN1 |
4.938e-03 | -5.31 | regulation of lipoprotein lipid oxidation | biological process | GO:0060587 | 2 | 1 | 18204 | 45 |
APOD |
4.939e-03 | -5.31 | Ribosomal_L28e | pfam domains | PF01778 | 2 | 1 | 17795 | 44 |
RPL28 |
4.939e-03 | -5.31 | MARCKS | pfam domains | PF02063 | 2 | 1 | 17795 | 44 |
MARCKSL1 |
4.939e-03 | -5.31 | SARA_C | pfam domains | PF11979 | 2 | 1 | 17795 | 44 |
ZFYVE16 |
4.939e-03 | -5.31 | NDUF_C2 | pfam domains | PF06374 | 2 | 1 | 17795 | 44 |
NDUFC2 |
5.031e-03 | -5.29 | CSM1 (Csm1p) | protein interactions | 850447 | 2 | 1 | 19454 | 49 |
DBNDD2 |
5.031e-03 | -5.29 | FCRL1 (Fc receptor like 1) | protein interactions | 115350 | 2 | 1 | 19454 | 49 |
APOD |
5.031e-03 | -5.29 | MDM2 (MDM2 proto-oncogene) | protein interactions | 100125959 | 2 | 1 | 19454 | 49 |
RPL11 |
5.031e-03 | -5.29 | cdh11.S (cadherin 11 S homeolog) | protein interactions | 100337621 | 2 | 1 | 19454 | 49 |
ERBB4 |
5.031e-03 | -5.29 | cki1 (serine/threonine protein kinase Cki1) | protein interactions | 2539610 | 2 | 1 | 19454 | 49 |
PPP1R14A |
5.069e-03 | -5.28 | PLXDC | interpro domains | IPR031152 | 2 | 1 | 18521 | 47 |
PLXDC2 |
5.069e-03 | -5.28 | SARA/endofin | interpro domains | IPR035438 | 2 | 1 | 18521 | 47 |
ZFYVE16 |
5.069e-03 | -5.28 | CNDP/DUG1 | interpro domains | IPR017153 | 2 | 1 | 18521 | 47 |
CNDP1 |
5.069e-03 | -5.28 | Lipocalin_ApoD | interpro domains | IPR022271 | 2 | 1 | 18521 | 47 |
APOD |
5.069e-03 | -5.28 | MARCKS | interpro domains | IPR002101 | 2 | 1 | 18521 | 47 |
MARCKSL1 |
5.069e-03 | -5.28 | CBR1-like | interpro domains | IPR045313 | 2 | 1 | 18521 | 47 |
CBR1 |
5.069e-03 | -5.28 | NDUC2 | interpro domains | IPR009423 | 2 | 1 | 18521 | 47 |
NDUFC2 |
5.069e-03 | -5.28 | SARA-like_C | interpro domains | IPR022557 | 2 | 1 | 18521 | 47 |
ZFYVE16 |
5.069e-03 | -5.28 | FCHSD_SH3_1 | interpro domains | IPR035460 | 2 | 1 | 18521 | 47 |
FCHSD2 |
5.069e-03 | -5.28 | Ribosomal_eL28/Mak16 | interpro domains | IPR029004 | 2 | 1 | 18521 | 47 |
RPL28 |
5.131e-03 | -5.27 | sarcolemma | cellular component | GO:0042383 | 142 | 3 | 19108 | 47 |
ANK3,CAPN3,LAMA2 |
5.167e-03 | -5.27 | cerebellum | COSMIC cancer mutations | cerebellum | 769 | 7 | 16828 | 47 |
ERBB4,NRXN3,NLGN1,IL1RAPL1,PLLP,AUTS2,PLXDC2 |
5.254e-03 | -5.25 | TMEM230 (transmembrane protein 230) | protein interactions | 29058 | 43 | 2 | 19454 | 49 |
ERBB4,RPL28 |
5.254e-03 | -5.25 | IL1RN (interleukin 1 receptor antagonist) | protein interactions | 3557 | 43 | 2 | 19454 | 49 |
PPP2R2B,FTH1 |
5.292e-03 | -5.24 | receptor localization to synapse | biological process | GO:0097120 | 44 | 2 | 18204 | 45 |
NLGN1,ERBB4 |
5.292e-03 | -5.24 | regulation of mononuclear cell migration | biological process | GO:0071675 | 143 | 3 | 18204 | 45 |
CD9,APOD,CD81 |
5.294e-03 | -5.24 | cell junction assembly | biological process | GO:0034329 | 285 | 4 | 18204 | 45 |
IL1RAPL1,CD9,NLGN1,ERBB4 |
5.359e-03 | -5.23 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | 981 | 8 | 16828 | 47 |
ANK3,NRXN3,NLGN1,OMG,AUTS2,PLXDC2,LAMA2,CADM2 |
5.377e-03 | -5.23 | skin-hand-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-hand-carcinoma-squamous_cell_carcinoma | 407 | 5 | 16828 | 47 |
ERBB4,LAMA2,NLGN1,ZNF565,CADM2 |
5.382e-03 | -5.22 | FKBP7 (FKBP prolyl isomerase 7) | protein interactions | 51661 | 141 | 3 | 19454 | 49 |
CD81,APOD,PLLP |
5.489e-03 | -5.21 | PPAN-P2RY11 (PPAN-P2RY11 readthrough) | protein interactions | 692312 | 142 | 3 | 19454 | 49 |
RPL11,FTL,RPL28 |
5.529e-03 | -5.20 | regulation of macrophage migration | biological process | GO:1905521 | 45 | 2 | 18204 | 45 |
CD81,CD9 |
5.667e-03 | -5.17 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 6 | 18204 | 45 |
IL1RAPL1,NLGN1,AUTS2,CTNNA2,B2M,SPP1 |
5.736e-03 | -5.16 | MARCKS_1 | prosite domains | PS00826 | 2 | 1 | 12186 | 35 |
MARCKSL1 |
5.736e-03 | -5.16 | MARCKS_2 | prosite domains | PS00827 | 2 | 1 | 12186 | 35 |
MARCKSL1 |
5.742e-03 | -5.16 | NCOA4 (nuclear receptor coactivator 4) | protein interactions | 8031 | 45 | 2 | 19454 | 49 |
FTL,FTH1 |
5.742e-03 | -5.16 | ZNF518A (zinc finger protein 518A) | protein interactions | 9849 | 45 | 2 | 19454 | 49 |
FTL,CBR1 |
5.754e-03 | -5.16 | Salicylic Acid Action Pathway | SMPDB pathways | SMP0000709 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Tolmetin Action Pathway | SMPDB pathways | SMP0000704 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Piroxicam Action Pathway | SMPDB pathways | SMP0000077 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Valdecoxib Action Pathway | SMPDB pathways | SMP0000116 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Nepafenac Action Pathway | SMPDB pathways | SMP0000702 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Suprofen Action Pathway | SMPDB pathways | SMP0000101 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Ketoprofen Action Pathway | SMPDB pathways | SMP0000085 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Mefenamic Acid Action Pathway | SMPDB pathways | SMP0000109 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Magnesium Salicylate Action Pathway | SMPDB pathways | SMP0000698 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Bromfenac Action Pathway | SMPDB pathways | SMP0000102 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Phenylbutazone Action Pathway | SMPDB pathways | SMP0000701 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Flurbiprofen Action Pathway | SMPDB pathways | SMP0000697 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Trisalicylate-Choline Action Pathway | SMPDB pathways | SMP0000703 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Sulindac Action Pathway | SMPDB pathways | SMP0000094 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Tiaprofenic Acid Action Pathway | SMPDB pathways | SMP0000705 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Acetylsalicylic Acid Action Pathway | SMPDB pathways | SMP0000083 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Etodolac Action Pathway | SMPDB pathways | SMP0000084 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Fenoprofen Action Pathway | SMPDB pathways | SMP0000696 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Diclofenac Action Pathway | SMPDB pathways | SMP0000093 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Lornoxicam Action Pathway | SMPDB pathways | SMP0000700 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Ketorolac Action Pathway | SMPDB pathways | SMP0000098 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Tenoxicam Action Pathway | SMPDB pathways | SMP0000706 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Arachidonic Acid Metabolism | SMPDB pathways | SMP0000075 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Nabumetone Action Pathway | SMPDB pathways | SMP0000114 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Meloxicam Action Pathway | SMPDB pathways | SMP0000106 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Oxaprozin Action Pathway | SMPDB pathways | SMP0000113 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Etoricoxib Action Pathway | SMPDB pathways | SMP0000695 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Rofecoxib Action Pathway | SMPDB pathways | SMP0000087 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Leukotriene C4 Synthesis Deficiency | SMPDB pathways | SMP0000353 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Diflunisal Action Pathway | SMPDB pathways | SMP0000289 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Acetaminophen Action Pathway | SMPDB pathways | SMP0000710 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Salicylate-Sodium Action Pathway | SMPDB pathways | SMP0000708 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Salsalate Action Pathway | SMPDB pathways | SMP0000707 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Antrafenine Action Pathway | SMPDB pathways | SMP0000693 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Naproxen Action Pathway | SMPDB pathways | SMP0000120 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Lumiracoxib Action Pathway | SMPDB pathways | SMP0000699 | 28 | 2 | 1369 | 6 |
CBR1,PTGDS |
5.754e-03 | -5.16 | Carprofen Action Pathway | SMPDB pathways | SMP0000694 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.754e-03 | -5.16 | Antipyrine Action Pathway | SMPDB pathways | SMP0000692 | 28 | 2 | 1369 | 6 |
PTGDS,CBR1 |
5.771e-03 | -5.15 | regulation of oligodendrocyte differentiation | biological process | GO:0048713 | 46 | 2 | 18204 | 45 |
NKX6-2,OPALIN |
5.772e-03 | -5.15 | LRR_1 | pfam domains | PF00560 | 46 | 2 | 17795 | 44 |
LRRTM3,OMG |
5.816e-03 | -5.15 | BCL2L13 (BCL2 like 13) | protein interactions | 23786 | 145 | 3 | 19454 | 49 |
APOD,PLLP,BCL2L14 |
5.994e-03 | -5.12 | MYO3B (myosin IIIB) | protein interactions | 140469 | 46 | 2 | 19454 | 49 |
OPALIN,APOD |
5.994e-03 | -5.12 | ZNF865 (zinc finger protein 865) | protein interactions | 100507290 | 46 | 2 | 19454 | 49 |
FTL,RPL28 |
6.019e-03 | -5.11 | Ank_4 | pfam domains | PF13637 | 47 | 2 | 17795 | 44 |
ANK3,ANKUB1 |
6.041e-03 | -5.11 | PIP5K1A (phosphatidylinositol-4-phosphate 5-kinase type 1 alpha) | protein interactions | 8394 | 147 | 3 | 19454 | 49 |
NRXN3,PLXDC2,FTL |
6.044e-03 | -5.11 | positive regulation of nervous system development | biological process | GO:0051962 | 296 | 4 | 18204 | 45 |
IL1RAPL1,LRRTM3,NKX6-2,NLGN1 |
6.058e-03 | -5.11 | positive regulation of developmental process | biological process | GO:0051094 | 1385 | 9 | 18204 | 45 |
LAMA2,NLGN1,EMC10,IL1RAPL1,PDE5A,NKX6-2,ERBB4,CAPN3,LRRTM3 |
6.083e-03 | -5.10 | endomembrane system | cellular component | GO:0012505 | 4764 | 20 | 19108 | 47 |
ANK3,DAD1,NLGN1,B2M,ZFYVE16,TRIM59,EMC10,NDUFC2,ITM2B,PTGDS,FTH1,OPALIN,APOD,ITM2A,BCL2L14,SPP1,FTL,FCHSD2,CD9,RNASEK |
6.093e-03 | -5.10 | regulation of multicellular organismal process | biological process | GO:0051239 | 3113 | 15 | 18204 | 45 |
LRRTM3,CD81,NLGN1,B2M,PTGDS,EMC10,ERBB4,NKX6-2,PDE5A,CAPN3,APOD,LAMA2,SPP1,CD9,IL1RAPL1 |
6.163e-03 | -5.09 | anchoring junction | cellular component | GO:0070161 | 902 | 7 | 19108 | 47 |
ANK3,CD81,OPALIN,CTNNA2,B2M,FCHSD2,CD9 |
6.168e-03 | -5.09 | Indomethacin Action Pathway | SMPDB pathways | SMP0000104 | 29 | 2 | 1369 | 6 |
PTGDS,CBR1 |
6.243e-03 | -5.08 | integrin binding | molecular function | GO:0005178 | 158 | 3 | 18094 | 43 |
CD9,CD81,SPP1 |
6.250e-03 | -5.08 | MYOC (myocilin) | protein interactions | 4653 | 47 | 2 | 19454 | 49 |
CD81,FTL |
6.270e-03 | -5.07 | icosanoid biosynthetic process | biological process | GO:0046456 | 48 | 2 | 18204 | 45 |
PTGDS,CBR1 |
6.286e-03 | -5.07 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | molecular function | GO:0016655 | 50 | 2 | 18094 | 43 |
NDUFC2,CBR1 |
6.393e-03 | -5.05 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 6 | 18204 | 45 |
IL1RAPL1,CTNNA2,B2M,SPP1,NLGN1,AUTS2 |
6.453e-03 | -5.04 | Binding and Uptake of Ligands by Scavenger Receptors | REACTOME pathways | R-HSA-2173782 | 43 | 2 | 10285 | 29 |
FTL,FTH1 |
6.468e-03 | -5.04 | anatomical structure morphogenesis | biological process | GO:0009653 | 2225 | 12 | 18204 | 45 |
LAMA2,CD9,APOD,CTNNA2,AUTS2,ERBB4,CAPN3,NLGN1,EMC10,CD81,NRXN3,ANK3 |
6.505e-03 | -5.04 | SLC18A1 (solute carrier family 18 member A1) | protein interactions | 6570 | 151 | 3 | 19454 | 49 |
CD81,NDUFC2,EMC10 |
6.511e-03 | -5.03 | ASH1L (ASH1 like histone lysine methyltransferase) | protein interactions | 55870 | 48 | 2 | 19454 | 49 |
RPL28,FTL |
6.511e-03 | -5.03 | VNN2 (vanin 2) | protein interactions | 8875 | 48 | 2 | 19454 | 49 |
CLDND1,APOD |
6.573e-03 | -5.02 | cell morphogenesis | biological process | GO:0000902 | 687 | 6 | 18204 | 45 |
ANK3,NRXN3,AUTS2,NLGN1,LAMA2,CTNNA2 |
6.656e-03 | -5.01 | plasma membrane bounded cell projection organization | biological process | GO:0120036 | 1152 | 8 | 18204 | 45 |
LAMA2,NLGN1,APOD,NRXN3,ANK3,OMG,CTNNA2,AUTS2 |
6.745e-03 | -5.00 | RSBN1 (round spermatid basic protein 1) | protein interactions | 54665 | 153 | 3 | 19454 | 49 |
RPL11,RPL28,APOD |
6.749e-03 | -5.00 | Iron uptake and transport | REACTOME pathways | R-HSA-917937 | 44 | 2 | 10285 | 29 |
FTL,FTH1 |
6.777e-03 | -4.99 | PTGFRN (prostaglandin F2 receptor inhibitor) | protein interactions | 5738 | 49 | 2 | 19454 | 49 |
CD9,CD81 |
6.850e-03 | -4.98 | TMFOUR | prints domains | PR00259 | 30 | 2 | 5227 | 22 |
CD9,CD81 |
7.040e-03 | -4.96 | cholesterol binding | molecular function | GO:0015485 | 53 | 2 | 18094 | 43 |
CD81,APOD |
7.049e-03 | -4.95 | TREX1 (three prime repair exonuclease 1) | protein interactions | 11277 | 50 | 2 | 19454 | 49 |
CD81,RNASEK |
7.049e-03 | -4.95 | TGFBR3 (transforming growth factor beta receptor 3) | protein interactions | 7049 | 50 | 2 | 19454 | 49 |
ITM2B,LRRTM3 |
7.054e-03 | -4.95 | vesicle | cellular component | GO:0031982 | 4141 | 18 | 19108 | 47 |
CBR1,RPL28,CD9,FCHSD2,RNASEK,FTL,SPP1,ITM2B,NDUFC2,FTH1,APOD,PTGDS,CD81,RNASE1,ZFYVE16,B2M,MARCKSL1,RPL11 |
7.054e-03 | -4.95 | positive regulation of protein binding | biological process | GO:0032092 | 51 | 2 | 18204 | 45 |
B2M,RPL11 |
7.113e-03 | -4.95 | epidermal growth factor receptor activity | molecular function | GO:0005006 | 3 | 1 | 18094 | 43 |
ERBB4 |
7.113e-03 | -4.95 | neuregulin receptor activity | molecular function | GO:0038131 | 3 | 1 | 18094 | 43 |
ERBB4 |
7.113e-03 | -4.95 | prostaglandin-D synthase activity | molecular function | GO:0004667 | 3 | 1 | 18094 | 43 |
PTGDS |
7.173e-03 | -4.94 | plasma membrane | cellular component | GO:0005886 | 5538 | 22 | 19108 | 47 |
MARCKSL1,CLDND1,B2M,OMG,NLGN1,IL1RAPL1,ANK3,FCHSD2,RNASEK,CD9,LAMA2,LRRTM3,NRXN3,CAPN3,CADM2,ITM2A,OPALIN,CTNNA2,CD81,ITM2B,ERBB4,NDUFC2 |
7.239e-03 | -4.93 | - | gene3d domains | 6.10.250.2510 | 3 | 1 | 14470 | 35 |
CTNNA2 |
7.239e-03 | -4.93 | - | gene3d domains | 2.60.40.2660 | 3 | 1 | 14470 | 35 |
ANK3 |
7.261e-03 | -4.93 | T-tubule | cellular component | GO:0030315 | 52 | 2 | 19108 | 47 |
ANK3,CAPN3 |
7.325e-03 | -4.92 | TSPAN4 (tetraspanin 4) | protein interactions | 7106 | 51 | 2 | 19454 | 49 |
CD81,CD9 |
7.398e-03 | -4.91 | regulation of adaptive immune memory response | biological process | GO:1905674 | 3 | 1 | 18204 | 45 |
CD81 |
7.398e-03 | -4.91 | positive regulation of cell communication by electrical coupling | biological process | GO:0010650 | 3 | 1 | 18204 | 45 |
ANK3 |
7.398e-03 | -4.91 | positive regulation of synaptic vesicle exocytosis | biological process | GO:2000302 | 3 | 1 | 18204 | 45 |
NLGN1 |
7.398e-03 | -4.91 | regulation of estradiol secretion | biological process | GO:2000864 | 3 | 1 | 18204 | 45 |
SPP1 |
7.398e-03 | -4.91 | regulation of satellite cell activation involved in skeletal muscle regeneration | biological process | GO:0014717 | 3 | 1 | 18204 | 45 |
CAPN3 |
7.398e-03 | -4.91 | negative regulation of forebrain neuron differentiation | biological process | GO:2000978 | 3 | 1 | 18204 | 45 |
B2M |
7.398e-03 | -4.91 | positive regulation of circadian sleep/wake cycle, wakefulness | biological process | GO:0010841 | 3 | 1 | 18204 | 45 |
NLGN1 |
7.398e-03 | -4.91 | regulation of oocyte development | biological process | GO:0060281 | 3 | 1 | 18204 | 45 |
PDE5A |
7.398e-03 | -4.91 | regulation of oogenesis | biological process | GO:1905879 | 3 | 1 | 18204 | 45 |
PDE5A |
7.398e-03 | -4.91 | central nervous system morphogenesis | biological process | GO:0021551 | 3 | 1 | 18204 | 45 |
ERBB4 |
7.398e-03 | -4.91 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | biological process | GO:2001190 | 3 | 1 | 18204 | 45 |
CD81 |
7.398e-03 | -4.91 | radial glia guided migration of Purkinje cell | biological process | GO:0021942 | 3 | 1 | 18204 | 45 |
CTNNA2 |
7.400e-03 | -4.91 | Dysbindin | pfam domains | PF04440 | 3 | 1 | 17795 | 44 |
DBNDD2 |
7.400e-03 | -4.91 | TM_ErbB1 | pfam domains | PF21314 | 3 | 1 | 17795 | 44 |
ERBB4 |
7.400e-03 | -4.91 | Auts2 | pfam domains | PF15336 | 3 | 1 | 17795 | 44 |
AUTS2 |
7.400e-03 | -4.91 | UPA_2 | pfam domains | PF17809 | 3 | 1 | 17795 | 44 |
ANK3 |
7.496e-03 | -4.89 | CEP57 (centrosomal protein 57) | protein interactions | 9702 | 159 | 3 | 19454 | 49 |
FTL,FTH1,RPL11 |
7.513e-03 | -4.89 | endocytosis | biological process | GO:0006897 | 499 | 5 | 18204 | 45 |
NLGN1,FCHSD2,CD9,RNASEK,CD81 |
7.538e-03 | -4.89 | PGBD2 (piggyBac transposable element derived 2) | protein interactions | 267002 | 3 | 1 | 19454 | 49 |
FTL |
7.538e-03 | -4.89 | Hk2 (hexokinase 2) | protein interactions | 25059 | 3 | 1 | 19454 | 49 |
PTGDS |
7.538e-03 | -4.89 | IGDCC3 (immunoglobulin superfamily DCC subclass member 3) | protein interactions | 9543 | 3 | 1 | 19454 | 49 |
FTL |
7.538e-03 | -4.89 | TP53 (tumor protein p53) | protein interactions | 397276 | 3 | 1 | 19454 | 49 |
RPL11 |
7.538e-03 | -4.89 | NRG3 (neuregulin 3) | protein interactions | 10718 | 3 | 1 | 19454 | 49 |
ERBB4 |
7.576e-03 | -4.88 | regulation of cell-cell adhesion | biological process | GO:0022407 | 500 | 5 | 18204 | 45 |
CD81,ANK3,B2M,PDE5A,CD9 |
7.594e-03 | -4.88 | Ankyrin_UPA | interpro domains | IPR040745 | 3 | 1 | 18521 | 47 |
ANK3 |
7.594e-03 | -4.88 | AUTS2 | interpro domains | IPR023246 | 3 | 1 | 18521 | 47 |
AUTS2 |
7.594e-03 | -4.88 | Dysbindin | interpro domains | IPR007531 | 3 | 1 | 18521 | 47 |
DBNDD2 |
7.594e-03 | -4.88 | Vinculin_CS | interpro domains | IPR000633 | 3 | 1 | 18521 | 47 |
CTNNA2 |
7.594e-03 | -4.88 | TM_ErbB1 | interpro domains | IPR049328 | 3 | 1 | 18521 | 47 |
ERBB4 |
7.600e-03 | -4.88 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | biological process | GO:0007157 | 53 | 2 | 18204 | 45 |
NLGN1,IL1RAPL1 |
7.736e-03 | -4.86 | LRRNT | smart domains | SM00013 | 54 | 2 | 9717 | 24 |
LRRTM3,OMG |
7.761e-03 | -4.86 | C20 prostanoid biosynthesis | BIOCYC pathways | META_PWY66-374 | 7 | 1 | 902 | 1 |
PTGDS |
7.761e-03 | -4.86 | C20 prostanoid biosynthesis | BIOCYC pathways | HUMAN_PWY66-374 | 7 | 1 | 902 | 1 |
PTGDS |
7.770e-03 | -4.86 | Ferroptosis | KEGG pathways | ko04216 | 40 | 2 | 7161 | 24 |
FTH1,FTL |
7.770e-03 | -4.86 | Ferroptosis | KEGG pathways | hsa04216 | 40 | 2 | 7161 | 24 |
FTH1,FTL |
7.812e-03 | -4.85 | cytosolic large ribosomal subunit | cellular component | GO:0022625 | 54 | 2 | 19108 | 47 |
RPL11,RPL28 |
7.890e-03 | -4.84 | EMC9 (ER membrane protein complex subunit 9) | protein interactions | 51016 | 162 | 3 | 19454 | 49 |
EMC10,RPL11,RPL28 |
7.890e-03 | -4.84 | ATP6V0A1 (ATPase H+ transporting V0 subunit a1) | protein interactions | 535 | 162 | 3 | 19454 | 49 |
CTNNA2,MARCKSL1,FTH1 |
7.891e-03 | -4.84 | CERS3 (ceramide synthase 3) | protein interactions | 204219 | 53 | 2 | 19454 | 49 |
PPP2R2B,CBR1 |
7.891e-03 | -4.84 | monoatomic cation homeostasis | biological process | GO:0055080 | 505 | 5 | 18204 | 45 |
FTH1,ANK3,RNASEK,FTL,B2M |
8.024e-03 | -4.83 | DLG4 (discs large MAGUK scaffold protein 4) | protein interactions | 1742 | 163 | 3 | 19454 | 49 |
NLGN1,ERBB4,FTH1 |
8.094e-03 | -4.82 | tertiary granule lumen | cellular component | GO:1904724 | 55 | 2 | 19108 | 47 |
FTH1,B2M |
8.162e-03 | -4.81 | system development | biological process | GO:0048731 | 3533 | 16 | 18204 | 45 |
OMG,NKX6-2,PLLP,CTNNA2,AUTS2,ERBB4,IL1RAPL1,MARCKSL1,CD9,LAMA2,APOD,NRXN3,ITM2B,ANK3,EMC10,NLGN1 |
8.165e-03 | -4.81 | protein localization to lysosome | biological process | GO:0061462 | 55 | 2 | 18204 | 45 |
CD81,ZFYVE16 |
8.165e-03 | -4.81 | regulation of glycoprotein biosynthetic process | biological process | GO:0010559 | 55 | 2 | 18204 | 45 |
ITM2A,ITM2B |
8.181e-03 | -4.81 | SYNM (synemin) | protein interactions | 23336 | 54 | 2 | 19454 | 49 |
PPP2R2B,ERBB4 |
8.248e-03 | -4.80 | maintenance of location | biological process | GO:0051235 | 168 | 3 | 18204 | 45 |
FTH1,ANK3,FTL |
8.293e-03 | -4.79 | LRRNT | interpro domains | IPR000372 | 54 | 2 | 18521 | 47 |
OMG,LRRTM3 |
8.296e-03 | -4.79 | EIF3K (eukaryotic translation initiation factor 3 subunit K) | protein interactions | 27335 | 165 | 3 | 19454 | 49 |
CD81,RPL11,SPP1 |
8.296e-03 | -4.79 | FTH1 (ferritin heavy chain 1) | protein interactions | 2495 | 165 | 3 | 19454 | 49 |
SPP1,FTH1,FTL |
8.401e-03 | -4.78 | MARCKS | prints domains | PR00963 | 2 | 1 | 5227 | 22 |
MARCKSL1 |
8.434e-03 | -4.78 | INO80B (INO80 complex subunit B) | protein interactions | 83444 | 166 | 3 | 19454 | 49 |
RPL11,RPL28,CD81 |
8.440e-03 | -4.77 | Celecoxib Action Pathway | SMPDB pathways | SMP0000096 | 34 | 2 | 1369 | 6 |
PTGDS,CBR1 |
8.446e-03 | -4.77 | regulation of protein stability | biological process | GO:0031647 | 326 | 4 | 18204 | 45 |
DAD1,CAPN3,RPL11,CD81 |
8.450e-03 | -4.77 | cell projection organization | biological process | GO:0030030 | 1200 | 8 | 18204 | 45 |
ANK3,OMG,NRXN3,AUTS2,CTNNA2,NLGN1,APOD,LAMA2 |
8.475e-03 | -4.77 | cell activation | biological process | GO:0001775 | 725 | 6 | 18204 | 45 |
CD81,PTGDS,CD9,PDE5A,B2M,ITM2A |
8.477e-03 | -4.77 | ZDBF2 (zinc finger DBF-type containing 2) | protein interactions | 57683 | 55 | 2 | 19454 | 49 |
FTL,RPL28 |
8.550e-03 | -4.76 | positive regulation of cellular component biogenesis | biological process | GO:0044089 | 515 | 5 | 18204 | 45 |
FCHSD2,AUTS2,NLGN1,LRRTM3,IL1RAPL1 |
8.550e-03 | -4.76 | monoatomic ion homeostasis | biological process | GO:0050801 | 515 | 5 | 18204 | 45 |
B2M,FTL,RNASEK,ANK3,FTH1 |
8.592e-03 | -4.76 | VINCULIN_1 | prosite domains | PS00663 | 3 | 1 | 12186 | 35 |
CTNNA2 |
8.672e-03 | -4.75 | protein complex involved in cell adhesion | cellular component | GO:0098636 | 57 | 2 | 19108 | 47 |
LAMA2,NLGN1 |
8.731e-03 | -4.74 | establishment of localization | biological process | GO:0051234 | 3887 | 17 | 18204 | 45 |
NLGN1,B2M,NDUFC2,PTGDS,FTH1,EMC10,ANK3,CD81,RNASEK,ZFYVE16,APOD,CD9,FTL,FCHSD2,ERBB4,PLLP,RPL11 |
8.752e-03 | -4.74 | RHOU (ras homolog family member U) | protein interactions | 58480 | 507 | 5 | 19454 | 49 |
ZFYVE16,ITM2B,TRIM59,ANK3,MARCKSL1 |
9.046e-03 | -4.71 | arachidonic acid metabolic process | biological process | GO:0019369 | 58 | 2 | 18204 | 45 |
PTGDS,CBR1 |
9.081e-03 | -4.70 | ICAM2 (intercellular adhesion molecule 2) | protein interactions | 3384 | 57 | 2 | 19454 | 49 |
ITM2B,DAD1 |
9.081e-03 | -4.70 | TREX2 (three prime repair exonuclease 2) | protein interactions | 11219 | 57 | 2 | 19454 | 49 |
FTH1,PPP2R2B |
9.081e-03 | -4.70 | ZNF771 (zinc finger protein 771) | protein interactions | 51333 | 57 | 2 | 19454 | 49 |
RPL11,RPL28 |
9.084e-03 | -4.70 | synapse organization | biological process | GO:0050808 | 333 | 4 | 18204 | 45 |
ERBB4,NLGN1,ANK3,IL1RAPL1 |
9.142e-03 | -4.69 | TP53 (tumor protein p53) | protein interactions | 7157 | 2268 | 12 | 19454 | 49 |
ERBB4,ANK3,RPL28,PPP2R2B,RPL11,BCL2L14,ZFYVE16,CD81,TRIM59,DAD1,CADM2,FTH1 |
9.172e-03 | -4.69 | MAPT (microtubule associated protein tau) | protein interactions | 4137 | 948 | 7 | 19454 | 49 |
CBR1,RPL11,PPP2R2B,CADM2,RPL28,ANK3,CTNNA2 |
9.181e-03 | -4.69 | regulation of biological quality | biological process | GO:0065008 | 2936 | 14 | 18204 | 45 |
DAD1,SPP1,CD9,IL1RAPL1,ERBB4,FCHSD2,CTNNA2,CAPN3,RPL11,NLGN1,ANK3,RNASEK,LRRTM3,CD81 |
9.340e-03 | -4.67 | human chr3p12.1 | chromosome location | human chr3p12.1 | 5 | 1 | 26134 | 49 |
CADM2 |
9.349e-03 | -4.67 | protein localization to synapse | biological process | GO:0035418 | 59 | 2 | 18204 | 45 |
ERBB4,NLGN1 |
9.390e-03 | -4.67 | AP1S1 (adaptor related protein complex 1 subunit sigma 1) | protein interactions | 1174 | 58 | 2 | 19454 | 49 |
FTH1,FTL |
9.473e-03 | -4.66 | phosphopyruvate hydratase activity | molecular function | GO:0004634 | 4 | 1 | 18094 | 43 |
ENO4 |
9.473e-03 | -4.66 | ribonuclease A activity | molecular function | GO:0004522 | 4 | 1 | 18094 | 43 |
RNASE1 |
9.641e-03 | -4.64 | CPI-17 | gene3d domains | 1.10.150.220 | 4 | 1 | 14470 | 35 |
PPP1R14A |
9.704e-03 | -4.64 | CAVIN2 (caveolae associated protein 2) | protein interactions | 8436 | 59 | 2 | 19454 | 49 |
CD9,RPL11 |
9.704e-03 | -4.64 | CD82 (CD82 molecule) | protein interactions | 3732 | 59 | 2 | 19454 | 49 |
CD81,CD9 |
9.758e-03 | -4.63 | cell junction organization | biological process | GO:0034330 | 532 | 5 | 18204 | 45 |
CD9,NLGN1,ERBB4,IL1RAPL1,ANK3 |
9.784e-03 | -4.63 | bone-humerus-other-chondroblastoma | COSMIC cancer mutations | bone-humerus-other-chondroblastoma | 301 | 4 | 16828 | 47 |
NRXN3,CD9,PPP2R2B,NLGN1 |
9.803e-03 | -4.63 | phosphopyruvate hydratase complex | cellular component | GO:0000015 | 4 | 1 | 19108 | 47 |
ENO4 |
9.845e-03 | -4.62 | Enolase_C | smart domains | SM01192 | 4 | 1 | 9717 | 24 |
ENO4 |
9.845e-03 | -4.62 | Enolase_N | smart domains | SM01193 | 4 | 1 | 9717 | 24 |
ENO4 |
9.852e-03 | -4.62 | regulation of circadian sleep/wake cycle, wakefulness | biological process | GO:0010840 | 4 | 1 | 18204 | 45 |
NLGN1 |
9.852e-03 | -4.62 | cardiac muscle tissue regeneration | biological process | GO:0061026 | 4 | 1 | 18204 | 45 |
ERBB4 |
9.852e-03 | -4.62 | response to iron(III) ion | biological process | GO:0010041 | 4 | 1 | 18204 | 45 |
B2M |
9.852e-03 | -4.62 | NMDA glutamate receptor clustering | biological process | GO:0097114 | 4 | 1 | 18204 | 45 |
NLGN1 |
9.852e-03 | -4.62 | regulation of smooth muscle cell-matrix adhesion | biological process | GO:2000097 | 4 | 1 | 18204 | 45 |
APOD |
9.852e-03 | -4.62 | negative regulation of protein neddylation | biological process | GO:2000435 | 4 | 1 | 18204 | 45 |
RPL11 |
9.852e-03 | -4.62 | synaptic vesicle targeting | biological process | GO:0016080 | 4 | 1 | 18204 | 45 |
NLGN1 |
9.852e-03 | -4.62 | negative regulation of germ cell proliferation | biological process | GO:1905937 | 4 | 1 | 18204 | 45 |
PTGDS |
9.852e-03 | -4.62 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib | biological process | GO:0002477 | 4 | 1 | 18204 | 45 |
B2M |
9.852e-03 | -4.62 | negative regulation of male germ cell proliferation | biological process | GO:2000255 | 4 | 1 | 18204 | 45 |
PTGDS |
9.855e-03 | -4.62 | PP1_inhibitor | pfam domains | PF05361 | 4 | 1 | 17795 | 44 |
PPP1R14A |
9.855e-03 | -4.62 | Enolase_C | pfam domains | PF00113 | 4 | 1 | 17795 | 44 |
ENO4 |
9.968e-03 | -4.61 | regulation of glycoprotein metabolic process | biological process | GO:1903018 | 61 | 2 | 18204 | 45 |
ITM2B,ITM2A |
1.004e-02 | -4.60 | B3GNTL1 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1) | protein interactions | 146712 | 4 | 1 | 19454 | 49 |
FTL |
1.004e-02 | -4.60 | IER5L (immediate early response 5 like) | protein interactions | 389792 | 4 | 1 | 19454 | 49 |
PPP2R2B |
1.004e-02 | -4.60 | DENND3 (DENN domain containing 3) | protein interactions | 22898 | 4 | 1 | 19454 | 49 |
CBR1 |
1.004e-02 | -4.60 | CLDN14 (claudin 14) | protein interactions | 23562 | 4 | 1 | 19454 | 49 |
PLLP |
1.005e-02 | -4.60 | response to metal ion | biological process | GO:0010038 | 343 | 4 | 18204 | 45 |
CAPN3,ANK3,B2M,NLGN1 |
1.010e-02 | -4.60 | negative regulation of cell projection organization | biological process | GO:0031345 | 181 | 3 | 18204 | 45 |
NLGN1,B2M,SPP1 |
1.011e-02 | -4.59 | Alpha_catenin | interpro domains | IPR001033 | 4 | 1 | 18521 | 47 |
CTNNA2 |
1.011e-02 | -4.59 | CPI-17 | interpro domains | IPR008025 | 4 | 1 | 18521 | 47 |
PPP1R14A |
1.011e-02 | -4.59 | CPI-17_sf | interpro domains | IPR036658 | 4 | 1 | 18521 | 47 |
PPP1R14A |
1.011e-02 | -4.59 | Enolase_C | interpro domains | IPR020810 | 4 | 1 | 18521 | 47 |
ENO4 |
1.011e-02 | -4.59 | PP2A_PR55_CS | interpro domains | IPR018067 | 4 | 1 | 18521 | 47 |
PPP2R2B |
1.011e-02 | -4.59 | PP2A_PR55 | interpro domains | IPR000009 | 4 | 1 | 18521 | 47 |
PPP2R2B |
1.011e-02 | -4.59 | ArgE/DapE_CS | interpro domains | IPR001261 | 4 | 1 | 18521 | 47 |
CNDP1 |
1.011e-02 | -4.59 | Enolase | interpro domains | IPR000941 | 4 | 1 | 18521 | 47 |
ENO4 |
1.011e-02 | -4.59 | Enolase_N | interpro domains | IPR020811 | 4 | 1 | 18521 | 47 |
ENO4 |
1.011e-02 | -4.59 | Tyr_kinase_EGF/ERB/XmrK_rcpt | interpro domains | IPR016245 | 4 | 1 | 18521 | 47 |
ERBB4 |
1.047e-02 | -4.56 | ADRB2 (adrenoceptor beta 2) | protein interactions | 154 | 340 | 4 | 19454 | 49 |
DAD1,CD9,CD81,PTGDS |
1.052e-02 | -4.55 | lytic vacuole | cellular component | GO:0000323 | 762 | 6 | 19108 | 47 |
FTL,RNASEK,FTH1,NDUFC2,ANK3,B2M |
1.052e-02 | -4.55 | lysosome | cellular component | GO:0005764 | 762 | 6 | 19108 | 47 |
ANK3,B2M,NDUFC2,FTH1,RNASEK,FTL |
1.062e-02 | -4.55 | membrane organization | biological process | GO:0061024 | 761 | 6 | 18204 | 45 |
ANK3,EMC10,IL1RAPL1,NLGN1,FCHSD2,CD9 |
1.066e-02 | -4.54 | regulation of cell population proliferation | biological process | GO:0042127 | 1790 | 10 | 18204 | 45 |
CD81,ERBB4,PDE5A,FTH1,MARCKSL1,PTGDS,EMC10,APOD,B2M,CD9 |
1.067e-02 | -4.54 | LRRN4CL (LRRN4 C-terminal like) | protein interactions | 221091 | 62 | 2 | 19454 | 49 |
ITM2B,CTNNA2 |
1.067e-02 | -4.54 | USP42 (ubiquitin specific peptidase 42) | protein interactions | 84132 | 62 | 2 | 19454 | 49 |
SPP1,RPL11 |
1.067e-02 | -4.54 | DLG2 (discs large MAGUK scaffold protein 2) | protein interactions | 1740 | 62 | 2 | 19454 | 49 |
ERBB4,NLGN1 |
1.067e-02 | -4.54 | ZNF184 (zinc finger protein 184) | protein interactions | 7738 | 62 | 2 | 19454 | 49 |
RPL11,RPL28 |
1.067e-02 | -4.54 | ZCCHC7 (zinc finger CCHC-type containing 7) | protein interactions | 84186 | 62 | 2 | 19454 | 49 |
RPL28,RPL11 |
1.084e-02 | -4.52 | cell-cell adhesion | biological process | GO:0098609 | 546 | 5 | 18204 | 45 |
CADM2,IL1RAPL1,NRXN3,NLGN1,CTNNA2 |
1.101e-02 | -4.51 | ARHGAP22 (Rho GTPase activating protein 22) | protein interactions | 58504 | 63 | 2 | 19454 | 49 |
IL1RAPL1,ANK3 |
1.101e-02 | -4.51 | FAM111A (FAM111 trypsin like peptidase A) | protein interactions | 63901 | 63 | 2 | 19454 | 49 |
RPL11,RPL28 |
1.106e-02 | -4.50 | sterol binding | molecular function | GO:0032934 | 67 | 2 | 18094 | 43 |
APOD,CD81 |
1.113e-02 | -4.50 | Golgi Associated Vesicle Biogenesis | REACTOME pathways | R-HSA-432722 | 57 | 2 | 10285 | 29 |
FTL,FTH1 |
1.134e-02 | -4.48 | ND5 (NADH dehydrogenase subunit 5) | protein interactions | 4540 | 64 | 2 | 19454 | 49 |
NDUFC2,OPALIN |
1.134e-02 | -4.48 | FRMD5 (FERM domain containing 5) | protein interactions | 84978 | 64 | 2 | 19454 | 49 |
OPALIN,FTL |
1.141e-02 | -4.47 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 1117 | 8 | 16828 | 47 |
ANK3,NRXN3,ZFYVE16,ERBB4,IL1RAPL1,NLGN1,AUTS2,LAMA2 |
1.144e-02 | -4.47 | cell projection | cellular component | GO:0042995 | 2398 | 12 | 19108 | 47 |
IL1RAPL1,NLGN1,ANK3,APOD,CTNNA2,CADM2,AUTS2,LAMA2,SPP1,NRXN3,FCHSD2,RPL28 |
1.144e-02 | -4.47 | ARGE_DAPE_CPG2_2 | prosite domains | PS00759 | 4 | 1 | 12186 | 35 |
CNDP1 |
1.144e-02 | -4.47 | PR55_2 | prosite domains | PS01025 | 4 | 1 | 12186 | 35 |
PPP2R2B |
1.144e-02 | -4.47 | PR55_1 | prosite domains | PS01024 | 4 | 1 | 12186 | 35 |
PPP2R2B |
1.160e-02 | -4.46 | NRF2 pathway | WikiPathways | WP2884 | 143 | 3 | 5310 | 18 |
FTL,FTH1,CBR1 |
1.168e-02 | -4.45 | IL27RA (interleukin 27 receptor subunit alpha) | protein interactions | 9466 | 65 | 2 | 19454 | 49 |
DAD1,ITM2B |
1.168e-02 | -4.45 | SNX21 (sorting nexin family member 21) | protein interactions | 90203 | 65 | 2 | 19454 | 49 |
FTH1,MARCKSL1 |
1.183e-02 | -4.44 | metal ion sequestering activity | molecular function | GO:0140487 | 5 | 1 | 18094 | 43 |
FTH1 |
1.183e-02 | -4.44 | neuroligin family protein binding | molecular function | GO:0097109 | 5 | 1 | 18094 | 43 |
NRXN3 |
1.189e-02 | -4.43 | Arachidonic acid metabolism | REACTOME pathways | R-HSA-2142753 | 59 | 2 | 10285 | 29 |
PTGDS,CBR1 |
1.192e-02 | -4.43 | plasma membrane region | cellular component | GO:0098590 | 1278 | 8 | 19108 | 47 |
ANK3,ERBB4,IL1RAPL1,CD81,NLGN1,CLDND1,LRRTM3,NRXN3 |
1.203e-02 | -4.42 | AGPAT5 (1-acylglycerol-3-phosphate O-acyltransferase 5) | protein interactions | 55326 | 66 | 2 | 19454 | 49 |
OPALIN,FTL |
1.204e-02 | -4.42 | Enolase-like, N-terminal domain | gene3d domains | 3.30.390.10 | 5 | 1 | 14470 | 35 |
ENO4 |
1.204e-02 | -4.42 | Enolase-like C-terminal domain | gene3d domains | 3.20.20.120 | 5 | 1 | 14470 | 35 |
ENO4 |
1.224e-02 | -4.40 | early endosome lumen | cellular component | GO:0031905 | 5 | 1 | 19108 | 47 |
B2M |
1.224e-02 | -4.40 | protein complex involved in cell-cell adhesion | cellular component | GO:0098635 | 5 | 1 | 19108 | 47 |
NLGN1 |
1.227e-02 | -4.40 | cell-cell recognition | biological process | GO:0009988 | 68 | 2 | 18204 | 45 |
CD81,CD9 |
1.230e-02 | -4.40 | plasma cell differentiation | biological process | GO:0002317 | 5 | 1 | 18204 | 45 |
ITM2A |
1.230e-02 | -4.40 | regulation of membrane depolarization during cardiac muscle cell action potential | biological process | GO:1900825 | 5 | 1 | 18204 | 45 |
ANK3 |
1.230e-02 | -4.40 | AMPA glutamate receptor clustering | biological process | GO:0097113 | 5 | 1 | 18204 | 45 |
NLGN1 |
1.230e-02 | -4.40 | regulation of forebrain neuron differentiation | biological process | GO:2000977 | 5 | 1 | 18204 | 45 |
B2M |
1.230e-02 | -4.40 | negative regulation of lipoprotein metabolic process | biological process | GO:0050748 | 5 | 1 | 18204 | 45 |
APOD |
1.230e-02 | -4.40 | androgen catabolic process | biological process | GO:0006710 | 5 | 1 | 18204 | 45 |
SPP1 |
1.230e-02 | -4.40 | positive regulation of receptor binding | biological process | GO:1900122 | 5 | 1 | 18204 | 45 |
B2M |
1.230e-02 | -4.40 | glutamate receptor clustering | biological process | GO:0097688 | 5 | 1 | 18204 | 45 |
NLGN1 |
1.230e-02 | -4.40 | terminal button organization | biological process | GO:0072553 | 5 | 1 | 18204 | 45 |
NLGN1 |
1.230e-02 | -4.40 | positive regulation of skeletal muscle tissue regeneration | biological process | GO:0043415 | 5 | 1 | 18204 | 45 |
CAPN3 |
1.230e-02 | -4.40 | cGMP catabolic process | biological process | GO:0046069 | 5 | 1 | 18204 | 45 |
PDE5A |
1.230e-02 | -4.40 | ERBB2-ERBB4 signaling pathway | biological process | GO:0038135 | 5 | 1 | 18204 | 45 |
ERBB4 |
1.230e-02 | -4.40 | Vinculin | pfam domains | PF01044 | 5 | 1 | 17795 | 44 |
CTNNA2 |
1.230e-02 | -4.40 | Laminin_II | pfam domains | PF06009 | 5 | 1 | 17795 | 44 |
LAMA2 |
1.230e-02 | -4.40 | Laminin_I | pfam domains | PF06008 | 5 | 1 | 17795 | 44 |
LAMA2 |
1.231e-02 | -4.40 | GRB2 (growth factor receptor bound protein 2) | protein interactions | 2885 | 769 | 6 | 19454 | 49 |
FTH1,B2M,CBR1,CD81,FTL,ERBB4 |
1.236e-02 | -4.39 | RNA endonuclease activity | molecular function | GO:0004521 | 71 | 2 | 18094 | 43 |
RNASE1,RNASEK |
1.238e-02 | -4.39 | MMP14 (matrix metallopeptidase 14) | protein interactions | 4323 | 67 | 2 | 19454 | 49 |
PLLP,CLDND1 |
1.238e-02 | -4.39 | SKA1 (spindle and kinetochore associated complex subunit 1) | protein interactions | 220134 | 67 | 2 | 19454 | 49 |
PPP2R2B,FTL |
1.239e-02 | -4.39 | vesicle-mediated transport | biological process | GO:0016192 | 1283 | 8 | 18204 | 45 |
ZFYVE16,FCHSD2,NLGN1,CD9,PTGDS,ANK3,CD81,RNASEK |
1.240e-02 | -4.39 | RAC1 (Rac family small GTPase 1) | protein interactions | 5879 | 1005 | 7 | 19454 | 49 |
CLDND1,ANK3,MARCKSL1,B2M,NDUFC2,PPP2R2B,ZFYVE16 |
1.242e-02 | -4.39 | Mineral absorption | KEGG pathways | hsa04978 | 51 | 2 | 7161 | 24 |
FTH1,FTL |
1.242e-02 | -4.39 | Mineral absorption | KEGG pathways | ko04978 | 51 | 2 | 7161 | 24 |
FTL,FTH1 |
1.253e-02 | -4.38 | HLA-DOA (major histocompatibility complex, class II, DO alpha) | protein interactions | 3111 | 5 | 1 | 19454 | 49 |
ITM2A |
1.253e-02 | -4.38 | NRG2 (neuregulin 2) | protein interactions | 9542 | 5 | 1 | 19454 | 49 |
ERBB4 |
1.253e-02 | -4.38 | DSEL (dermatan sulfate epimerase like) | protein interactions | 92126 | 5 | 1 | 19454 | 49 |
SPP1 |
1.253e-02 | -4.38 | PTGER2 (prostaglandin E receptor 2) | protein interactions | 5732 | 5 | 1 | 19454 | 49 |
PTGDS |
1.253e-02 | -4.38 | CNGA1 (cyclic nucleotide gated channel subunit alpha 1) | protein interactions | 1259 | 5 | 1 | 19454 | 49 |
NKX6-2 |
1.253e-02 | -4.38 | Hk3 (hexokinase 3) | protein interactions | 25060 | 5 | 1 | 19454 | 49 |
PTGDS |
1.253e-02 | -4.38 | TAAR1 (trace amine associated receptor 1) | protein interactions | 134864 | 5 | 1 | 19454 | 49 |
RNASEK |
1.258e-02 | -4.38 | FIBROSIN1LPF | prints domains | PR02044 | 3 | 1 | 5227 | 22 |
AUTS2 |
1.258e-02 | -4.38 | PGNDSYNTHASE | prints domains | PR01254 | 3 | 1 | 5227 | 22 |
PTGDS |
1.263e-02 | -4.37 | Enolase-like_N | interpro domains | IPR029017 | 5 | 1 | 18521 | 47 |
ENO4 |
1.263e-02 | -4.37 | MAL | interpro domains | IPR013295 | 5 | 1 | 18521 | 47 |
PLLP |
1.263e-02 | -4.37 | Enolase-like_C_sf | interpro domains | IPR036849 | 5 | 1 | 18521 | 47 |
ENO4 |
1.263e-02 | -4.37 | Vinculin/catenin | interpro domains | IPR006077 | 5 | 1 | 18521 | 47 |
CTNNA2 |
1.263e-02 | -4.37 | Laminin_aI | interpro domains | IPR009254 | 5 | 1 | 18521 | 47 |
LAMA2 |
1.263e-02 | -4.37 | Nlgn | interpro domains | IPR000460 | 5 | 1 | 18521 | 47 |
NLGN1 |
1.263e-02 | -4.37 | Laminin_dom_II | interpro domains | IPR010307 | 5 | 1 | 18521 | 47 |
LAMA2 |
1.274e-02 | -4.36 | TNFSF18 (TNF superfamily member 18) | protein interactions | 8995 | 68 | 2 | 19454 | 49 |
NLGN1,ITM2B |
1.274e-02 | -4.36 | SHBG (sex hormone binding globulin) | protein interactions | 6462 | 68 | 2 | 19454 | 49 |
APOD,PTGDS |
1.287e-02 | -4.35 | multicellular organismal process | biological process | GO:0032501 | 6177 | 23 | 18204 | 45 |
APOD,CD9,AUTS2,ITM2A,ERBB4,PDE5A,NLGN1,ANK3,ITM2B,DAD1,LAMA2,SPP1,MARCKSL1,IL1RAPL1,CTNNA2,NKX6-2,PLLP,OMG,B2M,PTGDS,EMC10,NRXN3,CD81 |
1.297e-02 | -4.35 | positive regulation of T cell mediated immunity | biological process | GO:0002711 | 70 | 2 | 18204 | 45 |
B2M,CD81 |
1.298e-02 | -4.34 | pharynx | COSMIC cancer mutations | pharynx | 2696 | 14 | 16828 | 47 |
CADM2,FTH1,LAMA2,LRRTM3,B2M,IL1RAPL1,CAPN3,ITM2A,AUTS2,RPL11,CBR1,ANKUB1,NRXN3,ANK3 |
1.330e-02 | -4.32 | DNAJC5 (DnaJ heat shock protein family (Hsp40) member C5) | protein interactions | 80331 | 365 | 4 | 19454 | 49 |
NRXN3,ITM2B,ANK3,MARCKSL1 |
1.346e-02 | -4.31 | PTPDC1 (protein tyrosine phosphatase domain containing 1) | protein interactions | 138639 | 70 | 2 | 19454 | 49 |
ERBB4,PPP2R2B |
1.346e-02 | -4.31 | MTMR9 (myotubularin related protein 9) | protein interactions | 66036 | 70 | 2 | 19454 | 49 |
ERBB4,APOD |
1.346e-02 | -4.31 | CD27 (CD27 molecule) | protein interactions | 939 | 70 | 2 | 19454 | 49 |
CTNNA2,DAD1 |
1.346e-02 | -4.31 | CTDNEP1 (CTD nuclear envelope phosphatase 1) | protein interactions | 23399 | 70 | 2 | 19454 | 49 |
PLXDC2,FTL |
1.369e-02 | -4.29 | cellular response to calcium ion | biological process | GO:0071277 | 72 | 2 | 18204 | 45 |
CAPN3,NLGN1 |
1.376e-02 | -4.29 | RPL7L1 (ribosomal protein L7 like 1) | protein interactions | 285855 | 199 | 3 | 19454 | 49 |
RPL11,FTL,RPL28 |
1.376e-02 | -4.29 | CAPN1 (calpain 1) | protein interactions | 823 | 199 | 3 | 19454 | 49 |
PPP2R2B,CAPN3,PTGDS |
1.377e-02 | -4.28 | coated vesicle membrane | cellular component | GO:0030662 | 204 | 3 | 19108 | 47 |
RNASEK,CD9,B2M |
1.383e-02 | -4.28 | HEPHL1 (hephaestin like 1) | protein interactions | 341208 | 71 | 2 | 19454 | 49 |
HEPN1,PPP2R2B |
1.383e-02 | -4.28 | regulation of neurogenesis | biological process | GO:0050767 | 377 | 4 | 18204 | 45 |
B2M,NKX6-2,SPP1,IL1RAPL1 |
1.384e-02 | -4.28 | ORF3a (ORF3a protein) | protein interactions | 43740569 | 789 | 6 | 19454 | 49 |
TRIM59,ITM2B,B2M,CBR1,ZFYVE16,MARCKSL1 |
1.402e-02 | -4.27 | Sperm:Oocyte Membrane Binding | REACTOME pathways | R-HSA-1300652 | 5 | 1 | 10285 | 29 |
CD9 |
1.405e-02 | -4.27 | receptor internalization | biological process | GO:0031623 | 73 | 2 | 18204 | 45 |
CD9,CD81 |
1.417e-02 | -4.26 | ARAF (A-Raf proto-oncogene, serine/threonine kinase) | protein interactions | 369 | 372 | 4 | 19454 | 49 |
APOD,RPL28,OPALIN,RPL11 |
1.418e-02 | -4.26 | ferroxidase activity | molecular function | GO:0004322 | 6 | 1 | 18094 | 43 |
FTH1 |
1.418e-02 | -4.26 | oxidoreductase activity, acting on metal ions, oxygen as acceptor | molecular function | GO:0016724 | 6 | 1 | 18094 | 43 |
FTH1 |
1.420e-02 | -4.25 | MAP1LC3C (microtubule associated protein 1 light chain 3 gamma) | protein interactions | 440738 | 72 | 2 | 19454 | 49 |
ANK3,CAPN3 |
1.420e-02 | -4.25 | SEMG2 (semenogelin 2) | protein interactions | 6407 | 72 | 2 | 19454 | 49 |
PPP2R2B,FTH1 |
1.429e-02 | -4.25 | cell-cell contact zone | cellular component | GO:0044291 | 74 | 2 | 19108 | 47 |
ANK3,OPALIN |
1.440e-02 | -4.24 | RPL5 (ribosomal protein L5) | protein interactions | 6125 | 574 | 5 | 19454 | 49 |
CD81,CD9,RPL28,SPP1,RPL11 |
1.443e-02 | -4.24 | - | gene3d domains | 3.30.70.360 | 6 | 1 | 14470 | 35 |
CNDP1 |
1.459e-02 | -4.23 | regulation of cell migration | biological process | GO:0030334 | 1061 | 7 | 18204 | 45 |
ERBB4,CTNNA2,CD81,APOD,CD9,LAMA2,EMC10 |
1.474e-02 | -4.22 | neuronal signal transduction | biological process | GO:0023041 | 6 | 1 | 18204 | 45 |
NLGN1 |
1.474e-02 | -4.22 | osteoclast fusion | biological process | GO:0072675 | 6 | 1 | 18204 | 45 |
CD81 |
1.474e-02 | -4.22 | positive regulation of synaptic vesicle endocytosis | biological process | GO:1900244 | 6 | 1 | 18204 | 45 |
NLGN1 |
1.474e-02 | -4.22 | postsynaptic density protein 95 clustering | biological process | GO:0097119 | 6 | 1 | 18204 | 45 |
NLGN1 |
1.474e-02 | -4.22 | negative regulation of monocyte chemotactic protein-1 production | biological process | GO:0071638 | 6 | 1 | 18204 | 45 |
APOD |
1.474e-02 | -4.22 | positive regulation of protein catabolic process in the vacuole | biological process | GO:1904352 | 6 | 1 | 18204 | 45 |
CD81 |
1.474e-02 | -4.22 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | biological process | GO:2001188 | 6 | 1 | 18204 | 45 |
CD81 |
1.474e-02 | -4.22 | MHC class I protein complex assembly | biological process | GO:0002397 | 6 | 1 | 18204 | 45 |
B2M |
1.474e-02 | -4.22 | peptide antigen assembly with MHC class I protein complex | biological process | GO:0002502 | 6 | 1 | 18204 | 45 |
B2M |
1.474e-02 | -4.22 | positive regulation of synaptic transmission, cholinergic | biological process | GO:0032224 | 6 | 1 | 18204 | 45 |
LAMA2 |
1.474e-02 | -4.22 | negative regulation of T cell migration | biological process | GO:2000405 | 6 | 1 | 18204 | 45 |
APOD |
1.474e-02 | -4.22 | ERBB4-ERBB4 signaling pathway | biological process | GO:0038138 | 6 | 1 | 18204 | 45 |
ERBB4 |
1.474e-02 | -4.22 | regulation of membrane depolarization during action potential | biological process | GO:0098902 | 6 | 1 | 18204 | 45 |
ANK3 |
1.474e-02 | -4.22 | G1 to G0 transition involved in cell differentiation | biological process | GO:0070315 | 6 | 1 | 18204 | 45 |
CAPN3 |
1.474e-02 | -4.22 | paranodal junction assembly | biological process | GO:0030913 | 6 | 1 | 18204 | 45 |
CD9 |
1.475e-02 | -4.22 | Ig_6 | pfam domains | PF18452 | 6 | 1 | 17795 | 44 |
IL1RAPL1 |
1.475e-02 | -4.22 | Syndecan | pfam domains | PF01034 | 6 | 1 | 17795 | 44 |
NRXN3 |
1.475e-02 | -4.22 | GF_recep_IV | pfam domains | PF14843 | 6 | 1 | 17795 | 44 |
ERBB4 |
1.475e-02 | -4.22 | Peptidase_M20 | pfam domains | PF01546 | 6 | 1 | 17795 | 44 |
CNDP1 |
1.475e-02 | -4.22 | M20_dimer | pfam domains | PF07687 | 6 | 1 | 17795 | 44 |
CNDP1 |
1.479e-02 | -4.21 | regulation of behavior | biological process | GO:0050795 | 75 | 2 | 18204 | 45 |
PTGDS,NLGN1 |
1.490e-02 | -4.21 | human chr7q11.22 | chromosome location | human chr7q11.22 | 8 | 1 | 26134 | 49 |
AUTS2 |
1.502e-02 | -4.20 | ZNF804A (zinc finger protein 804A) | protein interactions | 91752 | 6 | 1 | 19454 | 49 |
SPP1 |
1.502e-02 | -4.20 | NRG4 (neuregulin 4) | protein interactions | 145957 | 6 | 1 | 19454 | 49 |
ERBB4 |
1.502e-02 | -4.20 | MROH6 (maestro heat like repeat family member 6) | protein interactions | 642475 | 6 | 1 | 19454 | 49 |
FTL |
1.502e-02 | -4.20 | NEK5 (NIMA related kinase 5) | protein interactions | 341676 | 6 | 1 | 19454 | 49 |
FTL |
1.502e-02 | -4.20 | PGBD5 (piggyBac transposable element derived 5) | protein interactions | 79605 | 6 | 1 | 19454 | 49 |
FTL |
1.502e-02 | -4.20 | TPPP3 (tubulin polymerization promoting protein family member 3) | protein interactions | 51673 | 6 | 1 | 19454 | 49 |
PPP2R2B |
1.502e-02 | -4.20 | AKR1C4 (aldo-keto reductase family 1 member C4) | protein interactions | 1109 | 6 | 1 | 19454 | 49 |
PLXDC2 |
1.513e-02 | -4.19 | Peptidase_M20_dimer | interpro domains | IPR011650 | 6 | 1 | 18521 | 47 |
CNDP1 |
1.513e-02 | -4.19 | Peptidase_M20 | interpro domains | IPR002933 | 6 | 1 | 18521 | 47 |
CNDP1 |
1.513e-02 | -4.19 | Syndecan/Neurexin_dom | interpro domains | IPR027789 | 6 | 1 | 18521 | 47 |
NRXN3 |
1.513e-02 | -4.19 | IL-1RAcP-like_ig | interpro domains | IPR041416 | 6 | 1 | 18521 | 47 |
IL1RAPL1 |
1.513e-02 | -4.19 | GF_recep_IV | interpro domains | IPR032778 | 6 | 1 | 18521 | 47 |
ERBB4 |
1.514e-02 | -4.19 | oxidoreductase activity, acting on NAD(P)H | molecular function | GO:0016651 | 79 | 2 | 18094 | 43 |
CBR1,NDUFC2 |
1.516e-02 | -4.19 | extracellular space | cellular component | GO:0005615 | 3443 | 15 | 19108 | 47 |
APOD,FTH1,PTGDS,RNASE1,CD81,ITM2B,FTL,CD9,LRRTM3,SPP1,CBR1,RPL28,RPL11,MARCKSL1,B2M |
1.516e-02 | -4.19 | myotube differentiation | biological process | GO:0014902 | 76 | 2 | 18204 | 45 |
CD81,CD9 |
1.534e-02 | -4.18 | GZF1 (GDNF inducible zinc finger protein 1) | protein interactions | 64412 | 75 | 2 | 19454 | 49 |
RPL11,RPL28 |
1.535e-02 | -4.18 | immune effector process | biological process | GO:0002252 | 389 | 4 | 18204 | 45 |
B2M,ITM2A,CD81,PTGDS |
1.547e-02 | -4.17 | RYK (receptor like tyrosine kinase) | protein interactions | 6259 | 208 | 3 | 19454 | 49 |
ANK3,ITM2B,CTNNA2 |
1.566e-02 | -4.16 | leukocyte activation | biological process | GO:0045321 | 599 | 5 | 18204 | 45 |
PTGDS,CD81,ITM2A,PDE5A,B2M |
1.567e-02 | -4.16 | NLE1 (notchless homolog 1) | protein interactions | 54475 | 209 | 3 | 19454 | 49 |
RPL11,FTH1,RPL28 |
1.567e-02 | -4.16 | BMS1 (BMS1 ribosome biogenesis factor) | protein interactions | 9790 | 209 | 3 | 19454 | 49 |
RPL11,FTL,RPL28 |
1.573e-02 | -4.15 | CD1B (CD1b molecule) | protein interactions | 910 | 76 | 2 | 19454 | 49 |
ITM2B,B2M |
1.579e-02 | -4.15 | GABA-ergic synapse | cellular component | GO:0098982 | 78 | 2 | 19108 | 47 |
ERBB4,NLGN1 |
1.585e-02 | -4.14 | Ibuprofen Action Pathway | SMPDB pathways | SMP0000086 | 47 | 2 | 1369 | 6 |
CBR1,PTGDS |
1.595e-02 | -4.14 | localization | biological process | GO:0051179 | 4474 | 18 | 18204 | 45 |
ANK3,CD81,RNASEK,PTGDS,FTH1,EMC10,NLGN1,B2M,NDUFC2,CAPN3,RPL11,FCHSD2,ERBB4,PLLP,FTL,APOD,ZFYVE16,CD9 |
1.607e-02 | -4.13 | PTPRF (protein tyrosine phosphatase receptor type F) | protein interactions | 5792 | 211 | 3 | 19454 | 49 |
CLDND1,CBR1,OPALIN |
1.613e-02 | -4.13 | PDZK1IP1 (PDZK1 interacting protein 1) | protein interactions | 10158 | 77 | 2 | 19454 | 49 |
APOD,CD81 |
1.618e-02 | -4.12 | regulation of transport | biological process | GO:0051049 | 1621 | 9 | 18204 | 45 |
CAPN3,CD81,ANK3,B2M,SPP1,NLGN1,APOD,ZFYVE16,IL1RAPL1 |
1.624e-02 | -4.12 | regulation of cell differentiation | biological process | GO:0045595 | 1622 | 9 | 18204 | 45 |
PDE5A,NKX6-2,CAPN3,B2M,SPP1,LAMA2,NLGN1,OPALIN,IL1RAPL1 |
1.630e-02 | -4.12 | PAN2 (poly(A) specific ribonuclease subunit PAN2) | protein interactions | 9924 | 388 | 4 | 19454 | 49 |
CTNNA2,RPL11,RPL28,MARCKSL1 |
1.632e-02 | -4.12 | regulation of glial cell differentiation | biological process | GO:0045685 | 79 | 2 | 18204 | 45 |
OPALIN,NKX6-2 |
1.648e-02 | -4.11 | NSA2 (NSA2 ribosome biogenesis factor) | protein interactions | 10412 | 213 | 3 | 19454 | 49 |
CD9,RPL28,RPL11 |
1.652e-02 | -4.10 | MHC class II protein binding | molecular function | GO:0042289 | 7 | 1 | 18094 | 43 |
CD81 |
1.652e-02 | -4.10 | RNA endonuclease activity, producing 3'-phosphomonoesters | molecular function | GO:0016892 | 7 | 1 | 18094 | 43 |
RNASE1 |
1.652e-02 | -4.10 | ANKRD40 (ankyrin repeat domain 40) | protein interactions | 91369 | 78 | 2 | 19454 | 49 |
NDUFC2,LAMA2 |
1.652e-02 | -4.10 | CPA4 (carboxypeptidase A4) | protein interactions | 51200 | 78 | 2 | 19454 | 49 |
FTH1,PPP2R2B |
1.673e-02 | -4.09 | PP2APR55 | prints domains | PR00600 | 4 | 1 | 5227 | 22 |
PPP2R2B |
1.673e-02 | -4.09 | ALPHACATENIN | prints domains | PR00805 | 4 | 1 | 5227 | 22 |
CTNNA2 |
1.680e-02 | -4.09 | Uptake and function of diphtheria toxin | REACTOME pathways | R-HSA-5336415 | 6 | 1 | 10285 | 29 |
CD9 |
1.681e-02 | -4.09 | Receptor L-domain | gene3d domains | 3.80.20.20 | 7 | 1 | 14470 | 35 |
ERBB4 |
1.693e-02 | -4.08 | PRDM15 (PR/SET domain 15) | protein interactions | 63977 | 79 | 2 | 19454 | 49 |
RPL28,RPL11 |
1.693e-02 | -4.08 | NCS1 (neuronal calcium sensor 1) | protein interactions | 23413 | 79 | 2 | 19454 | 49 |
SPP1,IL1RAPL1 |
1.700e-02 | -4.07 | positive regulation of transport | biological process | GO:0051050 | 844 | 6 | 18204 | 45 |
CAPN3,CD81,ANK3,B2M,SPP1,NLGN1 |
1.711e-02 | -4.07 | positive regulation of cytokine production involved in immune response | biological process | GO:0002720 | 81 | 2 | 18204 | 45 |
B2M,CD81 |
1.717e-02 | -4.06 | GAF | smart domains | SM00065 | 7 | 1 | 9717 | 24 |
PDE5A |
1.718e-02 | -4.06 | trans-synaptic signaling by trans-synaptic complex | biological process | GO:0099545 | 7 | 1 | 18204 | 45 |
IL1RAPL1 |
1.718e-02 | -4.06 | negative regulation of cardiac muscle contraction | biological process | GO:0055118 | 7 | 1 | 18204 | 45 |
PDE5A |
1.718e-02 | -4.06 | negative regulation of dendritic spine morphogenesis | biological process | GO:0061002 | 7 | 1 | 18204 | 45 |
NLGN1 |
1.718e-02 | -4.06 | cellular response to magnesium ion | biological process | GO:0071286 | 7 | 1 | 18204 | 45 |
ANK3 |
1.718e-02 | -4.06 | peripheral nervous system axon regeneration | biological process | GO:0014012 | 7 | 1 | 18204 | 45 |
APOD |
1.718e-02 | -4.06 | negative regulation of Arp2/3 complex-mediated actin nucleation | biological process | GO:0034316 | 7 | 1 | 18204 | 45 |
CTNNA2 |
1.718e-02 | -4.06 | cellular response to iron ion | biological process | GO:0071281 | 7 | 1 | 18204 | 45 |
B2M |
1.718e-02 | -4.06 | regulation of male germ cell proliferation | biological process | GO:2000254 | 7 | 1 | 18204 | 45 |
PTGDS |
1.718e-02 | -4.06 | Furin-like | pfam domains | PF00757 | 7 | 1 | 17795 | 44 |
ERBB4 |
1.718e-02 | -4.06 | Recep_L_domain | pfam domains | PF01030 | 7 | 1 | 17795 | 44 |
ERBB4 |
1.718e-02 | -4.06 | GAF | pfam domains | PF01590 | 7 | 1 | 17795 | 44 |
PDE5A |
1.723e-02 | -4.06 | leukocyte mediated immunity | biological process | GO:0002443 | 221 | 3 | 18204 | 45 |
B2M,CD81,PTGDS |
1.733e-02 | -4.06 | KCNJ6 (potassium inwardly rectifying channel subfamily J member 6) | protein interactions | 3763 | 80 | 2 | 19454 | 49 |
APOD,PLLP |
1.739e-02 | -4.05 | Golgi apparatus | cellular component | GO:0005794 | 1645 | 9 | 19108 | 47 |
B2M,RNASEK,SPP1,ITM2B,ANK3,NLGN1,ITM2A,PTGDS,OPALIN |
1.750e-02 | -4.05 | SKI6 (exosome non-catalytic core subunit SKI6) | protein interactions | 853109 | 7 | 1 | 19454 | 49 |
CAPN3 |
1.750e-02 | -4.05 | C2orf72 (chromosome 2 open reading frame 72) | protein interactions | 257407 | 7 | 1 | 19454 | 49 |
CD81 |
1.750e-02 | -4.05 | FIBCD1 (fibrinogen C domain containing 1) | protein interactions | 84929 | 7 | 1 | 19454 | 49 |
CLDND1 |
1.750e-02 | -4.05 | CYP4F8 (cytochrome P450 family 4 subfamily F member 8) | protein interactions | 11283 | 7 | 1 | 19454 | 49 |
APOD |
1.750e-02 | -4.05 | RIMS4 (regulating synaptic membrane exocytosis 4) | protein interactions | 140730 | 7 | 1 | 19454 | 49 |
SPP1 |
1.750e-02 | -4.05 | CAPN9 (calpain 9) | protein interactions | 10753 | 7 | 1 | 19454 | 49 |
CAPN3 |
1.750e-02 | -4.05 | HS3ST3B1 (heparan sulfate-glucosamine 3-sulfotransferase 3B1) | protein interactions | 9953 | 7 | 1 | 19454 | 49 |
FTL |
1.750e-02 | -4.05 | CHL1 (cell adhesion molecule L1 like) | protein interactions | 10752 | 7 | 1 | 19454 | 49 |
ANK3 |
1.763e-02 | -4.04 | GAF | interpro domains | IPR003018 | 7 | 1 | 18521 | 47 |
PDE5A |
1.763e-02 | -4.04 | Furin-like_Cys-rich_dom | interpro domains | IPR006211 | 7 | 1 | 18521 | 47 |
ERBB4 |
1.763e-02 | -4.04 | Alpha-catenin/vinculin-like_sf | interpro domains | IPR036723 | 7 | 1 | 18521 | 47 |
CTNNA2 |
1.763e-02 | -4.04 | Rcpt_L-dom | interpro domains | IPR000494 | 7 | 1 | 18521 | 47 |
ERBB4 |
1.763e-02 | -4.04 | Rcpt_L-dom_sf | interpro domains | IPR036941 | 7 | 1 | 18521 | 47 |
ERBB4 |
1.765e-02 | -4.04 | humerus | COSMIC cancer mutations | humerus | 546 | 5 | 16828 | 47 |
NLGN1,PPP2R2B,LAMA2,NRXN3,CD9 |
1.773e-02 | -4.03 | follicular_lymphoma | COSMIC cancer mutations | follicular_lymphoma | 1209 | 8 | 16828 | 47 |
ANK3,NRXN3,NLGN1,OMG,AUTS2,PLXDC2,LAMA2,CADM2 |
1.774e-02 | -4.03 | CAND2 (cullin associated and neddylation dissociated 2 (putative)) | protein interactions | 23066 | 81 | 2 | 19454 | 49 |
BCL2L14,OPALIN |
1.774e-02 | -4.03 | KLHL15 (kelch like family member 15) | protein interactions | 80311 | 81 | 2 | 19454 | 49 |
PPP2R2B,RPL28 |
1.783e-02 | -4.03 | trans-Golgi Network Vesicle Budding | REACTOME pathways | R-HSA-199992 | 73 | 2 | 10285 | 29 |
FTL,FTH1 |
1.783e-02 | -4.03 | Clathrin derived vesicle budding | REACTOME pathways | R-HSA-421837 | 73 | 2 | 10285 | 29 |
FTL,FTH1 |
1.786e-02 | -4.03 | regulation of developmental process | biological process | GO:0050793 | 2540 | 12 | 18204 | 45 |
ERBB4,PDE5A,NKX6-2,LRRTM3,CAPN3,NLGN1,OPALIN,B2M,SPP1,LAMA2,EMC10,IL1RAPL1 |
1.791e-02 | -4.02 | protein localization to vacuole | biological process | GO:0072665 | 83 | 2 | 18204 | 45 |
ZFYVE16,CD81 |
1.792e-02 | -4.02 | vacuole | cellular component | GO:0005773 | 857 | 6 | 19108 | 47 |
NDUFC2,ANK3,FTH1,B2M,RNASEK,FTL |
1.801e-02 | -4.02 | Arachidonic acid metabolism | KEGG pathways | ko00590 | 62 | 2 | 7161 | 24 |
CBR1,PTGDS |
1.801e-02 | -4.02 | Arachidonic acid metabolism | KEGG pathways | hsa00590 | 62 | 2 | 7161 | 24 |
PTGDS,CBR1 |
1.806e-02 | -4.01 | striated muscle cell differentiation | biological process | GO:0051146 | 225 | 3 | 18204 | 45 |
CAPN3,CD81,CD9 |
1.816e-02 | -4.01 | TUBA8 (tubulin alpha 8) | protein interactions | 51807 | 82 | 2 | 19454 | 49 |
CD81,RPL28 |
1.816e-02 | -4.01 | RPS4Y1 (ribosomal protein S4 Y-linked 1) | protein interactions | 6192 | 82 | 2 | 19454 | 49 |
FTL,CD81 |
1.832e-02 | -4.00 | glutamatergic synapse | cellular component | GO:0098978 | 412 | 4 | 19108 | 47 |
ERBB4,NLGN1,IL1RAPL1,LRRTM3 |
1.858e-02 | -3.99 | SERPINB8 (serpin family B member 8) | protein interactions | 5271 | 83 | 2 | 19454 | 49 |
PPP2R2B,PLXDC2 |
1.858e-02 | -3.99 | ZNHIT6 (zinc finger HIT-type containing 6) | protein interactions | 54680 | 83 | 2 | 19454 | 49 |
FTL,RPL11 |
1.886e-02 | -3.97 | metallodipeptidase activity | molecular function | GO:0070573 | 8 | 1 | 18094 | 43 |
CNDP1 |
1.886e-02 | -3.97 | ubiquitin ligase inhibitor activity | molecular function | GO:1990948 | 8 | 1 | 18094 | 43 |
RPL11 |
1.886e-02 | -3.97 | sodium ion binding | molecular function | GO:0031402 | 8 | 1 | 18094 | 43 |
CAPN3 |
1.900e-02 | -3.96 | CLDN7 (claudin 7) | protein interactions | 1366 | 84 | 2 | 19454 | 49 |
ITM2A,APOD |
1.900e-02 | -3.96 | GORAB (golgin, RAB6 interacting) | protein interactions | 92344 | 84 | 2 | 19454 | 49 |
CD81,APOD |
1.907e-02 | -3.96 | regulation of cell activation | biological process | GO:0050865 | 630 | 5 | 18204 | 45 |
B2M,PDE5A,CD9,CD81,CAPN3 |
1.915e-02 | -3.96 | protein localization to cell junction | biological process | GO:1902414 | 86 | 2 | 18204 | 45 |
NLGN1,ERBB4 |
1.919e-02 | -3.95 | - | gene3d domains | 3.30.450.40 | 8 | 1 | 14470 | 35 |
PDE5A |
1.929e-02 | -3.95 | regulation of cell motility | biological process | GO:2000145 | 1122 | 7 | 18204 | 45 |
APOD,ERBB4,CD9,LAMA2,CTNNA2,CD81,EMC10 |
1.933e-02 | -3.95 | cellular component organization | biological process | GO:0016043 | 5636 | 21 | 18204 | 45 |
ANK3,RNASEK,NRXN3,EMC10,NLGN1,B2M,NDUFC2,OMG,RPL11,CAPN3,ERBB4,AUTS2,FCHSD2,CTNNA2,MARCKSL1,IL1RAPL1,ZFYVE16,APOD,SPP1,LAMA2,CD9 |
1.935e-02 | -3.95 | regulation of leukocyte migration | biological process | GO:0002685 | 231 | 3 | 18204 | 45 |
CD9,APOD,CD81 |
1.936e-02 | -3.94 | alcohol binding | molecular function | GO:0043178 | 90 | 2 | 18094 | 43 |
APOD,CD81 |
1.943e-02 | -3.94 | SIRPA (signal regulatory protein alpha) | protein interactions | 140885 | 85 | 2 | 19454 | 49 |
CD81,FTH1 |
1.951e-02 | -3.94 | HFE-transferrin receptor complex | cellular component | GO:1990712 | 8 | 1 | 19108 | 47 |
B2M |
1.951e-02 | -3.94 | MHC class I peptide loading complex | cellular component | GO:0042824 | 8 | 1 | 19108 | 47 |
B2M |
1.960e-02 | -3.93 | LamB | smart domains | SM00281 | 8 | 1 | 9717 | 24 |
LAMA2 |
1.961e-02 | -3.93 | regulation of skeletal muscle tissue regeneration | biological process | GO:0043416 | 8 | 1 | 18204 | 45 |
CAPN3 |
1.961e-02 | -3.93 | regulation of synapse structural plasticity | biological process | GO:0051823 | 8 | 1 | 18204 | 45 |
CTNNA2 |
1.961e-02 | -3.93 | positive regulation of Arp2/3 complex-mediated actin nucleation | biological process | GO:2000601 | 8 | 1 | 18204 | 45 |
FCHSD2 |
1.961e-02 | -3.93 | positive regulation of synaptic vesicle recycling | biological process | GO:1903423 | 8 | 1 | 18204 | 45 |
NLGN1 |
1.961e-02 | -3.93 | regulation of iron ion transport | biological process | GO:0034756 | 8 | 1 | 18204 | 45 |
B2M |
1.961e-02 | -3.93 | multinuclear osteoclast differentiation | biological process | GO:0072674 | 8 | 1 | 18204 | 45 |
CD81 |
1.961e-02 | -3.93 | regulation of synaptic transmission, cholinergic | biological process | GO:0032222 | 8 | 1 | 18204 | 45 |
LAMA2 |
1.961e-02 | -3.93 | regulation of nitric oxide mediated signal transduction | biological process | GO:0010749 | 8 | 1 | 18204 | 45 |
PDE5A |
1.961e-02 | -3.93 | regulation of germ cell proliferation | biological process | GO:1905936 | 8 | 1 | 18204 | 45 |
PTGDS |
1.961e-02 | -3.93 | ERBB4 signaling pathway | biological process | GO:0038130 | 8 | 1 | 18204 | 45 |
ERBB4 |
1.961e-02 | -3.93 | Laminin_B | pfam domains | PF00052 | 8 | 1 | 17795 | 44 |
LAMA2 |
1.979e-02 | -3.92 | ribosome | cellular component | GO:0005840 | 234 | 3 | 19108 | 47 |
APOD,RPL11,RPL28 |
1.986e-02 | -3.92 | PLBD1 (phospholipase B domain containing 1) | protein interactions | 79887 | 86 | 2 | 19454 | 49 |
FTH1,PPP2R2B |
1.986e-02 | -3.92 | NEMP1 (nuclear envelope integral membrane protein 1) | protein interactions | 23306 | 86 | 2 | 19454 | 49 |
B2M,CD81 |
1.994e-02 | -3.92 | cell periphery | cellular component | GO:0071944 | 6020 | 22 | 19108 | 47 |
RNASEK,CD9,ITM2B,ERBB4,CADM2,CTNNA2,OPALIN,IL1RAPL1,FCHSD2,LAMA2,LRRTM3,NRXN3,NDUFC2,CAPN3,ITM2A,CD81,CLDND1,B2M,MARCKSL1,ANK3,OMG,NLGN1 |
1.998e-02 | -3.91 | SCN2A (sodium voltage-gated channel alpha subunit 2) | protein interactions | 6326 | 8 | 1 | 19454 | 49 |
ANK3 |
1.998e-02 | -3.91 | FAM216A (family with sequence similarity 216 member A) | protein interactions | 29902 | 8 | 1 | 19454 | 49 |
FTL |
1.998e-02 | -3.91 | MS4A12 (membrane spanning 4-domains A12) | protein interactions | 54860 | 8 | 1 | 19454 | 49 |
PLLP |
1.998e-02 | -3.91 | TAFA1 (TAFA chemokine like family member 1) | protein interactions | 407738 | 8 | 1 | 19454 | 49 |
NRXN3 |
1.998e-02 | -3.91 | Emc1 (ER membrane protein complex subunit 1) | protein interactions | 230866 | 8 | 1 | 19454 | 49 |
EMC10 |
1.998e-02 | -3.91 | GJA4 (gap junction protein alpha 4) | protein interactions | 2701 | 8 | 1 | 19454 | 49 |
CD81 |
1.998e-02 | -3.91 | PTGER1 (prostaglandin E receptor 1) | protein interactions | 5731 | 8 | 1 | 19454 | 49 |
PTGDS |
1.998e-02 | -3.91 | LILRB1 (leukocyte immunoglobulin like receptor B1) | protein interactions | 10859 | 8 | 1 | 19454 | 49 |
B2M |
1.998e-02 | -3.91 | SH3BGR (SH3 domain binding glutamate rich protein) | protein interactions | 6450 | 8 | 1 | 19454 | 49 |
FCHSD2 |
1.998e-02 | -3.91 | CD1D (CD1d molecule) | protein interactions | 912 | 8 | 1 | 19454 | 49 |
B2M |
1.998e-02 | -3.91 | ZDHHC4 (zinc finger DHHC-type palmitoyltransferase 4) | protein interactions | 55146 | 8 | 1 | 19454 | 49 |
CLDND1 |
1.998e-02 | -3.91 | MTERF2 (mitochondrial transcription termination factor 2) | protein interactions | 80298 | 8 | 1 | 19454 | 49 |
APOD |
1.998e-02 | -3.91 | ZCWPW1 (zinc finger CW-type and PWWP domain containing 1) | protein interactions | 55063 | 8 | 1 | 19454 | 49 |
PLXDC2 |
1.998e-02 | -3.91 | Tamalin (trafficking regulator and scaffold protein tamalin) | protein interactions | 192254 | 8 | 1 | 19454 | 49 |
FCHSD2 |
1.998e-02 | -3.91 | CAPN8 (calpain 8) | protein interactions | 388743 | 8 | 1 | 19454 | 49 |
CAPN3 |
2.013e-02 | -3.91 | RNaseA_AS | interpro domains | IPR023411 | 8 | 1 | 18521 | 47 |
RNASE1 |
2.013e-02 | -3.91 | Laminin_IV | interpro domains | IPR000034 | 8 | 1 | 18521 | 47 |
LAMA2 |
2.013e-02 | -3.91 | GAF-like_dom_sf | interpro domains | IPR029016 | 8 | 1 | 18521 | 47 |
PDE5A |
2.028e-02 | -3.90 | hand | COSMIC cancer mutations | hand | 566 | 5 | 16828 | 47 |
LAMA2,NLGN1,ZNF565,CADM2,ERBB4 |
2.029e-02 | -3.90 | MICA (MHC class I polypeptide-related sequence A) | protein interactions | 100507436 | 87 | 2 | 19454 | 49 |
CLDND1,ITM2B |
2.029e-02 | -3.90 | CMTM6 (CKLF like MARVEL transmembrane domain containing 6) | protein interactions | 54918 | 87 | 2 | 19454 | 49 |
OPALIN,CLDND1 |
2.029e-02 | -3.90 | FGR (FGR proto-oncogene, Src family tyrosine kinase) | protein interactions | 2268 | 87 | 2 | 19454 | 49 |
APOD,ERBB4 |
2.042e-02 | -3.89 | negative regulation of protein modification by small protein conjugation or removal | biological process | GO:1903321 | 89 | 2 | 18204 | 45 |
RPL11,CAPN3 |
2.059e-02 | -3.88 | protein phosphatase regulator activity | molecular function | GO:0019888 | 93 | 2 | 18094 | 43 |
PPP2R2B,PPP1R14A |
2.073e-02 | -3.88 | NLGN3 (neuroligin 3) | protein interactions | 54413 | 88 | 2 | 19454 | 49 |
NRXN3,NLGN1 |
2.073e-02 | -3.88 | RAP2A (RAP2A, member of RAS oncogene family) | protein interactions | 5911 | 88 | 2 | 19454 | 49 |
FTH1,FTL |
2.086e-02 | -3.87 | KPNA3 (karyopherin subunit alpha 3) | protein interactions | 3839 | 233 | 3 | 19454 | 49 |
RPL11,B2M,FTL |
2.088e-02 | -3.87 | NEUROLIGIN | prints domains | PR01090 | 5 | 1 | 5227 | 22 |
NLGN1 |
2.088e-02 | -3.87 | MALPROTEIN | prints domains | PR01884 | 5 | 1 | 5227 | 22 |
PLLP |
2.092e-02 | -3.87 | protein localization to cell periphery | biological process | GO:1990778 | 238 | 3 | 18204 | 45 |
CD81,ANK3,ERBB4 |
2.102e-02 | -3.86 | intracellular monoatomic cation homeostasis | biological process | GO:0030003 | 428 | 4 | 18204 | 45 |
RNASEK,FTL,FTH1,B2M |
2.117e-02 | -3.85 | FNDC9 (fibronectin type III domain containing 9) | protein interactions | 408263 | 89 | 2 | 19454 | 49 |
ITM2A,PLLP |
2.117e-02 | -3.85 | SERPINB13 (serpin family B member 13) | protein interactions | 5275 | 89 | 2 | 19454 | 49 |
FTH1,PPP2R2B |
2.119e-02 | -3.85 | 5S rRNA binding | molecular function | GO:0008097 | 9 | 1 | 18094 | 43 |
RPL11 |
2.119e-02 | -3.85 | carbonyl reductase (NADPH) activity | molecular function | GO:0004090 | 9 | 1 | 18094 | 43 |
CBR1 |
2.121e-02 | -3.85 | axon | cellular component | GO:0030424 | 650 | 5 | 19108 | 47 |
CADM2,IL1RAPL1,CTNNA2,AUTS2,ANK3 |
2.147e-02 | -3.84 | SDCBP (syndecan binding protein) | protein interactions | 6386 | 422 | 4 | 19454 | 49 |
FTH1,RPL28,FTL,CD9 |
2.156e-02 | -3.84 | CREB3 (cAMP responsive element binding protein 3) | protein interactions | 10488 | 236 | 3 | 19454 | 49 |
PLLP,ITM2B,APOD |
2.162e-02 | -3.83 | SEMG1 (semenogelin 1) | protein interactions | 6406 | 90 | 2 | 19454 | 49 |
FTH1,PPP2R2B |
2.162e-02 | -3.83 | Prkab1 (protein kinase AMP-activated non-catalytic subunit beta 1) | protein interactions | 83803 | 90 | 2 | 19454 | 49 |
RPL28,RPL11 |
2.162e-02 | -3.83 | RARS2 (arginyl-tRNA synthetase 2, mitochondrial) | protein interactions | 57038 | 90 | 2 | 19454 | 49 |
BCL2L14,PLXDC2 |
2.173e-02 | -3.83 | purine ribonucleotide catabolic process | biological process | GO:0009154 | 92 | 2 | 18204 | 45 |
PDE5A,ENO4 |
2.180e-02 | -3.83 | cell surface | cellular component | GO:0009986 | 896 | 6 | 19108 | 47 |
IL1RAPL1,CD9,NLGN1,B2M,CLDND1,ANK3 |
2.180e-02 | -3.83 | CEBPZ (CCAAT enhancer binding protein zeta) | protein interactions | 10153 | 237 | 3 | 19454 | 49 |
RPL28,RPL11,LRRTM3 |
2.181e-02 | -3.83 | negative regulation of protein metabolic process | biological process | GO:0051248 | 893 | 6 | 18204 | 45 |
CAPN3,RPL11,ITM2B,APOD,ITM2A,DBNDD2 |
2.183e-02 | -3.82 | inorganic ion homeostasis | biological process | GO:0098771 | 433 | 4 | 18204 | 45 |
B2M,ANK3,FTH1,FTL |
2.193e-02 | -3.82 | spectrin-associated cytoskeleton | cellular component | GO:0014731 | 9 | 1 | 19108 | 47 |
ANK3 |
2.197e-02 | -3.82 | RANBP9 (RAN binding protein 9) | protein interactions | 10048 | 425 | 4 | 19454 | 49 |
SPP1,APOD,CBR1,RPL28 |
2.202e-02 | -3.82 | ZU5 | smart domains | SM00218 | 9 | 1 | 9717 | 24 |
ANK3 |
2.203e-02 | -3.82 | cellular response to nicotine | biological process | GO:0071316 | 9 | 1 | 18204 | 45 |
B2M |
2.203e-02 | -3.82 | hindbrain radial glia guided cell migration | biological process | GO:0021932 | 9 | 1 | 18204 | 45 |
CTNNA2 |
2.203e-02 | -3.82 | negative regulation of actin nucleation | biological process | GO:0051126 | 9 | 1 | 18204 | 45 |
CTNNA2 |
2.203e-02 | -3.82 | negative regulation of striated muscle contraction | biological process | GO:0045988 | 9 | 1 | 18204 | 45 |
PDE5A |
2.203e-02 | -3.82 | negative regulation of ubiquitin protein ligase activity | biological process | GO:1904667 | 9 | 1 | 18204 | 45 |
RPL11 |
2.203e-02 | -3.82 | protein localization to axon | biological process | GO:0099612 | 9 | 1 | 18204 | 45 |
ANK3 |
2.203e-02 | -3.82 | positive regulation of T-helper 2 cell cytokine production | biological process | GO:2000553 | 9 | 1 | 18204 | 45 |
CD81 |
2.204e-02 | -3.81 | EF-hand_6 | pfam domains | PF13405 | 9 | 1 | 17795 | 44 |
CAPN3 |
2.207e-02 | -3.81 | PTPN21 (protein tyrosine phosphatase non-receptor type 21) | protein interactions | 11099 | 91 | 2 | 19454 | 49 |
ERBB4,RPL28 |
2.207e-02 | -3.81 | ACVR1B (activin A receptor type 1B) | protein interactions | 91 | 91 | 2 | 19454 | 49 |
CLDND1,OPALIN |
2.217e-02 | -3.81 | negative regulation of post-translational protein modification | biological process | GO:1901874 | 93 | 2 | 18204 | 45 |
CAPN3,RPL11 |
2.227e-02 | -3.80 | human chr6q22.33 | chromosome location | human chr6q22.33 | 12 | 1 | 26134 | 49 |
LAMA2 |
2.233e-02 | -3.80 | amide binding | molecular function | GO:0033218 | 254 | 3 | 18094 | 43 |
ITM2B,NLGN1,ITM2A |
2.234e-02 | -3.80 | Transport of fatty acids | REACTOME pathways | R-HSA-804914 | 8 | 1 | 10285 | 29 |
APOD |
2.234e-02 | -3.80 | Axonal growth inhibition (RHOA activation) | REACTOME pathways | R-HSA-193634 | 8 | 1 | 10285 | 29 |
OMG |
2.234e-02 | -3.80 | Downregulation of ERBB4 signaling | REACTOME pathways | R-HSA-1253288 | 8 | 1 | 10285 | 29 |
ERBB4 |
2.245e-02 | -3.80 | MCEE (methylmalonyl-CoA epimerase) | protein interactions | 84693 | 9 | 1 | 19454 | 49 |
CD81 |
2.245e-02 | -3.80 | MUC4 (mucin 4, cell surface associated) | protein interactions | 4585 | 9 | 1 | 19454 | 49 |
ERBB4 |
2.245e-02 | -3.80 | NRXN2 (neurexin 2) | protein interactions | 9379 | 9 | 1 | 19454 | 49 |
NLGN1 |
2.245e-02 | -3.80 | AKR1D1 (aldo-keto reductase family 1 member D1) | protein interactions | 6718 | 9 | 1 | 19454 | 49 |
PLXDC2 |
2.245e-02 | -3.80 | GOLGA7B (golgin A7 family member B) | protein interactions | 401647 | 9 | 1 | 19454 | 49 |
CLDND1 |
2.245e-02 | -3.80 | Tyw3 (tRNA-yW synthesizing protein 3 homolog (S. cerevisiae)) | protein interactions | 209584 | 9 | 1 | 19454 | 49 |
CTNNA2 |
2.245e-02 | -3.80 | IER5 (immediate early response 5) | protein interactions | 51278 | 9 | 1 | 19454 | 49 |
PPP2R2B |
2.245e-02 | -3.80 | SLC35C1 (solute carrier family 35 member C1) | protein interactions | 55343 | 9 | 1 | 19454 | 49 |
APOD |
2.245e-02 | -3.80 | ADAM2 (ADAM metallopeptidase domain 2) | protein interactions | 2515 | 9 | 1 | 19454 | 49 |
CD9 |
2.245e-02 | -3.80 | CHKA (choline kinase alpha) | protein interactions | 1119 | 9 | 1 | 19454 | 49 |
FCHSD2 |
2.245e-02 | -3.80 | RBM43 (RNA binding motif protein 43) | protein interactions | 375287 | 9 | 1 | 19454 | 49 |
FTL |
2.245e-02 | -3.80 | CD164L2 (CD164 molecule like 2) | protein interactions | 388611 | 9 | 1 | 19454 | 49 |
PLLP |
2.245e-02 | -3.80 | ZNF888 (zinc finger protein 888) | protein interactions | 388559 | 9 | 1 | 19454 | 49 |
RPL11 |
2.245e-02 | -3.80 | PI3 (peptidase inhibitor 3) | protein interactions | 5266 | 9 | 1 | 19454 | 49 |
PPP2R2B |
2.246e-02 | -3.80 | Infectious disease | REACTOME pathways | R-HSA-5663205 | 388 | 4 | 10285 | 29 |
B2M,CD9,RPL28,RPL11 |
2.249e-02 | -3.79 | intracellular monoatomic ion homeostasis | biological process | GO:0006873 | 437 | 4 | 18204 | 45 |
B2M,FTL,RNASEK,FTH1 |
2.253e-02 | -3.79 | ZNF770 (zinc finger protein 770) | protein interactions | 54989 | 92 | 2 | 19454 | 49 |
RPL28,RPL11 |
2.253e-02 | -3.79 | TAF1D (TATA-box binding protein associated factor, RNA polymerase I subunit D) | protein interactions | 79101 | 92 | 2 | 19454 | 49 |
RPL28,RPL11 |
2.271e-02 | -3.78 | signaling receptor binding | molecular function | GO:0005102 | 1493 | 8 | 18094 | 43 |
CD9,LAMA2,SPP1,ERBB4,CD81,NRXN3,NLGN1,IL1RAPL1 |
2.275e-02 | -3.78 | LAMININ_IVA | prosite domains | PS51115 | 8 | 1 | 12186 | 35 |
LAMA2 |
2.275e-02 | -3.78 | RNASE_PANCREATIC | prosite domains | PS00127 | 8 | 1 | 12186 | 35 |
RNASE1 |
2.299e-02 | -3.77 | LCP1 (lymphocyte cytosolic protein 1) | protein interactions | 3936 | 93 | 2 | 19454 | 49 |
PPP2R2B,FTH1 |
2.299e-02 | -3.77 | CHRM4 (cholinergic receptor muscarinic 4) | protein interactions | 1132 | 93 | 2 | 19454 | 49 |
CD81,B2M |
2.299e-02 | -3.77 | MYADM (myeloid associated differentiation marker) | protein interactions | 91663 | 93 | 2 | 19454 | 49 |
CLDND1,OPALIN |
2.299e-02 | -3.77 | FKBP15 (FKBP prolyl isomerase family member 15) | protein interactions | 23307 | 93 | 2 | 19454 | 49 |
ZFYVE16,PDE5A |
2.310e-02 | -3.77 | regulation of locomotion | biological process | GO:0040012 | 1164 | 7 | 18204 | 45 |
CD81,EMC10,APOD,ERBB4,CD9,LAMA2,CTNNA2 |
2.324e-02 | -3.76 | N-glycosylation by oligosaccharyltransferase | KEGG pathways | hsa_M00072 | 7 | 1 | 7161 | 24 |
DAD1 |
2.324e-02 | -3.76 | N-glycosylation by oligosaccharyltransferase | KEGG pathways | M00072 | 7 | 1 | 7161 | 24 |
DAD1 |
2.340e-02 | -3.76 | transport | biological process | GO:0006810 | 3615 | 15 | 18204 | 45 |
CD81,RNASEK,ANK3,PTGDS,FTH1,NDUFC2,B2M,NLGN1,PLLP,FCHSD2,ERBB4,FTL,CD9,APOD,ZFYVE16 |
2.345e-02 | -3.75 | Prkaa1 (protein kinase AMP-activated catalytic subunit alpha 1) | protein interactions | 65248 | 94 | 2 | 19454 | 49 |
RPL28,RPL11 |
2.351e-02 | -3.75 | DDX31 (DEAD-box helicase 31) | protein interactions | 64794 | 244 | 3 | 19454 | 49 |
RPL11,RPL28,B2M |
2.352e-02 | -3.75 | NAD+ nucleosidase activity | molecular function | GO:0003953 | 10 | 1 | 18094 | 43 |
IL1RAPL1 |
2.352e-02 | -3.75 | interleukin-1 binding | molecular function | GO:0019966 | 10 | 1 | 18094 | 43 |
IL1RAPL1 |
2.352e-02 | -3.75 | negative regulation of response to wounding | biological process | GO:1903035 | 96 | 2 | 18204 | 45 |
CD9,SPP1 |
2.353e-02 | -3.75 | protein targeting | biological process | GO:0006605 | 249 | 3 | 18204 | 45 |
NLGN1,ZFYVE16,RPL11 |
2.386e-02 | -3.74 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | KEGG pathways | hsa05412 | 72 | 2 | 7161 | 24 |
CTNNA2,LAMA2 |
2.386e-02 | -3.74 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | KEGG pathways | ko05412 | 72 | 2 | 7161 | 24 |
LAMA2,CTNNA2 |
2.397e-02 | -3.73 | regulation of localization | biological process | GO:0032879 | 2028 | 10 | 18204 | 45 |
IL1RAPL1,ZFYVE16,APOD,NLGN1,SPP1,B2M,ANK3,CAPN3,CD81,ERBB4 |
2.401e-02 | -3.73 | PRKD2 (protein kinase D2) | protein interactions | 25865 | 246 | 3 | 19454 | 49 |
CBR1,PPP2R2B,OPALIN |
2.405e-02 | -3.73 | lung-carcinoma-mixed_small_cell_carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-mixed_small_cell_carcinoma-adenocarcinoma | 86 | 2 | 16828 | 47 |
LAMA2,NRXN3 |
2.411e-02 | -3.73 | human chr3q25.33 | chromosome location | human chr3q25.33 | 13 | 1 | 26134 | 49 |
TRIM59 |
2.433e-02 | -3.72 | MHC class I protein complex | cellular component | GO:0042612 | 10 | 1 | 19108 | 47 |
B2M |
2.433e-02 | -3.72 | tetraspanin-enriched microdomain | cellular component | GO:0097197 | 10 | 1 | 19108 | 47 |
CD81 |
2.433e-02 | -3.72 | vacuolar proton-transporting V-type ATPase, V0 domain | cellular component | GO:0000220 | 10 | 1 | 19108 | 47 |
RNASEK |
2.433e-02 | -3.72 | EMC complex | cellular component | GO:0072546 | 10 | 1 | 19108 | 47 |
EMC10 |
2.444e-02 | -3.71 | ribonucleotide catabolic process | biological process | GO:0009261 | 98 | 2 | 18204 | 45 |
PDE5A,ENO4 |
2.444e-02 | -3.71 | human chr14q11.2 | chromosome location | human chr14q11.2 | 129 | 2 | 26134 | 49 |
RNASE1,DAD1 |
2.445e-02 | -3.71 | negative regulation of cell fate commitment | biological process | GO:0010454 | 10 | 1 | 18204 | 45 |
NKX6-2 |
2.445e-02 | -3.71 | cellular response to salt stress | biological process | GO:0071472 | 10 | 1 | 18204 | 45 |
CAPN3 |
2.445e-02 | -3.71 | Golgi lumen acidification | biological process | GO:0061795 | 10 | 1 | 18204 | 45 |
RNASEK |
2.445e-02 | -3.71 | dendrite extension | biological process | GO:0097484 | 10 | 1 | 18204 | 45 |
AUTS2 |
2.445e-02 | -3.71 | pancreatic A cell differentiation | biological process | GO:0003310 | 10 | 1 | 18204 | 45 |
NKX6-2 |
2.445e-02 | -3.71 | positive regulation of B cell receptor signaling pathway | biological process | GO:0050861 | 10 | 1 | 18204 | 45 |
CD81 |
2.445e-02 | -3.71 | positive regulation of CD4-positive, alpha-beta T cell proliferation | biological process | GO:2000563 | 10 | 1 | 18204 | 45 |
CD81 |
2.445e-02 | -3.71 | positive regulation of Rac protein signal transduction | biological process | GO:0035022 | 10 | 1 | 18204 | 45 |
AUTS2 |
2.445e-02 | -3.71 | cellular response to testosterone stimulus | biological process | GO:0071394 | 10 | 1 | 18204 | 45 |
SPP1 |
2.445e-02 | -3.71 | mitochondrial fragmentation involved in apoptotic process | biological process | GO:0043653 | 10 | 1 | 18204 | 45 |
ERBB4 |
2.445e-02 | -3.71 | negative regulation of delayed rectifier potassium channel activity | biological process | GO:1902260 | 10 | 1 | 18204 | 45 |
ANK3 |
2.445e-02 | -3.71 | positive regulation of receptor clustering | biological process | GO:1903911 | 10 | 1 | 18204 | 45 |
CD81 |
2.445e-02 | -3.71 | postsynaptic membrane assembly | biological process | GO:0097104 | 10 | 1 | 18204 | 45 |
NLGN1 |
2.446e-02 | -3.71 | Claudin_2 | pfam domains | PF13903 | 10 | 1 | 17795 | 44 |
CLDND1 |
2.446e-02 | -3.71 | Laminin_G_1 | pfam domains | PF00054 | 10 | 1 | 17795 | 44 |
LAMA2 |
2.457e-02 | -3.71 | mixed_small_cell_carcinoma-adenocarcinoma | COSMIC cancer mutations | mixed_small_cell_carcinoma-adenocarcinoma | 87 | 2 | 16828 | 47 |
NRXN3,LAMA2 |
2.475e-02 | -3.70 | RHOQ (ras homolog family member Q) | protein interactions | 23433 | 441 | 4 | 19454 | 49 |
MARCKSL1,ITM2B,CLDND1,ZFYVE16 |
2.478e-02 | -3.70 | CSNK1D (casein kinase 1 delta) | protein interactions | 1453 | 249 | 3 | 19454 | 49 |
FTL,PPP1R14A,DBNDD2 |
2.486e-02 | -3.69 | GSDMA (gasdermin A) | protein interactions | 284110 | 97 | 2 | 19454 | 49 |
PPP2R2B,FTH1 |
2.491e-02 | -3.69 | MYBPH (myosin binding protein H) | protein interactions | 4608 | 10 | 1 | 19454 | 49 |
CAPN3 |
2.491e-02 | -3.69 | MYO3A (myosin IIIA) | protein interactions | 53904 | 10 | 1 | 19454 | 49 |
FTL |
2.491e-02 | -3.69 | C1RL (complement C1r subcomponent like) | protein interactions | 51279 | 10 | 1 | 19454 | 49 |
SPP1 |
2.491e-02 | -3.69 | LILRB3 (leukocyte immunoglobulin like receptor B3) | protein interactions | 11025 | 10 | 1 | 19454 | 49 |
ANK3 |
2.491e-02 | -3.69 | EREG (epiregulin) | protein interactions | 2069 | 10 | 1 | 19454 | 49 |
ERBB4 |
2.491e-02 | -3.69 | DEFA1B (defensin alpha 1B) | protein interactions | 728358 | 10 | 1 | 19454 | 49 |
PPP2R2B |
2.491e-02 | -3.69 | HMCN1 (hemicentin 1) | protein interactions | 83872 | 10 | 1 | 19454 | 49 |
B2M |
2.491e-02 | -3.69 | PTPRT (protein tyrosine phosphatase receptor type T) | protein interactions | 11122 | 10 | 1 | 19454 | 49 |
ERBB4 |
2.491e-02 | -3.69 | OTOF (otoferlin) | protein interactions | 9381 | 10 | 1 | 19454 | 49 |
B2M |
2.491e-02 | -3.69 | CFAP57 (cilia and flagella associated protein 57) | protein interactions | 149465 | 10 | 1 | 19454 | 49 |
APOD |
2.491e-02 | -3.69 | GPR3 (G protein-coupled receptor 3) | protein interactions | 2827 | 10 | 1 | 19454 | 49 |
APOD |
2.491e-02 | -3.69 | SBK1 (SH3 domain binding kinase 1) | protein interactions | 388228 | 10 | 1 | 19454 | 49 |
FTL |
2.495e-02 | -3.69 | cellular localization | biological process | GO:0051641 | 2660 | 12 | 18204 | 45 |
FTH1,PTGDS,EMC10,FTL,NLGN1,ZFYVE16,ANK3,RPL11,CD81,CAPN3,ERBB4,FCHSD2 |
2.501e-02 | -3.69 | RHOG (ras homolog family member G) | protein interactions | 391 | 902 | 6 | 19454 | 49 |
CLDND1,B2M,ANK3,MARCKSL1,EMC10,ZFYVE16 |
2.510e-02 | -3.68 | p75NTR regulates axonogenesis | REACTOME pathways | R-HSA-193697 | 9 | 1 | 10285 | 29 |
OMG |
2.525e-02 | -3.68 | basolateral plasma membrane | cellular component | GO:0016323 | 257 | 3 | 19108 | 47 |
CD81,ERBB4,ANK3 |
2.529e-02 | -3.68 | STX6 (syntaxin 6) | protein interactions | 10228 | 444 | 4 | 19454 | 49 |
CLDND1,ANK3,CBR1,ZFYVE16 |
2.534e-02 | -3.68 | ALOX12B (arachidonate 12-lipoxygenase, 12R type) | protein interactions | 242 | 98 | 2 | 19454 | 49 |
FTH1,PPP2R2B |
2.537e-02 | -3.67 | regulation of T cell mediated immunity | biological process | GO:0002709 | 100 | 2 | 18204 | 45 |
B2M,CD81 |
2.557e-02 | -3.67 | RAC2 (Rac family small GTPase 2) | protein interactions | 5880 | 666 | 5 | 19454 | 49 |
CD81,MARCKSL1,B2M,EMC10,ZFYVE16 |
2.563e-02 | -3.66 | postsynaptic density membrane | cellular component | GO:0098839 | 101 | 2 | 19108 | 47 |
ERBB4,LRRTM3 |
2.571e-02 | -3.66 | PINK1 (PTEN induced kinase 1) | protein interactions | 65018 | 667 | 5 | 19454 | 49 |
CBR1,RPL28,FTL,CD81,RPL11 |
2.581e-02 | -3.66 | phosphatase regulator activity | molecular function | GO:0019208 | 105 | 2 | 18094 | 43 |
PPP1R14A,PPP2R2B |
2.581e-02 | -3.66 | SET (SET nuclear proto-oncogene) | protein interactions | 6418 | 253 | 3 | 19454 | 49 |
FTH1,MARCKSL1,CD81 |
2.582e-02 | -3.66 | URB2 (URB2 ribosome biogenesis homolog) | protein interactions | 9816 | 99 | 2 | 19454 | 49 |
OPALIN,RPL28 |
2.584e-02 | -3.66 | ubiquitin-protein transferase inhibitor activity | molecular function | GO:0055105 | 11 | 1 | 18094 | 43 |
RPL11 |
2.584e-02 | -3.66 | structural constituent of myelin sheath | molecular function | GO:0019911 | 11 | 1 | 18094 | 43 |
PLLP |
2.584e-02 | -3.66 | transferrin receptor binding | molecular function | GO:1990459 | 11 | 1 | 18094 | 43 |
CD81 |
2.585e-02 | -3.66 | purine nucleotide catabolic process | biological process | GO:0006195 | 101 | 2 | 18204 | 45 |
ENO4,PDE5A |
2.634e-02 | -3.64 | TEX101 (testis expressed 101) | protein interactions | 83639 | 255 | 3 | 19454 | 49 |
CD9,CD81,APOD |
2.655e-02 | -3.63 | import into cell | biological process | GO:0098657 | 687 | 5 | 18204 | 45 |
RNASEK,CD81,CD9,NLGN1,FCHSD2 |
2.657e-02 | -3.63 | cell-cell adhesion via plasma-membrane adhesion molecules | biological process | GO:0098742 | 261 | 3 | 18204 | 45 |
NLGN1,IL1RAPL1,CADM2 |
2.667e-02 | -3.62 | Arrhythmogenic Right Ventricular Cardiomyopathy | WikiPathways | WP2118 | 76 | 2 | 5310 | 18 |
CTNNA2,LAMA2 |
2.673e-02 | -3.62 | steroid binding | molecular function | GO:0005496 | 107 | 2 | 18094 | 43 |
CD81,APOD |
2.679e-02 | -3.62 | CGRRF1 (cell growth regulator with ring finger domain 1) | protein interactions | 10668 | 101 | 2 | 19454 | 49 |
EMC10,CBR1 |
2.679e-02 | -3.62 | FAM241A (family with sequence similarity 241 member A) | protein interactions | 132720 | 101 | 2 | 19454 | 49 |
CLDND1,DAD1 |
2.679e-02 | -3.62 | AGTR1 (angiotensin II receptor type 1) | protein interactions | 185 | 101 | 2 | 19454 | 49 |
DBNDD2,CBR1 |
2.679e-02 | -3.62 | NECAB2 (N-terminal EF-hand calcium binding protein 2) | protein interactions | 54550 | 101 | 2 | 19454 | 49 |
CAPN3,TRIM59 |
2.680e-02 | -3.62 | unsaturated fatty acid metabolic process | biological process | GO:0033559 | 103 | 2 | 18204 | 45 |
CBR1,PTGDS |
2.685e-02 | -3.62 | cellular homeostasis | biological process | GO:0019725 | 689 | 5 | 18204 | 45 |
B2M,CAPN3,FTL,RNASEK,FTH1 |
2.685e-02 | -3.62 | RNAse_Pc | smart domains | SM00092 | 11 | 1 | 9717 | 24 |
RNASE1 |
2.687e-02 | -3.62 | positive regulation of steroid hormone secretion | biological process | GO:2000833 | 11 | 1 | 18204 | 45 |
SPP1 |
2.687e-02 | -3.62 | regulation of basement membrane organization | biological process | GO:0110011 | 11 | 1 | 18204 | 45 |
LAMA2 |
2.687e-02 | -3.62 | negative regulation of collateral sprouting | biological process | GO:0048671 | 11 | 1 | 18204 | 45 |
SPP1 |
2.687e-02 | -3.62 | receptor-mediated endocytosis of virus by host cell | biological process | GO:0019065 | 11 | 1 | 18204 | 45 |
RNASEK |
2.687e-02 | -3.62 | positive regulation of membrane depolarization | biological process | GO:1904181 | 11 | 1 | 18204 | 45 |
ANK3 |
2.687e-02 | -3.62 | negative regulation of platelet aggregation | biological process | GO:0090331 | 11 | 1 | 18204 | 45 |
CD9 |
2.687e-02 | -3.62 | magnesium ion homeostasis | biological process | GO:0010960 | 11 | 1 | 18204 | 45 |
ANK3 |
2.687e-02 | -3.62 | vitamin K metabolic process | biological process | GO:0042373 | 11 | 1 | 18204 | 45 |
CBR1 |
2.687e-02 | -3.62 | negative regulation of protein sumoylation | biological process | GO:0033234 | 11 | 1 | 18204 | 45 |
CAPN3 |
2.687e-02 | -3.62 | synaptic vesicle clustering | biological process | GO:0097091 | 11 | 1 | 18204 | 45 |
NLGN1 |
2.687e-02 | -3.62 | protein insertion into ER membrane by stop-transfer membrane-anchor sequence | biological process | GO:0045050 | 11 | 1 | 18204 | 45 |
EMC10 |
2.687e-02 | -3.62 | ZU5 | pfam domains | PF00791 | 11 | 1 | 17795 | 44 |
ANK3 |
2.688e-02 | -3.62 | WWP1 (WW domain containing E3 ubiquitin protein ligase 1) | protein interactions | 11059 | 257 | 3 | 19454 | 49 |
RPL11,ERBB4,RPL28 |
2.728e-02 | -3.60 | NRG1 (neuregulin 1) | protein interactions | 3084 | 102 | 2 | 19454 | 49 |
DAD1,ERBB4 |
2.728e-02 | -3.60 | HP (haptoglobin) | protein interactions | 3240 | 102 | 2 | 19454 | 49 |
PPP2R2B,RPL11 |
2.728e-02 | -3.60 | NCCRP1 (NCCRP1, F-box associated domain containing) | protein interactions | 342897 | 102 | 2 | 19454 | 49 |
FTH1,PPP2R2B |
2.737e-02 | -3.60 | CD38 (CD38 molecule) | protein interactions | 952 | 11 | 1 | 19454 | 49 |
CD9 |
2.737e-02 | -3.60 | TMEM168 (transmembrane protein 168) | protein interactions | 64418 | 11 | 1 | 19454 | 49 |
SPP1 |
2.737e-02 | -3.60 | VASH2 (vasohibin 2) | protein interactions | 79805 | 11 | 1 | 19454 | 49 |
FTL |
2.737e-02 | -3.60 | CHIT1 (chitinase 1) | protein interactions | 1118 | 11 | 1 | 19454 | 49 |
RPL11 |
2.737e-02 | -3.60 | GK3 (glycerol kinase 3) | protein interactions | 2713 | 11 | 1 | 19454 | 49 |
APOD |
2.737e-02 | -3.60 | PIP5K1P1 (phosphatidylinositol-4-phosphate 5-kinase type 1 pseudogene 1) | protein interactions | 206426 | 11 | 1 | 19454 | 49 |
NRXN3 |
2.737e-02 | -3.60 | C2orf50 (chromosome 2 open reading frame 50) | protein interactions | 130813 | 11 | 1 | 19454 | 49 |
SPP1 |
2.737e-02 | -3.60 | PTGDR (prostaglandin D2 receptor) | protein interactions | 5729 | 11 | 1 | 19454 | 49 |
PTGDS |
2.737e-02 | -3.60 | PYY (peptide YY) | protein interactions | 5697 | 11 | 1 | 19454 | 49 |
PLXDC2 |
2.742e-02 | -3.60 | FAM209A (family with sequence similarity 209 member A) | protein interactions | 200232 | 259 | 3 | 19454 | 49 |
PLLP,APOD,CD81 |
2.748e-02 | -3.59 | Viral mRNA Translation | REACTOME pathways | R-HSA-192823 | 92 | 2 | 10285 | 29 |
RPL11,RPL28 |
2.748e-02 | -3.59 | Peptide chain elongation | REACTOME pathways | R-HSA-156902 | 92 | 2 | 10285 | 29 |
RPL11,RPL28 |
2.757e-02 | -3.59 | C2_III | interpro domains | IPR033883 | 11 | 1 | 18521 | 47 |
CAPN3 |
2.757e-02 | -3.59 | IL-1_rcpt_fam | interpro domains | IPR015621 | 11 | 1 | 18521 | 47 |
IL1RAPL1 |
2.757e-02 | -3.59 | Bcl2-like | interpro domains | IPR002475 | 11 | 1 | 18521 | 47 |
BCL2L14 |
2.769e-02 | -3.59 | PTPN6 (protein tyrosine phosphatase non-receptor type 6) | protein interactions | 5777 | 260 | 3 | 19454 | 49 |
ERBB4,RPL28,RPL11 |
2.777e-02 | -3.58 | human chr10q21.2 | chromosome location | human chr10q21.2 | 15 | 1 | 26134 | 49 |
ANK3 |
2.777e-02 | -3.58 | human chr10p12.31 | chromosome location | human chr10p12.31 | 15 | 1 | 26134 | 49 |
PLXDC2 |
2.777e-02 | -3.58 | regulation of postsynapse organization | biological process | GO:0099175 | 105 | 2 | 18204 | 45 |
NLGN1,IL1RAPL1 |
2.777e-02 | -3.58 | positive regulation of protein localization to membrane | biological process | GO:1905477 | 105 | 2 | 18204 | 45 |
CD81,ANK3 |
2.778e-02 | -3.58 | FLG (filaggrin) | protein interactions | 2312 | 103 | 2 | 19454 | 49 |
PPP2R2B,FTH1 |
2.778e-02 | -3.58 | CSGALNACT2 (chondroitin sulfate N-acetylgalactosaminyltransferase 2) | protein interactions | 55454 | 103 | 2 | 19454 | 49 |
TRIM59,NDUFC2 |
2.778e-02 | -3.58 | CD63 (CD63 molecule) | protein interactions | 967 | 103 | 2 | 19454 | 49 |
CD9,CD81 |
2.785e-02 | -3.58 | PI3K events in ERBB4 signaling | REACTOME pathways | R-HSA-1250342 | 10 | 1 | 10285 | 29 |
ERBB4 |
2.785e-02 | -3.58 | Nef mediated downregulation of MHC class I complex cell surface expression | REACTOME pathways | R-HSA-164940 | 10 | 1 | 10285 | 29 |
B2M |
2.800e-02 | -3.58 | CTNNB1 (catenin beta 1) | protein interactions | 1499 | 926 | 6 | 19454 | 49 |
RPL28,ANK3,MARCKSL1,CTNNA2,RPL11,DAD1 |
2.813e-02 | -3.57 | structural constituent of cytoskeleton | molecular function | GO:0005200 | 110 | 2 | 18094 | 43 |
CTNNA2,ANK3 |
2.828e-02 | -3.57 | DDX51 (DEAD-box helicase 51) | protein interactions | 317781 | 104 | 2 | 19454 | 49 |
RPL11,RPL28 |
2.828e-02 | -3.57 | RSRC1 (arginine and serine rich coiled-coil 1) | protein interactions | 51319 | 104 | 2 | 19454 | 49 |
AUTS2,RPL11 |
2.828e-02 | -3.57 | HBA2 (hemoglobin subunit alpha 2) | protein interactions | 3040 | 104 | 2 | 19454 | 49 |
SPP1,PLLP |
2.851e-02 | -3.56 | RAB25 (RAB25, member RAS oncogene family) | protein interactions | 57111 | 263 | 3 | 19454 | 49 |
ZFYVE16,RPL11,PPP2R2B |
2.865e-02 | -3.55 | Alpha-catenin/vinculin-like | gene3d domains | 1.20.120.230 | 12 | 1 | 14470 | 35 |
CTNNA2 |
2.870e-02 | -3.55 | negative regulation of cell development | biological process | GO:0010721 | 269 | 3 | 18204 | 45 |
NKX6-2,B2M,SPP1 |
2.876e-02 | -3.55 | purine-containing compound catabolic process | biological process | GO:0072523 | 107 | 2 | 18204 | 45 |
PDE5A,ENO4 |
2.878e-02 | -3.55 | RSL24D1 (ribosomal L24 domain containing 1) | protein interactions | 51187 | 105 | 2 | 19454 | 49 |
RPL11,RPL28 |
2.878e-02 | -3.55 | CENPU (centromere protein U) | protein interactions | 79682 | 105 | 2 | 19454 | 49 |
RPL28,RPL11 |
2.879e-02 | -3.55 | PFKP (phosphofructokinase, platelet) | protein interactions | 5214 | 264 | 3 | 19454 | 49 |
CD81,RPL11,BCL2L14 |
2.913e-02 | -3.54 | proton-transporting V-type ATPase, V0 domain | cellular component | GO:0033179 | 12 | 1 | 19108 | 47 |
RNASEK |
2.916e-02 | -3.54 | Selenocysteine synthesis | REACTOME pathways | R-HSA-2408557 | 95 | 2 | 10285 | 29 |
RPL11,RPL28 |
2.920e-02 | -3.53 | CFTR (CF transmembrane conductance regulator) | protein interactions | 1080 | 1469 | 8 | 19454 | 49 |
MARCKSL1,FTH1,RPL28,IL1RAPL1,PPP2R2B,RPL11,B2M,CBR1 |
2.926e-02 | -3.53 | calpain_III | smart domains | SM00720 | 12 | 1 | 9717 | 24 |
CAPN3 |
2.927e-02 | -3.53 | response to macrophage colony-stimulating factor | biological process | GO:0036005 | 12 | 1 | 18204 | 45 |
SPP1 |
2.927e-02 | -3.53 | self proteolysis | biological process | GO:0097264 | 12 | 1 | 18204 | 45 |
CAPN3 |
2.927e-02 | -3.53 | hormone catabolic process | biological process | GO:0042447 | 12 | 1 | 18204 | 45 |
SPP1 |
2.927e-02 | -3.53 | positive regulation of integrin-mediated signaling pathway | biological process | GO:2001046 | 12 | 1 | 18204 | 45 |
LAMA2 |
2.927e-02 | -3.53 | positive regulation of membrane potential | biological process | GO:0045838 | 12 | 1 | 18204 | 45 |
ANK3 |
2.927e-02 | -3.53 | neurotransmitter-gated ion channel clustering | biological process | GO:0072578 | 12 | 1 | 18204 | 45 |
NLGN1 |
2.927e-02 | -3.53 | negative regulation of receptor binding | biological process | GO:1900121 | 12 | 1 | 18204 | 45 |
B2M |
2.928e-02 | -3.53 | cellular component organization or biogenesis | biological process | GO:0071840 | 5850 | 21 | 18204 | 45 |
ERBB4,FCHSD2,AUTS2,CTNNA2,OMG,RPL11,CAPN3,APOD,ZFYVE16,SPP1,CD9,LAMA2,MARCKSL1,IL1RAPL1,ANK3,RNASEK,NRXN3,NLGN1,B2M,NDUFC2,EMC10 |
2.929e-02 | -3.53 | SGCA (sarcoglycan alpha) | protein interactions | 6442 | 106 | 2 | 19454 | 49 |
DAD1,ITM2B |
2.929e-02 | -3.53 | TAF1C (TATA-box binding protein associated factor, RNA polymerase I subunit C) | protein interactions | 9013 | 106 | 2 | 19454 | 49 |
RPL11,RPL28 |
2.929e-02 | -3.53 | TTF1 (transcription termination factor 1) | protein interactions | 7270 | 106 | 2 | 19454 | 49 |
RPL28,RPL11 |
2.929e-02 | -3.53 | FAM98B (family with sequence similarity 98 member B) | protein interactions | 283742 | 106 | 2 | 19454 | 49 |
RPL28,CD81 |
2.929e-02 | -3.53 | BUD13 (BUD13 homolog) | protein interactions | 84811 | 106 | 2 | 19454 | 49 |
RPL11,RPL28 |
2.951e-02 | -3.52 | H1-1 (H1.1 linker histone, cluster member) | protein interactions | 3024 | 466 | 4 | 19454 | 49 |
LRRTM3,LAMA2,CD81,RPL28 |
2.958e-02 | -3.52 | lymphocyte activation | biological process | GO:0046649 | 476 | 4 | 18204 | 45 |
CD81,ITM2A,PDE5A,B2M |
2.959e-02 | -3.52 | human chr3q26.31 | chromosome location | human chr3q26.31 | 16 | 1 | 26134 | 49 |
NLGN1 |
2.973e-02 | -3.52 | Eukaryotic Translation Elongation | REACTOME pathways | R-HSA-156842 | 96 | 2 | 10285 | 29 |
RPL28,RPL11 |
2.973e-02 | -3.52 | Eukaryotic Translation Termination | REACTOME pathways | R-HSA-72764 | 96 | 2 | 10285 | 29 |
RPL28,RPL11 |
2.975e-02 | -3.51 | long-chain fatty acid metabolic process | biological process | GO:0001676 | 109 | 2 | 18204 | 45 |
CBR1,PTGDS |
2.982e-02 | -3.51 | RTN4RL1 (reticulon 4 receptor like 1) | protein interactions | 146760 | 12 | 1 | 19454 | 49 |
OMG |
2.982e-02 | -3.51 | HSP90B2P (heat shock protein 90 beta family member 2, pseudogene) | protein interactions | 7190 | 12 | 1 | 19454 | 49 |
CAPN3 |
2.982e-02 | -3.51 | RSC1A1 (regulator of solute carriers 1) | protein interactions | 6248 | 12 | 1 | 19454 | 49 |
SPP1 |
2.982e-02 | -3.51 | SMIM20 (small integral membrane protein 20) | protein interactions | 389203 | 12 | 1 | 19454 | 49 |
ERBB4 |
2.982e-02 | -3.51 | SERF1B (small EDRK-rich factor 1B) | protein interactions | 728492 | 12 | 1 | 19454 | 49 |
RNASEK |
2.982e-02 | -3.51 | MATCAP2 (microtubule associated tyrosine carboxypeptidase 2) | protein interactions | 23366 | 12 | 1 | 19454 | 49 |
FTL |
2.982e-02 | -3.51 | XDH (xanthine dehydrogenase) | protein interactions | 7498 | 12 | 1 | 19454 | 49 |
CBR1 |
2.982e-02 | -3.51 | PTPN20 (protein tyrosine phosphatase non-receptor type 20) | protein interactions | 26095 | 12 | 1 | 19454 | 49 |
ERBB4 |
2.982e-02 | -3.51 | METAP1D (methionyl aminopeptidase type 1D, mitochondrial) | protein interactions | 254042 | 12 | 1 | 19454 | 49 |
NDUFC2 |
2.982e-02 | -3.51 | GCSAML (germinal center associated signaling and motility like) | protein interactions | 148823 | 12 | 1 | 19454 | 49 |
PLXDC2 |
2.982e-02 | -3.51 | RNASE1 (ribonuclease A family member 1, pancreatic) | protein interactions | 6035 | 12 | 1 | 19454 | 49 |
RNASE1 |
2.988e-02 | -3.51 | negative regulation of cellular component organization | biological process | GO:0051129 | 709 | 5 | 18204 | 45 |
NLGN1,APOD,B2M,CTNNA2,SPP1 |
2.992e-02 | -3.51 | RET (ret proto-oncogene) | protein interactions | 5979 | 268 | 3 | 19454 | 49 |
B2M,ANK3,PTGDS |
3.004e-02 | -3.51 | Lipocalin | interpro domains | IPR002345 | 12 | 1 | 18521 | 47 |
PTGDS |
3.004e-02 | -3.51 | Calpain_III | interpro domains | IPR022683 | 12 | 1 | 18521 | 47 |
CAPN3 |
3.012e-02 | -3.50 | EV release from cardiac cells and their functional effects | WikiPathways | WP3297 | 9 | 1 | 5310 | 18 |
ERBB4 |
3.026e-02 | -3.50 | positive regulation of binding | biological process | GO:0051099 | 110 | 2 | 18204 | 45 |
B2M,RPL11 |
3.031e-02 | -3.50 | IMP4 (IMP U3 small nucleolar ribonucleoprotein 4) | protein interactions | 92856 | 108 | 2 | 19454 | 49 |
FTL,RPL11 |
3.031e-02 | -3.50 | CPLX4 (complexin 4) | protein interactions | 339302 | 108 | 2 | 19454 | 49 |
CD81,APOD |
3.031e-02 | -3.50 | TRADD (TNFRSF1A associated via death domain) | protein interactions | 8717 | 108 | 2 | 19454 | 49 |
PPP2R2B,NLGN1 |
3.034e-02 | -3.50 | g-Secretase Mediated ErbB4 Signalling Pathway | SMPDB pathways | SMP0089975 | 7 | 1 | 1369 | 6 |
ERBB4 |
3.036e-02 | -3.49 | gliogenesis | biological process | GO:0042063 | 275 | 3 | 18204 | 45 |
NKX6-2,LAMA2,CD9 |
3.037e-02 | -3.49 | ECM-receptor interaction | KEGG pathways | ko04512 | 82 | 2 | 7161 | 24 |
LAMA2,SPP1 |
3.037e-02 | -3.49 | ECM-receptor interaction | KEGG pathways | hsa04512 | 82 | 2 | 7161 | 24 |
SPP1,LAMA2 |
3.047e-02 | -3.49 | titin binding | molecular function | GO:0031432 | 13 | 1 | 18094 | 43 |
CAPN3 |
3.049e-02 | -3.49 | TCOF1 (treacle ribosome biogenesis factor 1) | protein interactions | 6949 | 270 | 3 | 19454 | 49 |
RPL11,RPL28,CD9 |
3.051e-02 | -3.49 | large ribosomal subunit | cellular component | GO:0015934 | 111 | 2 | 19108 | 47 |
RPL11,RPL28 |
3.062e-02 | -3.49 | bone-tibia-other-chondroblastoma | COSMIC cancer mutations | bone-tibia-other-chondroblastoma | 98 | 2 | 16828 | 47 |
NLGN1,NRXN3 |
3.083e-02 | -3.48 | ATP6V1B1 (ATPase H+ transporting V1 subunit B1) | protein interactions | 525 | 109 | 2 | 19454 | 49 |
FTH1,CD9 |
3.092e-02 | -3.48 | negative regulation of multicellular organismal process | biological process | GO:0051241 | 1237 | 7 | 18204 | 45 |
PTGDS,CD9,SPP1,B2M,APOD,NKX6-2,PDE5A |
3.100e-02 | -3.47 | - | gene3d domains | 2.60.220.30 | 13 | 1 | 14470 | 35 |
ANK3 |
3.100e-02 | -3.47 | - | gene3d domains | 2.60.120.380 | 13 | 1 | 14470 | 35 |
CAPN3 |
3.100e-02 | -3.47 | Blc2-like | gene3d domains | 1.10.437.10 | 13 | 1 | 14470 | 35 |
BCL2L14 |
3.116e-02 | -3.47 | BCL2_FAMILY | prosite domains | PS50062 | 11 | 1 | 12186 | 35 |
BCL2L14 |
3.135e-02 | -3.46 | KIT (KIT proto-oncogene, receptor tyrosine kinase) | protein interactions | 3815 | 110 | 2 | 19454 | 49 |
CD81,CD9 |
3.135e-02 | -3.46 | WDR74 (WD repeat domain 74) | protein interactions | 54663 | 110 | 2 | 19454 | 49 |
RPL11,RPL28 |
3.135e-02 | -3.46 | SBSN (suprabasin) | protein interactions | 374897 | 110 | 2 | 19454 | 49 |
FTH1,PPP2R2B |
3.146e-02 | -3.46 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | REACTOME pathways | R-HSA-975956 | 99 | 2 | 10285 | 29 |
RPL11,RPL28 |
3.159e-02 | -3.45 | positive regulation of cell adhesion | biological process | GO:0045785 | 486 | 4 | 18204 | 45 |
LAMA2,B2M,ANK3,CD81 |
3.167e-02 | -3.45 | positive regulation of protein exit from endoplasmic reticulum | biological process | GO:0070863 | 13 | 1 | 18204 | 45 |
CD81 |
3.167e-02 | -3.45 | positive regulation of inflammatory response to antigenic stimulus | biological process | GO:0002863 | 13 | 1 | 18204 | 45 |
CD81 |
3.167e-02 | -3.45 | prepulse inhibition | biological process | GO:0060134 | 13 | 1 | 18204 | 45 |
CTNNA2 |
3.167e-02 | -3.45 | regulation of protein catabolic process in the vacuole | biological process | GO:1904350 | 13 | 1 | 18204 | 45 |
CD81 |
3.167e-02 | -3.45 | olfactory bulb interneuron differentiation | biological process | GO:0021889 | 13 | 1 | 18204 | 45 |
ERBB4 |
3.167e-02 | -3.45 | endocytosis involved in viral entry into host cell | biological process | GO:0075509 | 13 | 1 | 18204 | 45 |
RNASEK |
3.167e-02 | -3.45 | negative regulation of platelet-derived growth factor receptor signaling pathway | biological process | GO:0010642 | 13 | 1 | 18204 | 45 |
APOD |
3.167e-02 | -3.45 | negative regulation of homotypic cell-cell adhesion | biological process | GO:0034111 | 13 | 1 | 18204 | 45 |
CD9 |
3.167e-02 | -3.45 | regulation of T-helper 2 cell cytokine production | biological process | GO:2000551 | 13 | 1 | 18204 | 45 |
CD81 |
3.168e-02 | -3.45 | Calpain_III | pfam domains | PF01067 | 13 | 1 | 17795 | 44 |
CAPN3 |
3.172e-02 | -3.45 | LMNA (lamin A/C) | protein interactions | 4000 | 1217 | 7 | 19454 | 49 |
APOD,ITM2B,CD81,RPL11,PLLP,MARCKSL1,DBNDD2 |
3.179e-02 | -3.45 | symbiont entry into host cell | biological process | GO:0046718 | 113 | 2 | 18204 | 45 |
RNASEK,CD81 |
3.179e-02 | -3.45 | positive regulation of plasma membrane bounded cell projection assembly | biological process | GO:0120034 | 113 | 2 | 18204 | 45 |
AUTS2,NLGN1 |
3.187e-02 | -3.45 | mast_cell_neoplasm | COSMIC cancer mutations | mast_cell_neoplasm | 248 | 3 | 16828 | 47 |
ANK3,ERBB4,IL1RAPL1 |
3.187e-02 | -3.45 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | 248 | 3 | 16828 | 47 |
IL1RAPL1,ANK3,ERBB4 |
3.188e-02 | -3.45 | DLG3 (discs large MAGUK scaffold protein 3) | protein interactions | 1741 | 111 | 2 | 19454 | 49 |
ERBB4,NLGN1 |
3.226e-02 | -3.43 | SDHAF4 (succinate dehydrogenase complex assembly factor 4) | protein interactions | 135154 | 13 | 1 | 19454 | 49 |
CD81 |
3.226e-02 | -3.43 | NFAM1 (NFAT activating protein with ITAM motif 1) | protein interactions | 150372 | 13 | 1 | 19454 | 49 |
APOD |
3.226e-02 | -3.43 | CST7 (cystatin F) | protein interactions | 8530 | 13 | 1 | 19454 | 49 |
APOD |
3.226e-02 | -3.43 | CAPN11 (calpain 11) | protein interactions | 11131 | 13 | 1 | 19454 | 49 |
CAPN3 |
3.226e-02 | -3.43 | IBSP (integrin binding sialoprotein) | protein interactions | 3381 | 13 | 1 | 19454 | 49 |
PLXDC2 |
3.226e-02 | -3.43 | PCAT1 (prostate cancer associated transcript 1) | protein interactions | 100750225 | 13 | 1 | 19454 | 49 |
RPL11 |
3.226e-02 | -3.43 | TUBA3D (tubulin alpha 3d) | protein interactions | 113457 | 13 | 1 | 19454 | 49 |
CD81 |
3.226e-02 | -3.43 | HRH1 (histamine receptor H1) | protein interactions | 3269 | 13 | 1 | 19454 | 49 |
CD81 |
3.231e-02 | -3.43 | regulation of circadian rhythm | biological process | GO:0042752 | 114 | 2 | 18204 | 45 |
PTGDS,NLGN1 |
3.231e-02 | -3.43 | icosanoid metabolic process | biological process | GO:0006690 | 114 | 2 | 18204 | 45 |
PTGDS,CBR1 |
3.241e-02 | -3.43 | SIGLECL1 (SIGLEC family like 1) | protein interactions | 284369 | 112 | 2 | 19454 | 49 |
APOD,ITM2B |
3.250e-02 | -3.43 | Carboxylesterase_B_CS | interpro domains | IPR019819 | 13 | 1 | 18521 | 47 |
NLGN1 |
3.250e-02 | -3.43 | RNaseA | interpro domains | IPR001427 | 13 | 1 | 18521 | 47 |
RNASE1 |
3.250e-02 | -3.43 | Calpain_III_sf | interpro domains | IPR036213 | 13 | 1 | 18521 | 47 |
CAPN3 |
3.250e-02 | -3.43 | Calpain_domain_III | interpro domains | IPR022682 | 13 | 1 | 18521 | 47 |
CAPN3 |
3.250e-02 | -3.43 | ZU5_dom | interpro domains | IPR000906 | 13 | 1 | 18521 | 47 |
ANK3 |
3.264e-02 | -3.42 | Amyloid fiber formation | REACTOME pathways | R-HSA-977225 | 101 | 2 | 10285 | 29 |
ITM2B,B2M |
3.264e-02 | -3.42 | env (Envelope surface glycoprotein gp160, precursor) | protein interactions | 155971 | 1501 | 8 | 19454 | 49 |
CD9,RNASE1,CAPN3,FTH1,LAMA2,CTNNA2,ITM2B,CD81 |
3.277e-02 | -3.42 | protein serine/threonine phosphatase inhibitor activity | molecular function | GO:0004865 | 14 | 1 | 18094 | 43 |
PPP1R14A |
3.283e-02 | -3.42 | symbiont entry into host | biological process | GO:0044409 | 115 | 2 | 18204 | 45 |
CD81,RNASEK |
3.283e-02 | -3.42 | fatty acid biosynthetic process | biological process | GO:0006633 | 115 | 2 | 18204 | 45 |
CBR1,PTGDS |
3.294e-02 | -3.41 | CDK20 (cyclin dependent kinase 20) | protein interactions | 23552 | 113 | 2 | 19454 | 49 |
FTL,APOD |
3.294e-02 | -3.41 | PTTG1 (PTTG1 regulator of sister chromatid separation, securin) | protein interactions | 9232 | 113 | 2 | 19454 | 49 |
B2M,RPL28 |
3.323e-02 | -3.40 | human chr18q22.3 | chromosome location | human chr18q22.3 | 18 | 1 | 26134 | 49 |
CNDP1 |
3.333e-02 | -3.40 | Endosomal/Vacuolar pathway | REACTOME pathways | R-HSA-1236977 | 12 | 1 | 10285 | 29 |
B2M |
3.357e-02 | -3.39 | regulation of cellular component organization | biological process | GO:0051128 | 2455 | 11 | 18204 | 45 |
LAMA2,SPP1,B2M,APOD,ZFYVE16,NLGN1,IL1RAPL1,CTNNA2,FCHSD2,AUTS2,LRRTM3 |
3.376e-02 | -3.39 | basal plasma membrane | cellular component | GO:0009925 | 288 | 3 | 19108 | 47 |
ANK3,ERBB4,CD81 |
3.390e-02 | -3.38 | oligosaccharyltransferase complex | cellular component | GO:0008250 | 14 | 1 | 19108 | 47 |
DAD1 |
3.390e-02 | -3.38 | compact myelin | cellular component | GO:0043218 | 14 | 1 | 19108 | 47 |
PLLP |
3.392e-02 | -3.38 | gag (Pr55(Gag)) | protein interactions | 155030 | 969 | 6 | 19454 | 49 |
RPL11,PPP2R2B,CD9,CD81,RPL28,PTGDS |
3.401e-02 | -3.38 | MTF1 (metal regulatory transcription factor 1) | protein interactions | 4520 | 115 | 2 | 19454 | 49 |
RPL28,RPL11 |
3.404e-02 | -3.38 | EMC4 (ER membrane protein complex subunit 4) | protein interactions | 51234 | 282 | 3 | 19454 | 49 |
RPL11,EMC10,RPL28 |
3.407e-02 | -3.38 | positive regulation of actin nucleation | biological process | GO:0051127 | 14 | 1 | 18204 | 45 |
FCHSD2 |
3.407e-02 | -3.38 | neurotransmitter receptor localization to postsynaptic specialization membrane | biological process | GO:0099645 | 14 | 1 | 18204 | 45 |
ERBB4 |
3.407e-02 | -3.38 | immunological synapse formation | biological process | GO:0001771 | 14 | 1 | 18204 | 45 |
CD81 |
3.407e-02 | -3.38 | cyclic nucleotide catabolic process | biological process | GO:0009214 | 14 | 1 | 18204 | 45 |
PDE5A |
3.407e-02 | -3.38 | negative regulation of dendritic spine development | biological process | GO:0061000 | 14 | 1 | 18204 | 45 |
NLGN1 |
3.407e-02 | -3.38 | endosomal lumen acidification | biological process | GO:0048388 | 14 | 1 | 18204 | 45 |
RNASEK |
3.407e-02 | -3.38 | protein localization to postsynaptic specialization membrane | biological process | GO:0099633 | 14 | 1 | 18204 | 45 |
ERBB4 |
3.407e-02 | -3.38 | relaxation of cardiac muscle | biological process | GO:0055119 | 14 | 1 | 18204 | 45 |
PDE5A |
3.407e-02 | -3.38 | regulation of NMDA receptor activity | biological process | GO:2000310 | 14 | 1 | 18204 | 45 |
NLGN1 |
3.407e-02 | -3.38 | negative regulation of oligodendrocyte differentiation | biological process | GO:0048715 | 14 | 1 | 18204 | 45 |
NKX6-2 |
3.407e-02 | -3.38 | positive regulation of sodium ion transmembrane transporter activity | biological process | GO:2000651 | 14 | 1 | 18204 | 45 |
ANK3 |
3.408e-02 | -3.38 | COesterase | pfam domains | PF00135 | 14 | 1 | 17795 | 44 |
NLGN1 |
3.443e-02 | -3.37 | muscle cell differentiation | biological process | GO:0042692 | 289 | 3 | 18204 | 45 |
CAPN3,CD81,CD9 |
3.448e-02 | -3.37 | - | gene3d domains | 2.60.120.200 | 121 | 2 | 14470 | 35 |
NRXN3,LAMA2 |
3.455e-02 | -3.37 | RBBP8 (RB binding protein 8, endonuclease) | protein interactions | 5932 | 116 | 2 | 19454 | 49 |
CTNNA2,FTL |
3.455e-02 | -3.37 | FCGRT (Fc gamma receptor and transporter) | protein interactions | 2217 | 116 | 2 | 19454 | 49 |
B2M,ITM2B |
3.462e-02 | -3.36 | DOPA-Responsive Dystonia | SMPDB pathways | SMP0000486 | 8 | 1 | 1369 | 6 |
CBR1 |
3.462e-02 | -3.36 | Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps) | SMPDB pathways | SMP0000488 | 8 | 1 | 1369 | 6 |
CBR1 |
3.462e-02 | -3.36 | Hyperphenylalaninemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency | SMPDB pathways | SMP0000487 | 8 | 1 | 1369 | 6 |
CBR1 |
3.462e-02 | -3.36 | Hyperphenylalaninemia Due to DHPR-Deficiency | SMPDB pathways | SMP0000489 | 8 | 1 | 1369 | 6 |
CBR1 |
3.462e-02 | -3.36 | Pterine Biosynthesis | SMPDB pathways | SMP0000005 | 8 | 1 | 1369 | 6 |
CBR1 |
3.462e-02 | -3.36 | Sepiapterin Reductase Deficiency | SMPDB pathways | SMP0000491 | 8 | 1 | 1369 | 6 |
CBR1 |
3.462e-02 | -3.36 | Segawa Syndrome | SMPDB pathways | SMP0000490 | 8 | 1 | 1369 | 6 |
CBR1 |
3.470e-02 | -3.36 | CXXC4 (CXXC finger protein 4) | protein interactions | 80319 | 14 | 1 | 19454 | 49 |
APOD |
3.470e-02 | -3.36 | Gtf3c2 (general transcription factor IIIC, polypeptide 2, beta) | protein interactions | 71752 | 14 | 1 | 19454 | 49 |
RPL28 |
3.470e-02 | -3.36 | JMJD7-PLA2G4B (JMJD7-PLA2G4B readthrough) | protein interactions | 8681 | 14 | 1 | 19454 | 49 |
PPP2R2B |
3.470e-02 | -3.36 | ANKRD33 (ankyrin repeat domain 33) | protein interactions | 341405 | 14 | 1 | 19454 | 49 |
TRIM59 |
3.470e-02 | -3.36 | SPRR2D (small proline rich protein 2D) | protein interactions | 6703 | 14 | 1 | 19454 | 49 |
PPP2R2B |
3.470e-02 | -3.36 | KCNC1 (potassium voltage-gated channel subfamily C member 1) | protein interactions | 3746 | 14 | 1 | 19454 | 49 |
ANK3 |
3.470e-02 | -3.36 | FCGBP (Fc gamma binding protein) | protein interactions | 8857 | 14 | 1 | 19454 | 49 |
PPP2R2B |
3.470e-02 | -3.36 | OTUD7A (OTU deubiquitinase 7A) | protein interactions | 161725 | 14 | 1 | 19454 | 49 |
ANK3 |
3.470e-02 | -3.36 | GPR34 (G protein-coupled receptor 34) | protein interactions | 2857 | 14 | 1 | 19454 | 49 |
NDUFC2 |
3.475e-02 | -3.36 | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | 105 | 2 | 16828 | 47 |
PLXDC2,AUTS2 |
3.496e-02 | -3.35 | Bcl-2-like_sf | interpro domains | IPR036834 | 14 | 1 | 18521 | 47 |
BCL2L14 |
3.496e-02 | -3.35 | Calpain_cysteine_protease | interpro domains | IPR022684 | 14 | 1 | 18521 | 47 |
CAPN3 |
3.496e-02 | -3.35 | CarbesteraseB | interpro domains | IPR002018 | 14 | 1 | 18521 | 47 |
NLGN1 |
3.504e-02 | -3.35 | human chr21q22.12 | chromosome location | human chr21q22.12 | 19 | 1 | 26134 | 49 |
CBR1 |
3.504e-02 | -3.35 | endonuclease activity | molecular function | GO:0004519 | 124 | 2 | 18094 | 43 |
RNASE1,RNASEK |
3.504e-02 | -3.35 | Formation of a pool of free 40S subunits | REACTOME pathways | R-HSA-72689 | 105 | 2 | 10285 | 29 |
RPL11,RPL28 |
3.507e-02 | -3.35 | 1-phosphatidylinositol binding | molecular function | GO:0005545 | 15 | 1 | 18094 | 43 |
ZFYVE16 |
3.507e-02 | -3.35 | neurexin family protein binding | molecular function | GO:0042043 | 15 | 1 | 18094 | 43 |
NLGN1 |
3.510e-02 | -3.35 | ABCF3 (ATP binding cassette subfamily F member 3) | protein interactions | 55324 | 117 | 2 | 19454 | 49 |
FCHSD2,SPP1 |
3.510e-02 | -3.35 | ARL14 (ADP ribosylation factor like GTPase 14) | protein interactions | 80117 | 117 | 2 | 19454 | 49 |
ANK3,MARCKSL1 |
3.548e-02 | -3.34 | regulation of cytokine production involved in immune response | biological process | GO:0002718 | 120 | 2 | 18204 | 45 |
CD81,B2M |
3.563e-02 | -3.33 | response to inorganic substance | biological process | GO:0010035 | 505 | 4 | 18204 | 45 |
CAPN3,ANK3,B2M,NLGN1 |
3.565e-02 | -3.33 | PLCD3 (phospholipase C delta 3) | protein interactions | 113026 | 118 | 2 | 19454 | 49 |
OPALIN,FTL |
3.569e-02 | -3.33 | Ribonuclease A-like domain | gene3d domains | 3.10.130.10 | 15 | 1 | 14470 | 35 |
RNASE1 |
3.606e-02 | -3.32 | ERBB2 Activates PTK6 Signaling | REACTOME pathways | R-HSA-8847993 | 13 | 1 | 10285 | 29 |
ERBB4 |
3.620e-02 | -3.32 | ATG4B (autophagy related 4B cysteine peptidase) | protein interactions | 23192 | 119 | 2 | 19454 | 49 |
RPL28,RPL11 |
3.620e-02 | -3.32 | H2BC18 (H2B clustered histone 18) | protein interactions | 440689 | 119 | 2 | 19454 | 49 |
CD81,RPL11 |
3.626e-02 | -3.32 | regulation of endocytosis | biological process | GO:0030100 | 295 | 3 | 18204 | 45 |
NLGN1,ZFYVE16,B2M |
3.644e-02 | -3.31 | CysPc | smart domains | SM00230 | 15 | 1 | 9717 | 24 |
CAPN3 |
3.645e-02 | -3.31 | Cytoplasmic Ribosomal Proteins | WikiPathways | WP477 | 90 | 2 | 5310 | 18 |
RPL11,RPL28 |
3.646e-02 | -3.31 | glucocorticoid metabolic process | biological process | GO:0008211 | 15 | 1 | 18204 | 45 |
CBR1 |
3.646e-02 | -3.31 | positive regulation of ruffle assembly | biological process | GO:1900029 | 15 | 1 | 18204 | 45 |
NLGN1 |
3.646e-02 | -3.31 | negative regulation of lymphocyte migration | biological process | GO:2000402 | 15 | 1 | 18204 | 45 |
APOD |
3.646e-02 | -3.31 | synapse maturation | biological process | GO:0060074 | 15 | 1 | 18204 | 45 |
NLGN1 |
3.646e-02 | -3.31 | positive regulation of synaptic transmission, GABAergic | biological process | GO:0032230 | 15 | 1 | 18204 | 45 |
NLGN1 |
3.646e-02 | -3.31 | negative regulation of ubiquitin-protein transferase activity | biological process | GO:0051444 | 15 | 1 | 18204 | 45 |
RPL11 |
3.646e-02 | -3.31 | negative regulation of protein import into nucleus | biological process | GO:0042308 | 15 | 1 | 18204 | 45 |
APOD |
3.646e-02 | -3.31 | regulation of circadian sleep/wake cycle, sleep | biological process | GO:0045187 | 15 | 1 | 18204 | 45 |
PTGDS |
3.646e-02 | -3.31 | negative regulation of axon regeneration | biological process | GO:0048681 | 15 | 1 | 18204 | 45 |
SPP1 |
3.647e-02 | -3.31 | RnaseA | pfam domains | PF00074 | 15 | 1 | 17795 | 44 |
RNASE1 |
3.647e-02 | -3.31 | Peptidase_C2 | pfam domains | PF00648 | 15 | 1 | 17795 | 44 |
CAPN3 |
3.656e-02 | -3.31 | acute_lymphoblastic_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_leukaemia | 2197 | 11 | 16828 | 47 |
MARCKSL1,AUTS2,SPP1,NKX6-2,CNDP1,ERBB4,NRXN3,ANK3,ZNF565,LAMA2,PLLP |
3.670e-02 | -3.31 | Nanoparticle triggered regulated necrosis | WikiPathways | WP2513 | 11 | 1 | 5310 | 18 |
FTL |
3.672e-02 | -3.30 | ZU5 | prosite domains | PS51145 | 13 | 1 | 12186 | 35 |
ANK3 |
3.672e-02 | -3.30 | CARBOXYLESTERASE_B_2 | prosite domains | PS00941 | 13 | 1 | 12186 | 35 |
NLGN1 |
3.676e-02 | -3.30 | ELP3 (elongator acetyltransferase complex subunit 3) | protein interactions | 55140 | 120 | 2 | 19454 | 49 |
ZFYVE16,FTL |
3.676e-02 | -3.30 | ZDHHC15 (zinc finger DHHC-type palmitoyltransferase 15) | protein interactions | 158866 | 120 | 2 | 19454 | 49 |
PLLP,LAMA2 |
3.678e-02 | -3.30 | Ribosome, eukaryotes | KEGG pathways | hsa_M00177 | 91 | 2 | 7161 | 24 |
RPL28,RPL11 |
3.678e-02 | -3.30 | Ribosome, eukaryotes | KEGG pathways | M00177 | 91 | 2 | 7161 | 24 |
RPL11,RPL28 |
3.713e-02 | -3.29 | RNA nuclease activity | molecular function | GO:0004540 | 128 | 2 | 18094 | 43 |
RNASEK,RNASE1 |
3.714e-02 | -3.29 | SLC28A2 (solute carrier family 28 member 2) | protein interactions | 9153 | 15 | 1 | 19454 | 49 |
EMC10 |
3.714e-02 | -3.29 | COQ10B (coenzyme Q10B) | protein interactions | 80219 | 15 | 1 | 19454 | 49 |
FTL |
3.714e-02 | -3.29 | MYH15 (myosin heavy chain 15) | protein interactions | 22989 | 15 | 1 | 19454 | 49 |
FTL |
3.714e-02 | -3.29 | RNASE13 (ribonuclease A family member 13 (inactive)) | protein interactions | 440163 | 15 | 1 | 19454 | 49 |
APOD |
3.714e-02 | -3.29 | CAPN13 (calpain 13) | protein interactions | 92291 | 15 | 1 | 19454 | 49 |
CAPN3 |
3.714e-02 | -3.29 | PLEKHM2 (pleckstrin homology and RUN domain containing M2) | protein interactions | 23207 | 15 | 1 | 19454 | 49 |
CBR1 |
3.714e-02 | -3.29 | Cry1 (cryptochrome circadian regulator 1) | protein interactions | 12952 | 15 | 1 | 19454 | 49 |
ANK3 |
3.714e-02 | -3.29 | TMEM255B (transmembrane protein 255B) | protein interactions | 348013 | 15 | 1 | 19454 | 49 |
PLXDC2 |
3.714e-02 | -3.29 | DEPDC7 (DEP domain containing 7) | protein interactions | 91614 | 15 | 1 | 19454 | 49 |
APOD |
3.714e-02 | -3.29 | Emc6 (ER membrane protein complex subunit 6) | protein interactions | 66048 | 15 | 1 | 19454 | 49 |
EMC10 |
3.714e-02 | -3.29 | protein localization to organelle | biological process | GO:0033365 | 752 | 5 | 18204 | 45 |
EMC10,RPL11,CD81,ERBB4,ZFYVE16 |
3.715e-02 | -3.29 | CD81 (CD81 molecule) | protein interactions | 975 | 292 | 3 | 19454 | 49 |
CD81,CD9,RPL11 |
3.732e-02 | -3.29 | HASPIN (histone H3 associated protein kinase) | protein interactions | 83903 | 121 | 2 | 19454 | 49 |
RPL28,MARCKSL1 |
3.737e-02 | -3.29 | NAD+ nucleotidase, cyclic ADP-ribose generating | molecular function | GO:0061809 | 16 | 1 | 18094 | 43 |
IL1RAPL1 |
3.737e-02 | -3.29 | cGMP binding | molecular function | GO:0030553 | 16 | 1 | 18094 | 43 |
PDE5A |
3.741e-02 | -3.29 | RNaseA_domain | interpro domains | IPR023412 | 15 | 1 | 18521 | 47 |
RNASE1 |
3.741e-02 | -3.29 | Peptidase_C2_calpain_cat | interpro domains | IPR001300 | 15 | 1 | 18521 | 47 |
CAPN3 |
3.741e-02 | -3.29 | RNaseA-like_dom_sf | interpro domains | IPR036816 | 15 | 1 | 18521 | 47 |
RNASE1 |
3.767e-02 | -3.28 | nucleotide catabolic process | biological process | GO:0009166 | 124 | 2 | 18204 | 45 |
PDE5A,ENO4 |
3.767e-02 | -3.28 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | 265 | 3 | 16828 | 47 |
LAMA2,B2M,NRXN3 |
3.782e-02 | -3.27 | regulation of cellular component biogenesis | biological process | GO:0044087 | 1016 | 6 | 18204 | 45 |
APOD,NLGN1,IL1RAPL1,AUTS2,FCHSD2,LRRTM3 |
3.788e-02 | -3.27 | ZNF768 (zinc finger protein 768) | protein interactions | 79724 | 122 | 2 | 19454 | 49 |
RPL28,RPL11 |
3.788e-02 | -3.27 | A2ML1 (alpha-2-macroglobulin like 1) | protein interactions | 144568 | 122 | 2 | 19454 | 49 |
PPP2R2B,FTH1 |
3.810e-02 | -3.27 | regulation of vesicle-mediated transport | biological process | GO:0060627 | 516 | 4 | 18204 | 45 |
IL1RAPL1,NLGN1,ZFYVE16,B2M |
3.822e-02 | -3.26 | cellular component assembly involved in morphogenesis | biological process | GO:0010927 | 125 | 2 | 18204 | 45 |
CD9,CAPN3 |
3.822e-02 | -3.26 | cellular anatomical entity morphogenesis | biological process | GO:0032989 | 125 | 2 | 18204 | 45 |
CAPN3,CD9 |
3.844e-02 | -3.26 | CSNK1E (casein kinase 1 epsilon) | protein interactions | 1454 | 296 | 3 | 19454 | 49 |
DBNDD2,PPP1R14A,FTL |
3.844e-02 | -3.26 | STAT5B (signal transducer and activator of transcription 5B) | protein interactions | 6777 | 123 | 2 | 19454 | 49 |
CBR1,ERBB4 |
3.844e-02 | -3.26 | NAMPT (nicotinamide phosphoribosyltransferase) | protein interactions | 10135 | 123 | 2 | 19454 | 49 |
FTL,CD81 |
3.865e-02 | -3.25 | asymmetric, glutamatergic, excitatory synapse | cellular component | GO:0098985 | 16 | 1 | 19108 | 47 |
NLGN1 |
3.865e-02 | -3.25 | node of Ranvier | cellular component | GO:0033268 | 16 | 1 | 19108 | 47 |
ANK3 |
3.876e-02 | -3.25 | RPL36AL (ribosomal protein L36a like) | protein interactions | 6166 | 297 | 3 | 19454 | 49 |
FTL,RPL28,RPL11 |
3.876e-02 | -3.25 | H2BC9 (H2B clustered histone 9) | protein interactions | 8345 | 297 | 3 | 19454 | 49 |
PDE5A,LAMA2,CD81 |
3.878e-02 | -3.25 | cytoplasmic translation | biological process | GO:0002181 | 126 | 2 | 18204 | 45 |
RPL28,RPL11 |
3.878e-02 | -3.25 | Degradation of the extracellular matrix | REACTOME pathways | R-HSA-1474228 | 111 | 2 | 10285 | 29 |
CAPN3,SPP1 |
3.878e-02 | -3.25 | SHC1 events in ERBB4 signaling | REACTOME pathways | R-HSA-1250347 | 14 | 1 | 10285 | 29 |
ERBB4 |
3.878e-02 | -3.25 | TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | REACTOME pathways | R-HSA-6803205 | 14 | 1 | 10285 | 29 |
BCL2L14 |
3.882e-02 | -3.25 | LamNT | smart domains | SM00136 | 16 | 1 | 9717 | 24 |
LAMA2 |
3.883e-02 | -3.25 | RAF1 (Raf-1 proto-oncogene, serine/threonine kinase) | protein interactions | 5894 | 1845 | 9 | 19454 | 49 |
DAD1,CTNNA2,MARCKSL1,FTH1,ANK3,CAPN3,OPALIN,PPP2R2B,FTL |
3.884e-02 | -3.25 | negative regulation of neuron projection regeneration | biological process | GO:0070571 | 16 | 1 | 18204 | 45 |
SPP1 |
3.884e-02 | -3.25 | peptide antigen assembly with MHC class II protein complex | biological process | GO:0002503 | 16 | 1 | 18204 | 45 |
B2M |
3.884e-02 | -3.25 | positive regulation of cell fate commitment | biological process | GO:0010455 | 16 | 1 | 18204 | 45 |
NKX6-2 |
3.884e-02 | -3.25 | negative regulation of focal adhesion assembly | biological process | GO:0051895 | 16 | 1 | 18204 | 45 |
APOD |
3.884e-02 | -3.25 | G1 to G0 transition | biological process | GO:0070314 | 16 | 1 | 18204 | 45 |
CAPN3 |
3.884e-02 | -3.25 | regulation of receptor binding | biological process | GO:1900120 | 16 | 1 | 18204 | 45 |
B2M |
3.884e-02 | -3.25 | MHC class II protein complex assembly | biological process | GO:0002399 | 16 | 1 | 18204 | 45 |
B2M |
3.884e-02 | -3.25 | negative regulation of cell-substrate junction organization | biological process | GO:0150118 | 16 | 1 | 18204 | 45 |
APOD |
3.884e-02 | -3.25 | regulation of cell communication by electrical coupling | biological process | GO:0010649 | 16 | 1 | 18204 | 45 |
ANK3 |
3.885e-02 | -3.25 | Laminin_N | pfam domains | PF00055 | 16 | 1 | 17795 | 44 |
LAMA2 |
3.885e-02 | -3.25 | EF-hand_1 | pfam domains | PF00036 | 16 | 1 | 17795 | 44 |
CAPN3 |
3.887e-02 | -3.25 | beta-Alanine Metabolism | SMPDB pathways | SMP0000007 | 9 | 1 | 1369 | 6 |
CNDP1 |
3.887e-02 | -3.25 | Carnosinuria- Carnosinemia | SMPDB pathways | SMP0000493 | 9 | 1 | 1369 | 6 |
CNDP1 |
3.887e-02 | -3.25 | GABA-Transaminase Deficiency | SMPDB pathways | SMP0000351 | 9 | 1 | 1369 | 6 |
CNDP1 |
3.901e-02 | -3.24 | ZNF622 (zinc finger protein 622) | protein interactions | 90441 | 124 | 2 | 19454 | 49 |
RPL11,FTL |
3.909e-02 | -3.24 | C1orf35 (chromosome 1 open reading frame 35) | protein interactions | 79169 | 298 | 3 | 19454 | 49 |
RPL11,FTL,CBR1 |
3.910e-02 | -3.24 | angioimmunoblastic_T_cell_lymphoma | COSMIC cancer mutations | angioimmunoblastic_T_cell_lymphoma | 269 | 3 | 16828 | 47 |
NRXN3,B2M,LAMA2 |
3.914e-02 | -3.24 | POLY (polyprotein;protein F) | protein interactions | 951475 | 510 | 4 | 19454 | 49 |
CD81,FTH1,RPL28,RPL11 |
3.925e-02 | -3.24 | muscle structure development | biological process | GO:0061061 | 521 | 4 | 18204 | 45 |
CD81,CAPN3,LAMA2,CD9 |
3.934e-02 | -3.24 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | biological process | GO:0002824 | 127 | 2 | 18204 | 45 |
CD81,B2M |
3.956e-02 | -3.23 | SLC8A3 (solute carrier family 8 member A3) | protein interactions | 6547 | 16 | 1 | 19454 | 49 |
APOD |
3.956e-02 | -3.23 | TUBE1 (tubulin epsilon 1) | protein interactions | 51175 | 16 | 1 | 19454 | 49 |
CD81 |
3.956e-02 | -3.23 | CAPN6 (calpain 6) | protein interactions | 827 | 16 | 1 | 19454 | 49 |
CAPN3 |
3.956e-02 | -3.23 | TMEM134 (transmembrane protein 134) | protein interactions | 80194 | 16 | 1 | 19454 | 49 |
ERBB4 |
3.956e-02 | -3.23 | CR2 (complement C3d receptor 2) | protein interactions | 1380 | 16 | 1 | 19454 | 49 |
CD81 |
3.956e-02 | -3.23 | RNF122 (ring finger protein 122) | protein interactions | 79845 | 16 | 1 | 19454 | 49 |
PLLP |
3.956e-02 | -3.23 | SAPCD1 (suppressor APC domain containing 1) | protein interactions | 401251 | 16 | 1 | 19454 | 49 |
CTNNA2 |
3.956e-02 | -3.23 | CDH12 (cadherin 12) | protein interactions | 1010 | 16 | 1 | 19454 | 49 |
CTNNA2 |
3.956e-02 | -3.23 | ORM2 (orosomucoid 2) | protein interactions | 5005 | 16 | 1 | 19454 | 49 |
PPP2R2B |
3.958e-02 | -3.23 | TAP1 (transporter 1, ATP binding cassette subfamily B member) | protein interactions | 6890 | 125 | 2 | 19454 | 49 |
OPALIN,B2M |
3.958e-02 | -3.23 | GPRASP2 (G protein-coupled receptor associated sorting protein 2) | protein interactions | 114928 | 125 | 2 | 19454 | 49 |
FCHSD2,RPL28 |
3.958e-02 | -3.23 | SCGB1D1 (secretoglobin family 1D member 1) | protein interactions | 10648 | 125 | 2 | 19454 | 49 |
EMC10,APOD |
3.963e-02 | -3.23 | basal part of cell | cellular component | GO:0045178 | 307 | 3 | 19108 | 47 |
ERBB4,ANK3,CD81 |
3.966e-02 | -3.23 | oxidoreductase activity, acting on metal ions | molecular function | GO:0016722 | 17 | 1 | 18094 | 43 |
FTH1 |
3.966e-02 | -3.23 | dipeptidase activity | molecular function | GO:0016805 | 17 | 1 | 18094 | 43 |
CNDP1 |
3.966e-02 | -3.23 | membrane insertase activity | molecular function | GO:0032977 | 17 | 1 | 18094 | 43 |
EMC10 |
3.966e-02 | -3.23 | calcium-dependent cysteine-type endopeptidase activity | molecular function | GO:0004198 | 17 | 1 | 18094 | 43 |
CAPN3 |
3.985e-02 | -3.22 | Laminin_N | interpro domains | IPR008211 | 16 | 1 | 18521 | 47 |
LAMA2 |
3.987e-02 | -3.22 | ORF7b (ORF7b) | protein interactions | 43740574 | 751 | 5 | 19454 | 49 |
CTNNA2,DAD1,B2M,TRIM59,CD81 |
3.990e-02 | -3.22 | regulation of protein binding | biological process | GO:0043393 | 128 | 2 | 18204 | 45 |
B2M,RPL11 |
3.997e-02 | -3.22 | Iron metabolism in placenta | WikiPathways | WP2007 | 12 | 1 | 5310 | 18 |
FTH1 |
4.009e-02 | -3.22 | RPL35 (ribosomal protein L35) | protein interactions | 11224 | 514 | 4 | 19454 | 49 |
RPL11,RPL28,FTL,CD81 |
4.016e-02 | -3.21 | IGKC (immunoglobulin kappa constant) | protein interactions | 3514 | 126 | 2 | 19454 | 49 |
FTH1,PPP2R2B |
4.016e-02 | -3.21 | PAK1IP1 (PAK1 interacting protein 1) | protein interactions | 55003 | 126 | 2 | 19454 | 49 |
RPL11,RPL28 |
4.016e-02 | -3.21 | NMNAT1 (nicotinamide nucleotide adenylyltransferase 1) | protein interactions | 64802 | 126 | 2 | 19454 | 49 |
RPL11,RNASE1 |
4.035e-02 | -3.21 | skin-chest-malignant_melanoma | COSMIC cancer mutations | skin-chest-malignant_melanoma | 114 | 2 | 16828 | 47 |
B2M,ERBB4 |
4.046e-02 | -3.21 | positive regulation of lymphocyte mediated immunity | biological process | GO:0002708 | 129 | 2 | 18204 | 45 |
B2M,CD81 |
4.069e-02 | -3.20 | Z disc | cellular component | GO:0030018 | 130 | 2 | 19108 | 47 |
CAPN3,ANK3 |
4.074e-02 | -3.20 | SLC35C2 (solute carrier family 35 member C2) | protein interactions | 51006 | 127 | 2 | 19454 | 49 |
PLLP,APOD |
4.074e-02 | -3.20 | SEC22A (SEC22 homolog A, vesicle trafficking protein) | protein interactions | 26984 | 127 | 2 | 19454 | 49 |
TRIM59,RNASEK |
4.074e-02 | -3.20 | CSNK1G3 (casein kinase 1 gamma 3) | protein interactions | 1456 | 127 | 2 | 19454 | 49 |
PPP1R14A,DBNDD2 |
4.074e-02 | -3.20 | ATP6V0A2 (ATPase H+ transporting V0 subunit a2) | protein interactions | 23545 | 127 | 2 | 19454 | 49 |
MARCKSL1,FTH1 |
4.102e-02 | -3.19 | MHC class II protein complex | cellular component | GO:0042613 | 17 | 1 | 19108 | 47 |
B2M |
4.102e-02 | -3.19 | protein complex involved in cell-matrix adhesion | cellular component | GO:0098637 | 17 | 1 | 19108 | 47 |
LAMA2 |
4.102e-02 | -3.19 | platelet alpha granule membrane | cellular component | GO:0031092 | 17 | 1 | 19108 | 47 |
CD9 |
4.102e-02 | -3.19 | inhibitory synapse | cellular component | GO:0060077 | 17 | 1 | 19108 | 47 |
NLGN1 |
4.104e-02 | -3.19 | negative regulation of cell adhesion | biological process | GO:0007162 | 310 | 3 | 18204 | 45 |
PDE5A,CD9,APOD |
4.122e-02 | -3.19 | T cell mediated cytotoxicity | biological process | GO:0001913 | 17 | 1 | 18204 | 45 |
B2M |
4.122e-02 | -3.19 | cGMP metabolic process | biological process | GO:0046068 | 17 | 1 | 18204 | 45 |
PDE5A |
4.122e-02 | -3.19 | regulation of receptor clustering | biological process | GO:1903909 | 17 | 1 | 18204 | 45 |
CD81 |
4.122e-02 | -3.19 | mammary gland epithelial cell differentiation | biological process | GO:0060644 | 17 | 1 | 18204 | 45 |
ERBB4 |
4.122e-02 | -3.19 | cell migration in hindbrain | biological process | GO:0021535 | 17 | 1 | 18204 | 45 |
CTNNA2 |
4.122e-02 | -3.19 | positive regulation of neurotransmitter secretion | biological process | GO:0001956 | 17 | 1 | 18204 | 45 |
NLGN1 |
4.122e-02 | -3.19 | regulation of lipoprotein metabolic process | biological process | GO:0050746 | 17 | 1 | 18204 | 45 |
APOD |
4.122e-02 | -3.19 | tail-anchored membrane protein insertion into ER membrane | biological process | GO:0071816 | 17 | 1 | 18204 | 45 |
EMC10 |
4.122e-02 | -3.19 | positive regulation of homotypic cell-cell adhesion | biological process | GO:0034112 | 17 | 1 | 18204 | 45 |
ANK3 |
4.130e-02 | -3.19 | regulation of protein metabolic process | biological process | GO:0051246 | 2218 | 10 | 18204 | 45 |
APOD,CNDP1,CAPN3,ITM2B,CD81,RPL11,LRRTM3,DBNDD2,ERBB4,ITM2A |
4.132e-02 | -3.19 | POLR2M (RNA polymerase II subunit M) | protein interactions | 81488 | 128 | 2 | 19454 | 49 |
FTL,APOD |
4.134e-02 | -3.19 | RIBONUCLEASE | prints domains | PR00794 | 10 | 1 | 5227 | 22 |
RNASE1 |
4.135e-02 | -3.19 | SRP-dependent cotranslational protein targeting to membrane | REACTOME pathways | R-HSA-1799339 | 115 | 2 | 10285 | 29 |
RPL28,RPL11 |
4.150e-02 | -3.18 | ERBB2 Regulates Cell Motility | REACTOME pathways | R-HSA-6785631 | 15 | 1 | 10285 | 29 |
ERBB4 |
4.160e-02 | -3.18 | response to calcium ion | biological process | GO:0051592 | 131 | 2 | 18204 | 45 |
NLGN1,CAPN3 |
4.162e-02 | -3.18 | CDK2 (cyclin dependent kinase 2) | protein interactions | 1017 | 760 | 5 | 19454 | 49 |
APOD,RPL28,MARCKSL1,RPL11,DAD1 |
4.194e-02 | -3.17 | GABA receptor binding | molecular function | GO:0050811 | 18 | 1 | 18094 | 43 |
ERBB4 |
4.198e-02 | -3.17 | C1QTNF8 (C1q and TNF related 8) | protein interactions | 390664 | 17 | 1 | 19454 | 49 |
APOD |
4.198e-02 | -3.17 | CAMTA2 (calmodulin binding transcription activator 2) | protein interactions | 23125 | 17 | 1 | 19454 | 49 |
FTL |
4.198e-02 | -3.17 | TMEM174 (transmembrane protein 174) | protein interactions | 134288 | 17 | 1 | 19454 | 49 |
PLLP |
4.198e-02 | -3.17 | PAX4 (paired box 4) | protein interactions | 5078 | 17 | 1 | 19454 | 49 |
NRXN3 |
4.198e-02 | -3.17 | SHD (Src homology 2 domain containing transforming protein D) | protein interactions | 56961 | 17 | 1 | 19454 | 49 |
ERBB4 |
4.198e-02 | -3.17 | SCN1B (sodium voltage-gated channel beta subunit 1) | protein interactions | 6324 | 17 | 1 | 19454 | 49 |
ANK3 |
4.198e-02 | -3.17 | ALKBH2 (alkB homolog 2, alpha-ketoglutarate dependent dioxygenase) | protein interactions | 121642 | 17 | 1 | 19454 | 49 |
FTL |
4.198e-02 | -3.17 | ZDHHC22 (zinc finger DHHC-type palmitoyltransferase 22) | protein interactions | 283576 | 17 | 1 | 19454 | 49 |
TRIM59 |
4.198e-02 | -3.17 | RGPD2 (RANBP2 like and GRIP domain containing 2) | protein interactions | 729857 | 17 | 1 | 19454 | 49 |
B2M |
4.201e-02 | -3.17 | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | 1425 | 8 | 16828 | 47 |
CADM2,LRRTM3,AUTS2,RPL11,B2M,CBR1,ANKUB1,ANK3 |
4.201e-02 | -3.17 | nasopharyngeal_carcinoma | COSMIC cancer mutations | nasopharyngeal_carcinoma | 1425 | 8 | 16828 | 47 |
CADM2,LRRTM3,AUTS2,RPL11,CBR1,B2M,ANKUB1,ANK3 |
4.225e-02 | -3.16 | CALPAIN_CAT | prosite domains | PS50203 | 15 | 1 | 12186 | 35 |
CAPN3 |
4.226e-02 | -3.16 | human chr2q34 | chromosome location | human chr2q34 | 23 | 1 | 26134 | 49 |
ERBB4 |
4.237e-02 | -3.16 | regulation of developmental growth | biological process | GO:0048638 | 314 | 3 | 18204 | 45 |
ERBB4,SPP1,CAPN3 |
4.239e-02 | -3.16 | tRNA Charging: Cysteine | SMPDB pathways | SMP0111860 | 79 | 2 | 1369 | 6 |
RPL28,RPL11 |
4.239e-02 | -3.16 | tRNA Charging: Asparagine | SMPDB pathways | SMP0111854 | 79 | 2 | 1369 | 6 |
RPL11,RPL28 |
4.239e-02 | -3.16 | tRNA Charging: Proline | SMPDB pathways | SMP0112609 | 79 | 2 | 1369 | 6 |
RPL11,RPL28 |
4.239e-02 | -3.16 | tRNA Charging: Arginine | SMPDB pathways | SMP0111853 | 79 | 2 | 1369 | 6 |
RPL28,RPL11 |
4.239e-02 | -3.16 | tRNA Charging: Serine | SMPDB pathways | SMP0119294 | 79 | 2 | 1369 | 6 |
RPL11,RPL28 |
4.239e-02 | -3.16 | tRNA Charging: Glutamine | SMPDB pathways | SMP0111862 | 79 | 2 | 1369 | 6 |
RPL11,RPL28 |
4.239e-02 | -3.16 | tRNA Charging: Glutamic Acid | SMPDB pathways | SMP0111864 | 79 | 2 | 1369 | 6 |
RPL28,RPL11 |
4.239e-02 | -3.16 | tRNA Charging: Histidine | SMPDB pathways | SMP0111871 | 79 | 2 | 1369 | 6 |
RPL11,RPL28 |
4.239e-02 | -3.16 | tRNA Charging: Leucine | SMPDB pathways | SMP0111873 | 79 | 2 | 1369 | 6 |
RPL28,RPL11 |
4.239e-02 | -3.16 | tRNA Charging: Isoleucine | SMPDB pathways | SMP0111872 | 79 | 2 | 1369 | 6 |
RPL11,RPL28 |
4.239e-02 | -3.16 | tRNA Charging: Valine | SMPDB pathways | SMP0119305 | 79 | 2 | 1369 | 6 |
RPL28,RPL11 |
4.239e-02 | -3.16 | tRNA Charging: Lysine | SMPDB pathways | SMP0111874 | 79 | 2 | 1369 | 6 |
RPL11,RPL28 |
4.239e-02 | -3.16 | tRNA Charging: Glycine | SMPDB pathways | SMP0111870 | 79 | 2 | 1369 | 6 |
RPL28,RPL11 |
4.239e-02 | -3.16 | tRNA Charging: Aspartic Acid | SMPDB pathways | SMP0111858 | 79 | 2 | 1369 | 6 |
RPL28,RPL11 |
4.239e-02 | -3.16 | tRNA Charging: Tryptophan | SMPDB pathways | SMP0119303 | 79 | 2 | 1369 | 6 |
RPL28,RPL11 |
4.239e-02 | -3.16 | tRNA Charging: Alanine | SMPDB pathways | SMP0100356 | 79 | 2 | 1369 | 6 |
RPL28,RPL11 |
4.239e-02 | -3.16 | tRNA Charging: Tyrosine | SMPDB pathways | SMP0119304 | 79 | 2 | 1369 | 6 |
RPL28,RPL11 |
4.239e-02 | -3.16 | tRNA Charging: Threonine | SMPDB pathways | SMP0119302 | 79 | 2 | 1369 | 6 |
RPL28,RPL11 |
4.239e-02 | -3.16 | tRNA Charging: Methionine | SMPDB pathways | SMP0111875 | 79 | 2 | 1369 | 6 |
RPL11,RPL28 |
4.249e-02 | -3.16 | NRBP1 (nuclear receptor binding protein 1) | protein interactions | 29959 | 130 | 2 | 19454 | 49 |
PLXDC2,ITM2B |
4.249e-02 | -3.16 | PIGR (polymeric immunoglobulin receptor) | protein interactions | 5284 | 130 | 2 | 19454 | 49 |
RPL11,LAMA2 |
4.266e-02 | -3.15 | GTP hydrolysis and joining of the 60S ribosomal subunit | REACTOME pathways | R-HSA-72706 | 117 | 2 | 10285 | 29 |
RPL28,RPL11 |
4.266e-02 | -3.15 | L13a-mediated translational silencing of Ceruloplasmin expression | REACTOME pathways | R-HSA-156827 | 117 | 2 | 10285 | 29 |
RPL28,RPL11 |
4.276e-02 | -3.15 | positive regulation of adaptive immune response | biological process | GO:0002821 | 133 | 2 | 18204 | 45 |
CD81,B2M |
4.276e-02 | -3.15 | nucleoside phosphate catabolic process | biological process | GO:1901292 | 133 | 2 | 18204 | 45 |
ENO4,PDE5A |
4.280e-02 | -3.15 | negative regulation of cellular process | biological process | GO:0048523 | 5320 | 19 | 18204 | 45 |
ITM2A,DBNDD2,ERBB4,NKX6-2,PDE5A,CTNNA2,CAPN3,APOD,DAD1,SPP1,CD9,TRIM59,IL1RAPL1,ANK3,ITM2B,NLGN1,B2M,PTGDS,FTH1 |
4.292e-02 | -3.15 | postsynaptic density | cellular component | GO:0014069 | 317 | 3 | 19108 | 47 |
ERBB4,LRRTM3,NLGN1 |
4.308e-02 | -3.14 | BIK (BCL2 interacting killer) | protein interactions | 638 | 131 | 2 | 19454 | 49 |
PLLP,APOD |
4.323e-02 | -3.14 | Osteopontin Signaling | WikiPathways | WP1434 | 13 | 1 | 5310 | 18 |
SPP1 |
4.338e-02 | -3.14 | costamere | cellular component | GO:0043034 | 18 | 1 | 19108 | 47 |
ANK3 |
4.338e-02 | -3.14 | protein phosphatase type 2A complex | cellular component | GO:0000159 | 18 | 1 | 19108 | 47 |
PPP2R2B |
4.357e-02 | -3.13 | FU | smart domains | SM00261 | 18 | 1 | 9717 | 24 |
ERBB4 |
4.359e-02 | -3.13 | coated vesicle | cellular component | GO:0030135 | 319 | 3 | 19108 | 47 |
RNASEK,CD9,B2M |
4.359e-02 | -3.13 | positive regulation of circadian rhythm | biological process | GO:0042753 | 18 | 1 | 18204 | 45 |
NLGN1 |
4.359e-02 | -3.13 | negative regulation of voltage-gated potassium channel activity | biological process | GO:1903817 | 18 | 1 | 18204 | 45 |
ANK3 |
4.359e-02 | -3.13 | positive regulation of T cell receptor signaling pathway | biological process | GO:0050862 | 18 | 1 | 18204 | 45 |
CD81 |
4.359e-02 | -3.13 | antigen processing and presentation of peptide antigen via MHC class Ib | biological process | GO:0002428 | 18 | 1 | 18204 | 45 |
B2M |
4.359e-02 | -3.13 | positive regulation of type 2 immune response | biological process | GO:0002830 | 18 | 1 | 18204 | 45 |
CD81 |
4.359e-02 | -3.13 | positive regulation of sodium ion transmembrane transport | biological process | GO:1902307 | 18 | 1 | 18204 | 45 |
ANK3 |
4.359e-02 | -3.13 | negative regulation of platelet activation | biological process | GO:0010544 | 18 | 1 | 18204 | 45 |
CD9 |
4.359e-02 | -3.13 | neuron projection arborization | biological process | GO:0140058 | 18 | 1 | 18204 | 45 |
NLGN1 |
4.359e-02 | -3.13 | regulation of delayed rectifier potassium channel activity | biological process | GO:1902259 | 18 | 1 | 18204 | 45 |
ANK3 |
4.367e-02 | -3.13 | HAL (histidine ammonia-lyase) | protein interactions | 3034 | 132 | 2 | 19454 | 49 |
PPP2R2B,FTH1 |
4.367e-02 | -3.13 | IVL (involucrin) | protein interactions | 3713 | 132 | 2 | 19454 | 49 |
FTH1,PPP2R2B |
4.392e-02 | -3.13 | positive regulation of production of molecular mediator of immune response | biological process | GO:0002702 | 135 | 2 | 18204 | 45 |
B2M,CD81 |
4.420e-02 | -3.12 | GRB2 events in ERBB2 signaling | REACTOME pathways | R-HSA-1963640 | 16 | 1 | 10285 | 29 |
ERBB4 |
4.420e-02 | -3.12 | PI3K events in ERBB2 signaling | REACTOME pathways | R-HSA-1963642 | 16 | 1 | 10285 | 29 |
ERBB4 |
4.422e-02 | -3.12 | alkali metal ion binding | molecular function | GO:0031420 | 19 | 1 | 18094 | 43 |
CAPN3 |
4.422e-02 | -3.12 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | molecular function | GO:0016894 | 19 | 1 | 18094 | 43 |
RNASE1 |
4.440e-02 | -3.11 | ARL17A (ADP ribosylation factor like GTPase 17A) | protein interactions | 51326 | 18 | 1 | 19454 | 49 |
FTL |
4.440e-02 | -3.11 | GNG7 (G protein subunit gamma 7) | protein interactions | 2788 | 18 | 1 | 19454 | 49 |
CD81 |
4.440e-02 | -3.11 | CNDP1 (carnosine dipeptidase 1) | protein interactions | 84735 | 18 | 1 | 19454 | 49 |
CNDP1 |
4.440e-02 | -3.11 | SNX25 (sorting nexin 25) | protein interactions | 83891 | 18 | 1 | 19454 | 49 |
NDUFC2 |
4.440e-02 | -3.11 | CYTB (cytochrome b) | protein interactions | 4519 | 18 | 1 | 19454 | 49 |
CLDND1 |
4.440e-02 | -3.11 | ACAP1 (ArfGAP with coiled-coil, ankyrin repeat and PH domains 1) | protein interactions | 9744 | 18 | 1 | 19454 | 49 |
FCHSD2 |
4.440e-02 | -3.11 | SERTAD4 (SERTA domain containing 4) | protein interactions | 56256 | 18 | 1 | 19454 | 49 |
PPP2R2B |
4.440e-02 | -3.11 | NAALADL2 (N-acetylated alpha-linked acidic dipeptidase like 2) | protein interactions | 254827 | 18 | 1 | 19454 | 49 |
ITM2B |
4.440e-02 | -3.11 | LRRC4 (leucine rich repeat containing 4) | protein interactions | 64101 | 18 | 1 | 19454 | 49 |
SPP1 |
4.440e-02 | -3.11 | AP1S3 (adaptor related protein complex 1 subunit sigma 3) | protein interactions | 130340 | 18 | 1 | 19454 | 49 |
FTL |
4.440e-02 | -3.11 | LRRTM2 (leucine rich repeat transmembrane neuronal 2) | protein interactions | 26045 | 18 | 1 | 19454 | 49 |
DAD1 |
4.440e-02 | -3.11 | TSPAN1 (tetraspanin 1) | protein interactions | 10103 | 18 | 1 | 19454 | 49 |
CD9 |
4.440e-02 | -3.11 | PTGFR (prostaglandin F receptor) | protein interactions | 5737 | 18 | 1 | 19454 | 49 |
PTGDS |
4.440e-02 | -3.11 | RHBDL1 (rhomboid like 1) | protein interactions | 9028 | 18 | 1 | 19454 | 49 |
APOD |
4.440e-02 | -3.11 | tRNA Charging: Phenylalanine | SMPDB pathways | SMP0111876 | 81 | 2 | 1369 | 6 |
RPL11,RPL28 |
4.466e-02 | -3.11 | Nonsense-Mediated Decay (NMD) | REACTOME pathways | R-HSA-927802 | 120 | 2 | 10285 | 29 |
RPL28,RPL11 |
4.466e-02 | -3.11 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | REACTOME pathways | R-HSA-975957 | 120 | 2 | 10285 | 29 |
RPL11,RPL28 |
4.473e-02 | -3.11 | Furin_repeat | interpro domains | IPR006212 | 18 | 1 | 18521 | 47 |
ERBB4 |
4.487e-02 | -3.10 | H3-7 (H3.7 histone (putative)) | protein interactions | 440686 | 134 | 2 | 19454 | 49 |
LAMA2,PPP2R2B |
4.487e-02 | -3.10 | HSPB2 (heat shock protein family B (small) member 2) | protein interactions | 3316 | 134 | 2 | 19454 | 49 |
B2M,RPL11 |
4.487e-02 | -3.10 | TENT4B (terminal nucleotidyltransferase 4B) | protein interactions | 64282 | 134 | 2 | 19454 | 49 |
RPL11,RPL28 |
4.500e-02 | -3.10 | LAMININ_NTER | prosite domains | PS51117 | 16 | 1 | 12186 | 35 |
LAMA2 |
4.510e-02 | -3.10 | cell recognition | biological process | GO:0008037 | 137 | 2 | 18204 | 45 |
CD9,CD81 |
4.531e-02 | -3.09 | clathrin-coated vesicle membrane | cellular component | GO:0030665 | 138 | 2 | 19108 | 47 |
RNASEK,CD9 |
4.533e-02 | -3.09 | Selenoamino acid metabolism | REACTOME pathways | R-HSA-2408522 | 121 | 2 | 10285 | 29 |
RPL11,RPL28 |
4.547e-02 | -3.09 | MTNR1B (melatonin receptor 1B) | protein interactions | 4544 | 135 | 2 | 19454 | 49 |
CLDND1,FTL |
4.574e-02 | -3.08 | filopodium tip | cellular component | GO:0032433 | 19 | 1 | 19108 | 47 |
NLGN1 |
4.574e-02 | -3.08 | intraciliary transport particle B | cellular component | GO:0030992 | 19 | 1 | 19108 | 47 |
TRIM59 |
4.585e-02 | -3.08 | human chr10q21.3 | chromosome location | human chr10q21.3 | 25 | 1 | 26134 | 49 |
LRRTM3 |
4.592e-02 | -3.08 | SAR1A (secretion associated Ras related GTPase 1A) | protein interactions | 56681 | 318 | 3 | 19454 | 49 |
PLLP,RPL28,CD81 |
4.595e-02 | -3.08 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex | KEGG pathways | M00147 | 14 | 1 | 7161 | 24 |
NDUFC2 |
4.595e-02 | -3.08 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex | KEGG pathways | hsa_M00147 | 14 | 1 | 7161 | 24 |
NDUFC2 |
4.596e-02 | -3.08 | positive regulation of cellular senescence | biological process | GO:2000774 | 19 | 1 | 18204 | 45 |
B2M |
4.596e-02 | -3.08 | regulation of synaptic vesicle endocytosis | biological process | GO:1900242 | 19 | 1 | 18204 | 45 |
NLGN1 |
4.596e-02 | -3.08 | positive regulation of bone resorption | biological process | GO:0045780 | 19 | 1 | 18204 | 45 |
SPP1 |
4.596e-02 | -3.08 | vocalization behavior | biological process | GO:0071625 | 19 | 1 | 18204 | 45 |
NRXN3 |
4.596e-02 | -3.08 | excitatory synapse assembly | biological process | GO:1904861 | 19 | 1 | 18204 | 45 |
NLGN1 |
4.596e-02 | -3.08 | regulation of protein neddylation | biological process | GO:2000434 | 19 | 1 | 18204 | 45 |
RPL11 |
4.597e-02 | -3.08 | TIR | pfam domains | PF01582 | 19 | 1 | 17795 | 44 |
IL1RAPL1 |
4.608e-02 | -3.08 | DNTTIP2 (deoxynucleotidyltransferase terminal interacting protein 2) | protein interactions | 30836 | 136 | 2 | 19454 | 49 |
SPP1,RPL28 |
4.608e-02 | -3.08 | NIBAN2 (niban apoptosis regulator 2) | protein interactions | 64855 | 136 | 2 | 19454 | 49 |
OPALIN,PPP2R2B |
4.617e-02 | -3.08 | Neutrophil degranulation | REACTOME pathways | R-HSA-6798695 | 487 | 4 | 10285 | 29 |
FTL,NDUFC2,FTH1,B2M |
4.629e-02 | -3.07 | positive regulation of cation transmembrane transport | biological process | GO:1904064 | 139 | 2 | 18204 | 45 |
CAPN3,ANK3 |
4.653e-02 | -3.07 | negative regulation of biological process | biological process | GO:0048519 | 5737 | 20 | 18204 | 45 |
ANK3,ITM2B,FTH1,PTGDS,NLGN1,B2M,RPL11,CAPN3,ITM2A,ERBB4,DBNDD2,NKX6-2,CTNNA2,PDE5A,IL1RAPL1,DAD1,APOD,TRIM59,CD9,SPP1 |
4.669e-02 | -3.06 | GNA13 (G protein subunit alpha 13) | protein interactions | 10672 | 137 | 2 | 19454 | 49 |
CD81,CLDND1 |
4.669e-02 | -3.06 | DCTN4 (dynactin subunit 4) | protein interactions | 51164 | 137 | 2 | 19454 | 49 |
RPL11,RPL28 |
4.672e-02 | -3.06 | human chr19q13.33 | chromosome location | human chr19q13.33 | 184 | 2 | 26134 | 49 |
FTL,EMC10 |
4.681e-02 | -3.06 | HTR4 (5-hydroxytryptamine receptor 4) | protein interactions | 3360 | 19 | 1 | 19454 | 49 |
CD81 |
4.681e-02 | -3.06 | SLC44A5 (solute carrier family 44 member 5) | protein interactions | 204962 | 19 | 1 | 19454 | 49 |
CLDND1 |
4.681e-02 | -3.06 | PLA2G4E (phospholipase A2 group IVE) | protein interactions | 123745 | 19 | 1 | 19454 | 49 |
PPP2R2B |
4.681e-02 | -3.06 | SPINK7 (serine peptidase inhibitor Kazal type 7) | protein interactions | 84651 | 19 | 1 | 19454 | 49 |
FTL |
4.681e-02 | -3.06 | ZNF532 (zinc finger protein 532) | protein interactions | 55205 | 19 | 1 | 19454 | 49 |
ERBB4 |
4.681e-02 | -3.06 | CABLES2 (Cdk5 and Abl enzyme substrate 2) | protein interactions | 81928 | 19 | 1 | 19454 | 49 |
FTL |
4.681e-02 | -3.06 | TPGS2 (tubulin polyglutamylase complex subunit 2) | protein interactions | 25941 | 19 | 1 | 19454 | 49 |
FTL |
4.681e-02 | -3.06 | SIT1 (signaling threshold regulating transmembrane adaptor 1) | protein interactions | 27240 | 19 | 1 | 19454 | 49 |
ITM2A |
4.681e-02 | -3.06 | CCR9 (C-C motif chemokine receptor 9) | protein interactions | 10803 | 19 | 1 | 19454 | 49 |
CD81 |
4.681e-02 | -3.06 | LRRC42 (leucine rich repeat containing 42) | protein interactions | 115353 | 19 | 1 | 19454 | 49 |
PLXDC2 |
4.681e-02 | -3.06 | LRRTM3 (leucine rich repeat transmembrane neuronal 3) | protein interactions | 347731 | 19 | 1 | 19454 | 49 |
NRXN3 |
4.681e-02 | -3.06 | HMGCLL1 (3-hydroxy-3-methylglutaryl-CoA lyase like 1) | protein interactions | 54511 | 19 | 1 | 19454 | 49 |
FTH1 |
4.681e-02 | -3.06 | RTTN (rotatin) | protein interactions | 25914 | 19 | 1 | 19454 | 49 |
OPALIN |
4.681e-02 | -3.06 | INPP4A (inositol polyphosphate-4-phosphatase type I A) | protein interactions | 3631 | 19 | 1 | 19454 | 49 |
CD81 |
4.689e-02 | -3.06 | B3GNT2 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2) | protein interactions | 10678 | 541 | 4 | 19454 | 49 |
RPL28,CBR1,RNASE1,RPL11 |
4.699e-02 | -3.06 | protein localization | biological process | GO:0008104 | 1954 | 9 | 18204 | 45 |
ZFYVE16,NLGN1,EMC10,FCHSD2,ERBB4,ANK3,RPL11,CAPN3,CD81 |
4.715e-02 | -3.05 | H1-2 (H1.2 linker histone, cluster member) | protein interactions | 3006 | 542 | 4 | 19454 | 49 |
LAMA2,RPL11,RPL28,CD81 |
4.715e-02 | -3.05 | PDEase | interpro domains | IPR023088 | 19 | 1 | 18521 | 47 |
PDE5A |
4.718e-02 | -3.05 | stomach-adenocarcinoma | COSMIC cancer mutations | stomach-adenocarcinoma | 4101 | 17 | 16828 | 47 |
ITM2B,CAPN3,B2M,NLGN1,IL1RAPL1,LRRTM3,FTH1,LAMA2,ERBB4,NRXN3,ANK3,PDE5A,NKX6-2,AUTS2,PLXDC2,PPP2R2B,BCL2L14 |
4.719e-02 | -3.05 | positive regulation of cell-cell adhesion | biological process | GO:0022409 | 328 | 3 | 18204 | 45 |
B2M,CD81,ANK3 |
4.730e-02 | -3.05 | NDUFA10 (NADH:ubiquinone oxidoreductase subunit A10) | protein interactions | 4705 | 138 | 2 | 19454 | 49 |
PLXDC2,NDUFC2 |
4.730e-02 | -3.05 | SIDT2 (SID1 transmembrane family member 2) | protein interactions | 51092 | 138 | 2 | 19454 | 49 |
NDUFC2,CLDND1 |
4.735e-02 | -3.05 | SRP72 (signal recognition particle 72) | protein interactions | 6731 | 322 | 3 | 19454 | 49 |
RPL28,FCHSD2,RPL11 |
4.735e-02 | -3.05 | ITGB1 (integrin subunit beta 1) | protein interactions | 3688 | 322 | 3 | 19454 | 49 |
SPP1,CD9,CD81 |
4.737e-02 | -3.05 | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | REACTOME pathways | R-HSA-198933 | 124 | 2 | 10285 | 29 |
B2M,CD81 |
4.792e-02 | -3.04 | LHFPL5 (LHFPL tetraspan subfamily member 5) | protein interactions | 222662 | 139 | 2 | 19454 | 49 |
PLLP,CD81 |
4.803e-02 | -3.04 | cellular macromolecule localization | biological process | GO:0070727 | 1962 | 9 | 18204 | 45 |
EMC10,NLGN1,ZFYVE16,CAPN3,RPL11,CD81,ANK3,ERBB4,FCHSD2 |
4.806e-02 | -3.04 | Cap-dependent Translation Initiation | REACTOME pathways | R-HSA-72737 | 125 | 2 | 10285 | 29 |
RPL11,RPL28 |
4.806e-02 | -3.04 | Eukaryotic Translation Initiation | REACTOME pathways | R-HSA-72613 | 125 | 2 | 10285 | 29 |
RPL11,RPL28 |
4.827e-02 | -3.03 | plasma membrane bounded cell projection | cellular component | GO:0120025 | 2285 | 10 | 19108 | 47 |
RPL28,FCHSD2,LAMA2,AUTS2,ANK3,CADM2,NLGN1,IL1RAPL1,APOD,CTNNA2 |
4.832e-02 | -3.03 | mammary gland lobule development | biological process | GO:0061377 | 20 | 1 | 18204 | 45 |
ERBB4 |
4.832e-02 | -3.03 | regulation of collateral sprouting | biological process | GO:0048670 | 20 | 1 | 18204 | 45 |
SPP1 |
4.832e-02 | -3.03 | response to magnesium ion | biological process | GO:0032026 | 20 | 1 | 18204 | 45 |
ANK3 |
4.832e-02 | -3.03 | response to salt stress | biological process | GO:0009651 | 20 | 1 | 18204 | 45 |
CAPN3 |
4.832e-02 | -3.03 | transport of virus | biological process | GO:0046794 | 20 | 1 | 18204 | 45 |
RNASEK |
4.832e-02 | -3.03 | positive regulation of amyloid-beta formation | biological process | GO:1902004 | 20 | 1 | 18204 | 45 |
LRRTM3 |
4.832e-02 | -3.03 | mammary gland alveolus development | biological process | GO:0060749 | 20 | 1 | 18204 | 45 |
ERBB4 |
4.842e-02 | -3.03 | endomembrane system organization | biological process | GO:0010256 | 558 | 4 | 18204 | 45 |
CD9,ANK3,RNASEK,EMC10 |
4.845e-02 | -3.03 | asymmetric synapse | cellular component | GO:0032279 | 333 | 3 | 19108 | 47 |
NLGN1,LRRTM3,ERBB4 |
4.890e-02 | -3.02 | I band | cellular component | GO:0031674 | 144 | 2 | 19108 | 47 |
CAPN3,ANK3 |
4.916e-02 | -3.01 | NCAPD3 (non-SMC condensin II complex subunit D3) | protein interactions | 23310 | 141 | 2 | 19454 | 49 |
OPALIN,BCL2L14 |
4.916e-02 | -3.01 | ACP3 (acid phosphatase 3) | protein interactions | 55 | 141 | 2 | 19454 | 49 |
FTH1,PPP2R2B |
4.921e-02 | -3.01 | SERF1A (small EDRK-rich factor 1A) | protein interactions | 8293 | 20 | 1 | 19454 | 49 |
RNASEK |
4.921e-02 | -3.01 | TTBK2 (tau tubulin kinase 2) | protein interactions | 146057 | 20 | 1 | 19454 | 49 |
FTL |
4.921e-02 | -3.01 | RNF183 (ring finger protein 183) | protein interactions | 138065 | 20 | 1 | 19454 | 49 |
PTGDS |
4.921e-02 | -3.01 | ATAT1 (alpha tubulin acetyltransferase 1) | protein interactions | 79969 | 20 | 1 | 19454 | 49 |
FTL |
4.921e-02 | -3.01 | GGT1 (gamma-glutamyltransferase 1) | protein interactions | 2678 | 20 | 1 | 19454 | 49 |
CD81 |
4.921e-02 | -3.01 | CLEC5A (C-type lectin domain containing 5A) | protein interactions | 23601 | 20 | 1 | 19454 | 49 |
DAD1 |
4.921e-02 | -3.01 | IL36A (interleukin 36 alpha) | protein interactions | 27179 | 20 | 1 | 19454 | 49 |
PPP2R2B |
4.921e-02 | -3.01 | C2orf73 (chromosome 2 open reading frame 73) | protein interactions | 129852 | 20 | 1 | 19454 | 49 |
FCHSD2 |
4.921e-02 | -3.01 | CCDC158 (coiled-coil domain containing 158) | protein interactions | 339965 | 20 | 1 | 19454 | 49 |
FCHSD2 |
4.921e-02 | -3.01 | MYL3 (myosin light chain 3) | protein interactions | 4634 | 20 | 1 | 19454 | 49 |
FTH1 |
4.921e-02 | -3.01 | LBP (lipopolysaccharide binding protein) | protein interactions | 3929 | 20 | 1 | 19454 | 49 |
FTH1 |
4.921e-02 | -3.01 | SYPL2 (synaptophysin like 2) | protein interactions | 284612 | 20 | 1 | 19454 | 49 |
PLLP |
4.931e-02 | -3.01 | regulated exocytosis | biological process | GO:0045055 | 144 | 2 | 18204 | 45 |
PTGDS,NLGN1 |
4.940e-02 | -3.01 | INTRLKN1R1F | prints domains | PR01537 | 12 | 1 | 5227 | 22 |
IL1RAPL1 |
4.943e-02 | -3.01 | human chr2p12 | chromosome location | human chr2p12 | 27 | 1 | 26134 | 49 |
CTNNA2 |
4.943e-02 | -3.01 | human chr4q26 | chromosome location | human chr4q26 | 27 | 1 | 26134 | 49 |
PDE5A |
4.960e-02 | -3.00 | cGMP effects | REACTOME pathways | R-HSA-418457 | 18 | 1 | 10285 | 29 |
PDE5A |
4.962e-02 | -3.00 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain | gene3d domains | 1.10.1300.10 | 21 | 1 | 14470 | 35 |
PDE5A |
4.962e-02 | -3.00 | Tie2 ligand-binding domain superfamily | gene3d domains | 2.170.300.10 | 21 | 1 | 14470 | 35 |
LAMA2 |
4.969e-02 | -3.00 | Extracellular matrix organization | REACTOME pathways | R-HSA-1474244 | 296 | 3 | 10285 | 29 |
CAPN3,SPP1,LAMA2 |
4.978e-02 | -3.00 | NDUFAF1 (NADH:ubiquinone oxidoreductase complex assembly factor 1) | protein interactions | 51103 | 142 | 2 | 19454 | 49 |
PPP2R2B,NDUFC2 |
4.983e-02 | -3.00 | RIOK1 (RIO kinase 1) | protein interactions | 83732 | 552 | 4 | 19454 | 49 |
RPL11,PPP1R14A,RPL28,CBR1 |
4.992e-02 | -3.00 | olefinic compound metabolic process | biological process | GO:0120254 | 145 | 2 | 18204 | 45 |
CBR1,PTGDS |